UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM N-CSR

 

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

 

Investment Company Act file number             811-06526            

 

Boston Trust Walden Funds
(Exact name of registrant as specified in charter)
 

  One Beacon Street, Boston MA   02108  
  (Address of principal executive offices)   (Zip code)  
         

4400 Easton Commons, Suite 200, Columbus, OH 43219
(Name and address of agent for service)

 

Registrant’s telephone number, including area code: 1-800-282-8782

 

Date of fiscal year end: December 31

 

Date of reporting period: December 31, 2020

 

 

 

 

 

 

Item 1. Reports to Stockholders.

 

 

 

 

Annual Report

December 31, 2020

 

 

 

 

Boston Trust Asset Management Fund

Boston Trust Equity Fund

Boston Trust Midcap Fund

Boston Trust SMID Cap Fund

Boston Trust Walden Balanced Fund

(formerly known as the Walden Balanced Fund)

Boston Trust Walden Equity Fund

(formerly known as the Walden Equity Fund)

Boston Trust Walden Midcap Fund

(formerly known as the Walden Midcap Fund)

Boston Trust Walden SMID Cap Fund

(formerly known as the Walden SMID Cap Fund)  

Boston Trust Walden Small Cap Fund

Boston Trust Walden International Equity Fund

(formerly known as the Walden International Equity Fund)

 

 

 

This page is intentionally left blank.

 

 

 

Table of Contents Annual Report
  December 31, 2019

 

Boston Trust Asset Management Fund  
Manager Commentary 2
Investment Performance 3
Schedule of Portfolio Investments 8
Financial Statements 10
Financial Highlights 12
   
Boston Trust Equity Fund  
Manager Commentary 2
Investment Performance 3
Schedule of Portfolio Investments 13
Financial Statements 14
Financial Highlights 16
   
Boston Trust Midcap Fund  
Manager Commentary 4
Investment Performance 5
Schedule of Portfolio Investments 17
Financial Statements 19
FinancialHighlights 21
   
Boston Trust SMID Cap Fund  
Manager Commentary 6
Investment Performance 7
Schedule of Portfolio Investments 22
Financial Statements 24
Financial Highlights 26
   
Annual ESG Report 27
   
Boston Trust Walden Balanced Fund  
Manager Commentary 28
Investment Performance 29
Schedule of Portfolio Investments 38
Financial Statements 41
Financial Highlights 43
   
Boston Trust Walden Equity Fund  
Manager Commentary 28
Investment Performance 29
Schedule of Portfolio Investments 44
Financial Statements 45
Financial Statements 47
   
Boston Trust Walden Midcap Fund  
Manager Commentary 30
Investment Performance 31
Schedule of Portfolio Investments 48
Financial Statements 49
Financial Highlights 51
   
Boston Trust Walden SMID Cap Fund  
Manager Commentary 32
Investment Performance 33
Schedule of Portfolio Investments 52
Financial Statements 53
Financial Highlights 55
   
Boston Trust Walden Small Cap Fund  
Manager Commentary 34
Investment Performance 35
Schedule of Portfolio Investments 56
Financial Statements 58
Financial Highlights 60
   
Boston Trust Walden International Equity Fund  
Manager Commentary 36
Investment Performance 37
Schedule of Portfolio Investments 61
Financial Statements 63
Financial Highlights 65
   
Notes to the Financial Statements 66
Report of Independent Registered Public Accounting Firm 75
Supplementary Information 77
Investment Adviser Contract Approval 83
Information about Trustees and Officers 85

 

Boston Trust Walden Inc., a subsidiary of Boston Trust Walden Company, serves as investment adviser (the “Adviser”) to the Boston Trust Walden Funds and receives a fee for its services. Boston Trust Walden Company provides certain administrative, operational, and investment support functions for the Adviser and is paid a fee for these services by the Adviser.

 

Shares of the Funds are not deposits of, obligations of, or guaranteed by Boston Trust Walden Company or its affiliates, nor are they federally insured by the FDIC. Investments in the Funds involve investment risks, including the possible loss of principal. Funds are distributed by Foreside Financial Services, LLC.

 

The foregoing information and opinions are for general information only. The Boston Trust Walden Funds and Boston Trust Walden Company do not assume liability for any loss, which may result from the reliance by any person upon any such information or opinions. Such information and opinions are subject to change without notice, are for general information only, and are not intended as an offer or solicitation with respect to the purchase or sale of any security or offering individual or personalized investment advice. Portfolio composition is as of December 31, 2020 and is subject to change without notice.

 

The Boston Trust Walden Funds may invest in foreign securities, which may involve risk not typically associated with U.S. investments.

 

To reduce expenses, we may only mail one copy of the Funds’ shareholder updates, such as their prospectus, annual report, and semi-annual report, to those addresses shared by two or more accounts. If you are a direct shareholder and wish to receive individual copies of these documents, please call us at 1-800- 282-8782 x7050. If you are not a direct shareholder, please contact your financial institution to opt out of householding. We will begin sending you individual copies thirty days after receiving your request.

 

Important Notice: The Securities and Exchange Commission will permit funds to deliver shareholder reports electronically beginning January 1, 2021. At that time, the Boston Trust Walden Funds will send a notice, either by mail or email, each time your fund’s updated report is available on our website (www.bostontrustwalden.com). Investors enrolled in electronic delivery will receive the notice by email with links to the updated report. Investors who are not enrolled in electronic delivery by January 1, 2021 will receive the notice in the mail. All investors who prefer to receive shareholder reports in paper may, at any time, choose that option free of charge by calling 1-800-282-8782 x7050.

 

1 

 

 

Boston Trust Asset Management Fund
Boston Trust Equity Fund 
December 31, 2020

Domenic Colasacco, CFA

Lead Portfolio Manager

 

Amy Crandall Kaser, CFP®

Portfolio Manager

 

Jason T. O’Connell, CFA, CAIA, CFP®

Portfolio Manager

 

Boston Trust Walden Inc.

 

Asset Management Fund Objective

The Fund seeks long-term capital growth and income through an actively managed portfolio of stocks, bonds and money market instruments.

 

Equity Fund Objective 

The Fund seeks long-term growth of capital through an actively managed portfolio of stocks.

 

Investment Concerns 

Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.

 

Foreign investing involves risks not typically associated with U.S. investments, including adverse political, social and economic developments and differing auditing and legal standards. These risks are magnified in emerging markets.

 

Small- to mid-capitalization companies typically have a higher risk of failure and historically have experienced a greater degree of volatility.

 

Bonds offer a relatively stable level of income, although bond prices will fluctuate, providing the potential for principal gain or loss. Intermediate-term, higher quality bonds generally offer less risk than longer-term bonds and a lower rate of return.

 

Cash equivalents offer low risk and low return potential.

 

Manager Commentary (Unaudited)

 

Management Discussion of Fund Performance

Stocks, as measured by the S&P 500 Index, rose by 18.40% in 2020, a remarkable outcome in its own right but more striking when considering the Index declined by one third during the first quarter of the year. Bond indices also advanced, with the Bloomberg Barclays U.S. Government/Credit Bond Index posting a total return of 8.93%. The rise in value of the Boston Trust Asset Management Fund and the Boston Trust Equity Fund was more muted compared to the rapid rise in many stock indices. For the 12-month period ended December 31, 2020, the Boston Trust Asset Management Fund posted a total return of 7.83%, while the Boston Trust Equity Fund had a total return of 14.53%.

 

Despite the prevailing turmoil associated with the Coronavirus (COVID-19) pandemic, we remained confident that the crisis would pass eventually. Yet the unknowable depth and duration of the pandemic, and the extent of the associated damage to overall business conditions, led us to assume a more conservative investment position in the Boston Trust Asset Management Fund. For the first time in nearly a decade, we decided to reduce the Fund’s equity allocation closer to the middle, rather than retain equities near the upper end of its specified policy range. We concluded that an equity allocation closer to 60% more prudently reflected the combination of clear near-term economic risks with our core confidence in a return to more normal conditions in time.

 

As time went on, economic reports suggested that the aggressive fiscal and monetary policy initiatives taken by the federal government had succeeded in removing the worst-case economic scenarios feared broadly in March, 2020. With the full benefit of hindsight, it became clear as well that the pandemic had aided rather than hurt operating conditions of many businesses, in particular those in the distribution and technology sectors that facilitated logistics and communication in our suddenly less mobile society. The cohort of stocks that led the market recovery included several of the giant technology-related companies but also a myriad of newer, less proven companies with, in some cases, astounding expectations for future growth. The Funds had sufficient exposure in the better-situated companies to participate in the market recovery. However, we remained disciplined in our approach and determined it was prudent to avoid what we judged to be more speculative securities, despite the fact that they were enjoying significant stock price momentum. Performance was aided by our decision to increase the Boston Trust Asset Management Fund’s equity allocation gradually through the summer and fall months closer to 70% of total asset value as our confidence in the resilience of the economy improved.*

 

Looking back, the Funds’ performance for 2020 may have been several percentage points higher had we taken more risk through the year—first by ignoring the pandemic related uncertainty in March, and later by including newer, less proven companies in the portfolio even though their stock valuations were at extreme levels. However, in each Fund’s long life, 2020 was not the first year when our lower risk approach was not rewarded. Nor is it likely to be the last. Yet we remain confident that the balanced, more prudent investment process we have followed since the Funds’ inception will continue to serve shareholders well over the longer term.

 

As we begin a new year, none of us know if another exogenous event may develop in 2021, or the actual business and political paths that lie ahead. With most stock indices at or near record highs, however, it is reasonable to assume that investors generally expect broad-based economic improvement through the year, with the adverse impact of the pandemic effectively behind us by next summer or fall. Strong gains in overall corporate profits, with continued low inflation and near-zero interest rates, also appear to be embedded in current aggregate stock values. Stocks generally are not undervalued at this time by virtually any traditional metric, but history suggests that overall equity values are likely to continue to trend higher in an environment of rising employment, corporate profits, and overall gross domestic product1, which we expect through the year. Despite our general optimism about trends in overall equity values, we prefer to continue to avoid the stocks of companies with extreme valuations and overly optimistic estimates of future business performance. In our experience, most of these newer companies will fail to achieve the business success embedded in current stock prices, disappointing their shareholders. Within the equity segment, we have focused instead on companies with a long history of profitability and business models that are tested against the usual competitive forces that surface eventually in every industry.*

 

 

* Portfolio composition is subject to change.

 

1 The Gross Domestic Product (GDP) is the value of goods and services produced in a given country in a given year.

 

2 

 

 

Investment Performance (Unaudited) Boston Trust Asset Management Fund
  Boston Trust Equity Fund
  December 31, 2020

 

    For the periods ended 12/31/20  
    Average Annual Total Returns  
                                                      Since       Since  
                                                      Inception       Inception  
      1 Year       3 Years       5 Years       10 Years       15 Years       20 Years       (12/1/95)     (10/1/03)
Boston Trust Asset Management Fund     7.83 %     10.10 %     11.20 %     9.81 %     8.32 %     7.30 %     8.39 %      
Boston Trust Equity Fund     14.53 %     13.71 %     14.72 %     12.11 %     9.57 %                 9.51 %
S&P 500 Index     18.40 %     14.18 %     15.22 %     13.88 %     9.88 %     7.47 %     9.60 %     10.08 %
Bloomberg Barclays U.S. Government/Credit Bond Index     8.93 %     5.97 %     4.98 %     4.19 %     4.64 %     5.01 %     5.28 %     4.41 %
FTSE 3 Month US T-Bill Index     0.58 %     1.56 %     1.16 %     0.60 %     1.16 %     1.43 %     2.19 %     1.27 %

 

Hypothetical Growth of a $100,000 Investment

 

 

The above charts represent a 10-year hypothetical $100,000 investment in the Boston Trust Asset Management Fund and the Boston Trust Equity Fund, and includes the reinvestment of dividends and capital gains in the Funds. The returns shown on the table and the graphs do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

 

The Boston Trust Asset Management Fund is measured against a combination of equity and fixed income indices. The Boston Trust Equity Fund is measured against the Standard & Poor’s 500 Index (“S&P 500”), which is widely regarded as a gauge of the U.S. equities market, includes 500 leading companies in leading industries of the U.S. economy. Although the S&P 500 focuses on the large-cap segment of the market, with approximately 75% coverage of U.S. equities, it is also widely viewed as a proxy for the total market. The Bloomberg Barclays U.S. Government/Credit Index includes Treasuries (i.e., public obligations of the U.S. Treasury that have remaining maturities of more than one year), government-related issues (e.g., agency, sovereign, supranational, and local authority debt), and USD Corporates. The Bloomberg Barclays U.S. Government/Credit Bond Index is a component of the Bloomberg Barclays U.S. Aggregate Bond Index. The FTSE 3 Month US T-Bill Index reflects monthly return equivalents of yield averages that are not marked to the market. The index is an average of the last three-month treasury bill issues. The three-month treasury bills are the short-term debt obligations of the U.S. Government. The indexes are unmanaged and their performance does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Funds’ performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 

Boston Trust Asset Management Fund

 

Fund Net Asset Value:   $ 56.29  
Gross Expense Ratio1:     0.90 %

 

Boston Trust Equity Fund

 

Fund Net Asset Value:   $ 32.89  
Gross Expense Ratio1:     0.91 %

 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

 

 
1 The Gross Expense Ratio is from each Fund’s most recent prospectus, dated May 1, 2020. Additional information pertaining to each Fund’s expense ratio as of December 31, 2020 can be found in the financial highlights included in this report.

  

3 

 

 

Boston Trust Midcap Fund

December 31, 2020

 

Stephen J. Amyouny, CFA

Lead Portfolio Manager

 

Richard Q. Williams, CFA

Portfolio Manager

 

Mark Zagata, CFA

Portfolio Manager

 

Boston Trust Walden Inc.

 

Fund Objective

The Fund seeks long-term capital growth through an actively managed portfolio of stocks of middle capitalization (“mid cap”) companies.

 

Investment Concerns

Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.

 

Mid cap funds typically carry additional risks since smaller companies generally have a higher risk of failure.

 

Manager Commentary (Unaudited)

 

Management Discussion of Fund Performance

The fourth quarter performance capped off a strong year for the Russell Midcap® Index (“Index”), which finished the year 17% higher than where it started in 2020, even with the 27.07% decline in the first quarter. Indeed, from the market trough in late March, the Index advanced nearly 90%. Even though the Boston Trust Midcap Fund outperformed the Index return (-24.25% versus -27.07%) during the first quarter decline, the Fund’s total return of 8.81% for the 12-month period ended December 31, 2020 trailed the Index by a wide margin.

 

It should perhaps not be surprising that the Fund failed to keep up in the strong market rally of the second, third, and fourth quarters of 2020. In contrast to the fourth quarter where our emphasis on quality and value detracted from results, the Fund’s full year underperformance stemmed primarily from maintaining our valuation discipline. That said, despite the in-line performance of high-quality stocks in general, it is worth highlighting the relative outperformance of loss making entities over profitable peers, which was stunning: loss-makers1 outperformed profitable companies by more than 60%. Loss-making entities also now comprise 10% of Index value. Given the Fund is entirely invested in stocks of profitable companies, avoiding the loss-making cohort explains much of the relative underperformance.

 

Outlook

Entering 2021, we can point to several reasons for the optimism that propelled the Index to new all-time highs in the fourth quarter. Among them included: the success in clinical trials and initial distribution of several Coronavirus (COVID-19) vaccines; continued economic recovery supported by significant monetary and fiscal stimuli; somewhat less political uncertainty following the presidential election; and historically low interest rates. However, we also continue to see risk in the current environment: a surge of COVID-19 case counts that is leading to new restrictions on economic activity; a fragile economic recovery still dependent on monetary and fiscal support; and continuing evidence of speculative activity among investors. We believe valuation risk in the market overall to be elevated.

 

While we do not seek to gain an edge through market timing, we continue to believe that over the long term stock prices ultimately reflect company fundamentals. We do not believe investors will perpetually favor as a group companies that cannot consistently generate profits or free cash flow and yet trade at elevated valuation multiples of sales. Of course, some of these individual companies will emerge as high-quality industry leaders. However, not all, or even a majority of them will succeed. As such, we continue to emphasize in our research and portfolio management activities those companies that have a demonstrated history of profitability, stability, and growth, have sustainable business models, high quality of earnings, and that are trading at reasonable valuations. As of December 31, 2020, the Fund exhibited strong financial characteristics and a more reasonable valuation profile than the Index. As a result, we continue to believe the Fund may provide favorable risk-adjusted returns over the long term.*

 

 

* Portfolio composition is subject to change.

 

1 Loss-makers are defined as companies with five-year cumulative EBIT (earnings before interest and taxes) less than $0.

 

4 

 

 

Investment Performance (Unaudited) Boston Trust Midcap Fund
  December 31, 2020

 

    For the periods ended 12/31/20  
    Average Annual Total Returns  
                                    Since  
                                    Inception  
    1 Year     3 Years     5 Years     10 Years     (09/24/07)
Boston Trust Midcap Fund1     8.81 %     10.58 %     12.72 %     11.25 %     9.74 %
Russell Midcap® Index     17.10 %     11.61 %     13.40 %     12.41 %     9.26 %

 

Hypothetical Growth of a $100,000 Investment

 

 

 

The above chart represents a 10-year hypothetical $100,000 investment in the Boston Trust Midcap Fund, and includes the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

 

The Boston Trust Midcap Fund is measured against the Russell Midcap® Index, which is an unmanaged index that tracks the performance of the mid-cap segment of the U.S. equity universe. The Russell Midcap® Index is a subset of the Russell 1000® Index. It includes approximately 800 of the smallest securities based on a combination of their market capitalization and current index membership. The Russell Midcap® Index represents approximately 31% of the total market capitalization of the Russell 1000 companies. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 

Fund Net Asset Value:   $ 21.02  
Gross Expense Ratio1:     1.04 %

 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. Returns less than one year are not annualized. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

 

 
1 The Gross Expense Ratio is from the Fund’s most recent prospectus, dated May 1, 2020. The contractual fee limit under the Fund’s expense limitation agreement is 1.00% of the Fund’s average annual net assets, subject to certain limitations as described in the Fund’s prospectus. Additional information pertaining to the Fund’s expense ratio as of December 31, 2020 can be found in the financial highlights included in this report. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through May 1, 2021 and may be renewed thereafter.

  

5 

 

 

Boston Trust SMID Cap Fund

December 31, 2020

 

Kenneth P. Scott, CFA

Lead Portfolio Manager

 

Richard Q. Williams, CFA

Portfolio Manager

 

Leanne Moore

Portfolio Manager

 

Boston Trust Walden Inc.

 

Fund Objective

The Fund seeks long-term capital growth through an actively managed portfolio of stocks of small to middle capitalization (“smid cap”) companies.

 

Investment Concerns

Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.

 

Smid cap companies typically have a higher risk of failure and historically have experienced a greater degree of volatility.

 

Manager Commentary (Unaudited)

 

Management Discussion of Fund Performance

The fourth quarter performance capped off a year of superlatives for the Russell 2500™ Index (“Index”), which finished the year 20% higher than where it started in 2020, despite the 29.72% decline in the first quarter. Indeed, from the market trough in late March, the Index doubled in value. Even with the outperformance of the Fund during the first quarter drawdown (-25.42% versus -29.72%), the Fund’s total return of 8.26% for the 12-month period ended December 31, 2020 underperformed the Index by a wide margin.

 

It should perhaps not be surprising that the Fund failed to keep up in the strong market rally of the second, third, and fourth quarters of 2020. But to reiterate a theme consistent throughout the year, the underperformance was largely due to style: stocks of higher quality companies, particularly the more reasonably valued cohort, underperformed the overall index by a wide margin, and the Fund performed similarly. The performance gap between stocks of profitable and unprofitable companies was stunning: loss-makers1 outperformed by more than 65%. Loss-making entities also now comprise 18% of the index’s value. Given the Fund is entirely invested in stocks of profitable companies, the “allocation” effect of avoiding the loss-making cohort presented headwinds too strong to overcome, even with execution of our approach that was consistent with expectations.

 

Outlook

Entering 2021, we can point to several reasons for the optimism that has propelled the Index to new all-time highs in the fourth quarter. Among them included: the success in clinical trials and initial distribution of several Coronavirus (COVID-19) vaccines; continued economic recovery; somewhat less political uncertainty following the U.S. presidential election; and historically low interest rates. However, we also continue to see some risks in the current environment: a new surge of COVID-19 case counts that is leading to new restrictions on economic activity; a fragile economic recovery still dependent on monetary and fiscal support; and continuing evidence of speculative activity among investors. We believe valuation risk in the market overall to be elevated.

 

While we do not seek to gain an edge through market timing, we continue to believe that over the long term stock prices ultimately reflect company fundamentals. We do not believe investors will perpetually favor as a group companies that cannot consistently generate profits or free cash flow and yet trade at elevated valuation multiples of sales. Of course, some of these individual companies will emerge as high-quality industry leaders. However, not all, or even a majority of them will succeed. As such, we continue to emphasize in our research and portfolio management activities those companies that have a demonstrated history of profitability, stability, and growth, have sustainable business models, high quality of earnings, and that are trading at reasonable valuations. As of December 31, 2020, the Fund exhibited strong financial characteristics and a more reasonable valuation profile than the Index. As a result, we continue to believe the Fund may provide favorable risk-adjusted returns over the long term.*

 

 

* Portfolio composition is subject to change.

 

1 Loss-makers are defined as companies with five-year cumulative EBIT (earnings before interest and taxes) less than $0.

 

6 

 

 

Investment Performance (Unaudited)   Boston Trust SMID Cap Fund
    December 31, 2020

 

    For the periods ended 12/31/20  
    Average Annual Total Returns  
                            Since  
                            Inception  
    1 Year     3 Years     5 Years     (11/30/11)
Boston Trust SMID Cap Fund1     8.26 %     9.00 %     13.00 %     11.60 %
Russell 2500TM Index     19.99 %     11.33 %     13.64 %     13.24 %

 

Hypothetical Growth of a $1,000,000 Investment

 

 

 

The above chart represents a hypothetical $1,000,000 investment in the Boston Trust SMID Cap Fund from November 30, 2011 to December 31, 2020, and includes the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and the graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

 

The Boston Trust SMID Cap Fund is measured against the Russell 2500™ Index, which is an unmanaged index that tracks the performance of the small- to mid-cap segment of the U.S. equity universe, commonly referred to as “smid” cap. The Russell 2500™ Index is a subset of the Russell 3000® Index. It includes approximately 2500 of the smallest securities based on a combination of their market cap and current index membership. Russell Investment Group is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of Russell Investment Group. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 

Fund Net Asset Value:   $ 19.23  
Gross Expense Ratio1:     0.95 %

 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. Returns less than one year are not annualized. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

 

 
1 The Gross Expense Ratio is from the Fund’s most recent prospectus, dated May 1, 2020. The contractual fee limit under the Fund’s expense limitation agreement is 0.75% of the Fund’s average annual net assets, subject to certain limitations as described in the Fund’s prospectus. Please see the Fund’s most recent prospectus for details. Additional information pertaining to the Fund’s expense ratio as of December 31, 2020 can be found in the financial highlights included in this report. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through May 1, 2021 and may be renewed thereafter.

 

7 

 

 

Schedule of Portfolio Investments   Boston Trust Asset Management Fund
December 31, 2020

 

Security Description   Shares     Fair Value ($)  
Common Stocks (72.7%)                
Communication Services (7.6%)                
Alphabet, Inc., Class A (a)     2,000       3,505,280  
Alphabet, Inc., Class C (a)     11,000       19,270,680  
Comcast Corp., Class A     200,000       10,480,000  
Facebook, Inc., Class B (a)     22,500       6,146,100  
Omnicom Group, Inc.     10,000       623,700  
Verizon Communications, Inc.     90,000       5,287,500  
              45,313,260  
Consumer Discretionary (6.1%)                
Autoliv, Inc.     20,000       1,842,000  
Lowe’s Cos., Inc.     25,000       4,012,750  
NIKE, Inc., Class B     115,000       16,269,050  
Ross Stores, Inc.     15,000       1,842,150  
Starbucks Corp.     100,000       10,698,000  
The Home Depot, Inc.     5,000       1,328,100  
The TJX Cos., Inc.     10,000       682,900  
              36,674,950  
Consumer Staples (6.7%)                
Church & Dwight Co., Inc.     50,000       4,361,500  
Costco Wholesale Corp.     40,000       15,071,200  
Diageo PLC, Sponsored ADR     25,000       3,970,250  
McCormick & Co., Inc.     40,000       3,824,000  
PepsiCo, Inc.     30,000       4,449,000  
Procter & Gamble Co. (The)     25,000       3,478,500  
Sysco Corp.     35,000       2,599,100  
The Hershey Co.     15,000       2,284,950  
              40,038,500  
Energy (1.2%)                
Chevron Corp.     20,000       1,689,000  
ConocoPhillips     25,000       999,750  
Exxon Mobil Corp.     60,000       2,473,200  
Schlumberger NV     100,000       2,183,000  
              7,344,950  
Financials (8.9%)                
American Express Co.     30,000       3,627,300  
Berkshire Hathaway, Inc., Class B (a)     22,500       5,217,075  
Chubb Ltd.     20,000       3,078,400  
Cincinnati Financial Corp.     60,000       5,242,200  
Comerica, Inc.     20,000       1,117,200  
JPMorgan Chase & Co.     85,000       10,800,950  
Moody’s Corp.     3,500       1,015,840  
Northern Trust Corp.     50,000       4,657,000  
PNC Financial Services Group, Inc.     30,000       4,470,000  
State Street Corp.     10,000       727,800  
T. Rowe Price Group, Inc.     55,000       8,326,450  
U.S. Bancorp     100,000       4,659,000  
              52,939,215  
Health Care (9.9%)                
Amgen, Inc.     10,000       2,299,200  
Becton, Dickinson & Co.     35,000       8,757,700  
Dentsply Sirona, Inc.     50,000       2,618,000  
Edwards Lifesciences Corp. (a)     105,000       9,579,150  
Henry Schein, Inc. (a)     10,000       668,600  
Johnson & Johnson     50,000       7,869,000  
Medtronic PLC     27,500       3,221,350  
Merck & Co., Inc.     50,000       4,090,000  
Mettler-Toledo International, Inc. (a)     5,000       5,698,400  
Stryker Corp.     25,000       6,126,000  
UnitedHealth Group, Inc.     17,500       6,136,900  
Waters Corp. (a)   7,500     1,855,650  
          58,919,950  
Industrials (8.2%)            
3M Co.   32,500     5,680,675  
Donaldson Co., Inc.   50,000     2,794,000  
Honeywell International, Inc.   15,000     3,190,500  
Hubbell, Inc.   42,500     6,663,575  
Illinois Tool Works, Inc.   30,000     6,116,400  
Union Pacific Corp.   45,000     9,369,900  
United Parcel Service, Inc., Class B   54,000     9,093,600  
W.W. Grainger, Inc.   15,000     6,125,100  
          49,033,750  
Information Technology (21.8%)            
Accenture PLC, Class A   67,500     17,631,675  
Apple, Inc.   300,000     39,807,000  
Automatic Data Processing, Inc.   81,000     14,272,200  
Cisco Systems, Inc.   65,000     2,908,750  
Intuit, Inc.   3,500     1,329,475  
Microsoft Corp.   145,000     32,250,900  
Oracle Corp.   100,000     6,469,000  
Visa, Inc., Class A   70,000     15,311,100  
          129,980,100  
Materials (1.4%)            
Air Products & Chemicals, Inc.   15,000     4,098,300  
AptarGroup, Inc.   32,500     4,448,925  
          8,547,225  
Utilities (0.9%)            
Eversource Energy   60,000     5,190,600  
          5,190,600  
TOTAL COMMON STOCKS (Cost $135,053,716)   433,982,500  

 

  Principal          
    Amount ($)          
Corporate Bonds (3.0%)                
                 
Communication Services (0.2%)                
Comcast Corp., 4.25%, 10/15/30, Callable 7/15/30 @ 100     900,000       1,109,106  
                 
Financials (1.6%)                
American Express Co., 2.65%, 12/2/22     1,926,000       2,011,000  
Berkshire Hathaway, Inc., 3.13%, 3/15/26, Callable 12/15/25 @ 100     2,000,000       2,235,643  
Cincinnati Financial Corp., 6.92%, 5/15/28     500,000       659,803  
JPMorgan Chase & Co., 3.90%, 7/15/25, Callable 4/15/25 @ 100     1,000,000       1,136,719  
JPMorgan Chase & Co., 4.01%, 4/23/29, Callable 4/23/28 @ 100     1,000,000       1,175,174  
Wells Fargo & Co., 3.55%, 9/29/25, MTN     2,000,000       2,247,670  
              9,466,009  
Health Care (0.2%)                
Becton, Dickinson & Co., 3.13%, 11/8/21     1,000,000       1,022,298  
                 
Industrials (0.2%)                
Hubbell, Inc., 3.50%, 2/15/28, Callable  11/15/27 @ 100     1,000,000       1,089,705  

 

See Notes to Financial Statements

 

8 

 

 

Schedule of Portfolio Investments   Boston Trust Asset Management Fund
December 31, 2020

 

 

    Principal        
Security Description   Amount ($)     Fair Value ($)  
Corporate Bonds, Continued            
             
Information Technology (0.8%)            
Apple, Inc., 3.25%, 2/23/26, Callable 11/23/25 @ 100   2,500,000     2,807,453  
Visa, Inc., 3.15%, 12/14/25, Callable 9/14/25 @ 100   2,000,000     2,245,174  
          5,052,627  
TOTAL CORPORATE BONDS (Cost $16,244,007)         17,739,745  
                 
Municipal Bonds (3.8%)                
                 
Massachusetts (3.8%)                
City of Newton Massachusetts, GO, 2.00%, 2/15/36, Callable 2/15/29 @ 100     545,000       563,334  
Commonwealth of Massachusetts Transportation Fund Revenue, Series A, 4.00%, 6/1/36, Callable 12/1/27 @ 100     500,000       591,775  
Commonwealth of Massachusetts, GO, Series C, 5.50%, 12/1/22, AGM     600,000       661,176  
Commonwealth of Massachusetts, GO, Series C, 4.00%, 7/1/31, Callable 7/1/22 @ 100     1,000,000       1,054,360  
Commonwealth of Massachusetts, GO, Series A, 5.00%, 3/1/32, Callable 3/1/24 @ 100     200,000       229,682  
Commonwealth of Massachusetts, GO, Series D, 3.00%, 5/1/35, Callable 5/1/29 @ 100 (b)     7,550,000       8,545,920  
Commonwealth of Massachusetts, GO, Series D, 3.00%, 5/1/36, Callable 5/1/29 @ 100 (b)     5,000,000       5,632,049  
Commonwealth of Massachusetts, GO, Series B, 5.00%, 4/1/37, Callable 4/1/27 @ 100     250,000       310,395  
Commonwealth of Massachusetts, GO, Series E, 4.00%, 9/1/37, Callable 9/1/25 @ 100     1,600,000       1,827,888  
Commonwealth of Massachusetts, GO, Series B, 5.00%, 7/1/38, Callable 7/1/26 @ 100     260,000       316,163  
Commonwealth of Massachusetts, GO, Series A, 5.00%, 1/1/43, Callable 1/1/28 @ 100     250,000       311,268  
Commonwealth of Massachusetts, GO, Series C, 5.00%, 5/1/46, Callable 5/1/29 @ 100     2,000,000       2,551,160  
              22,595,170  
Washington (0.0%) (c)                
State of Washington, Series A, 5.00%, 8/1/35, Callable 8/1/23 @ 100     250,000       278,508  
TOTAL MUNICIPAL BONDS (Cost $21,310,055)             22,873,678  
                 
U.S. Government & U.S. Government Agency Obligations (19.5%)                
                 
Federal Farm Credit Bank (2.3%)                
2.85%, 3/2/28     2,400,000       2,744,039  
2.95%, 1/27/25     2,000,000       2,210,943  
3.14%, 12/5/29     2,500,000       2,957,835  
3.39%, 2/1/28     2,000,000       2,358,736  
3.85%, 12/26/25     2,770,000       3,229,599  
              13,501,152  
Federal Home Loan Bank (2.6%)                
2.38%, 3/13/26     6,000,000       6,596,891  
2.50%, 12/10/27     1,500,000       1,695,340  
2.63%, 6/11/27     1,500,000       1,698,089  
2.88%, 9/13/24     2,500,000       2,742,677  
3.50%, 9/24/29     2,000,000       2,461,778  
              15,194,775  
U.S. Treasury Bill (2.1%)                
0.06%, 3/25/21             12,498,195  
                 
U.S. Treasury Note (12.5%)                
1.63%, 8/15/29             32,097,657  
2.75%, 2/15/24             43,220,313  
            75,317,970  
TOTAL U.S. GOVERNMENT & U.S. GOVERNMENT AGENCY OBLIGATIONS (Cost $109,432,127)             116,512,092  

 

    Shares          
Investment Companies (1.0%)                
                 
JPMorgan U.S. Government Money Market Fund, Capital Shares, 0.03% (d)     5,892,835       5,892,835  
TOTAL INVESTMENT COMPANIES (Cost $5,892,835)             5,892,835  
                 
Total Investments (Cost $287,932,740) — 100.0% (e)             597,000,850  
Other assets in excess of liabilities — 0.0%             11,954  
NET ASSETS — 100.0%           $ 597,012,804  

 

 

(a) Non-income producing security.

(b) These securities have been deemed illiquid and represents 2.37% of the Fund’s net assets.

(c) Represents less than 0.05%.

(d) Rate disclosed is the seven day yield as of December 31, 2020.

(e) See Federal Tax Information listed in the Notes to the Financial Statements.

 

ADR   American Depositary Receipt

AGM  Assured Guaranty Municipal Corporation

GO      General Obligation

MTN  Medium Term Note

PLC    Public Limited Company

 

See Notes to Financial Statements

 

9 

 

 

Financial Statements   Boston Trust Asset Management Fund

 

Statement of Assets and Liabilities

December 31, 2020

 

Assets:        
Investments, at fair value (cost $287,932,740)   $ 597,000,850  
Interest and dividends receivable     1,458,093  
Receivable for capital shares issued     88,346  
Prepaid expenses     22,622  
Total Assets     598,569,911  
Liabilities:        
Payable for investments purchased     775,042  
Payable for capital shares redeemed     352,282  
Accrued expenses and other liabilities:        
Investment adviser     358,365  
Administration and accounting     22,272  
Chief compliance officer     2,718  
Custodian     5,430  
Shareholder servicing fees     12,953  
Transfer agent     3,311  
Trustee     7,374  
Other     17,360  
Total Liabilities     1,557,107  
Net Assets   $ 597,012,804  
Composition of Net Assets:        
Paid in capital   $ 284,350,728  
Total distributable earnings/(loss)     312,662,076  
Net Assets   $ 597,012,804  
Shares outstanding (par value $0.01, unlimited number of shares authorized)     10,606,202  
Net Asset Value, Offering Price and Redemption price per share   $ 56.29  


 

Statement of Operations

For the year ended December 31, 2020

 

Investment Income:        
Interest   $ 3,106,909  
Dividends     7,351,806  
Total Investment Income     10,458,715  
Expenses:        
Investment adviser     4,097,254  
Administration and accounting     340,255  
Chief compliance officer     44,078  
Custodian     80,041  
Shareholder servicing     163,291  
Transfer agency     40,966  
Trustee     38,733  
Other     194,419  
Total expenses     4,999,037  
Net Expenses     4,999,037  
Net Investment Income     5,459,678  
Net Realized/Unrealized Gains (Losses) from        
Investments:        
Net realized gains from investment transactions     29,356,144  
Change in unrealized appreciation/depreciation on investments     3,371,961  
Net realized/unrealized gains (losses) on investments     32,728,105  
Change in Net Assets Resulting from Operations   $ 38,187,783  

 

See Notes to Financial Statements

 

10 

 

 

Financial Statements   Boston Trust Asset Management Fund

 

Statements of Changes in Net Assets

 

    For the year ended
December 31, 2020
    For the year ended
December 31, 2019
 
Investment Activities:                
Operations:                
Net investment income   $ 5,459,678     $ 5,405,837  
Net realized gains from investment transactions     29,356,144       6,224,056  
Change in unrealized appreciation/depreciation on investments     3,371,961       107,980,131  
Change in Net Assets Resulting from Operations     38,187,783       119,610,024  
Distributions to shareholders:                
Total Distributions     (32,394,639 )     (5,742,144 )
Change in Net Assets Resulting from distributions to shareholders     (32,394,639 )     (5,742,144 )
Capital Share Transactions:                
Proceeds from shares issued     30,212,741       50,601,734  
Proceeds from shares issued in subscriptions in-kind (a)           43,771,772  
Dividends reinvested     17,020,652       2,889,950  
Cost of shares redeemed     (79,164,955 )     (43,328,375 )
Cost of in-kind shares redeemed (a)           (5,777,713 )
Change in Net Assets Resulting from Capital Share Transactions     (31,931,562 )     48,157,368  
Change in Net Assets     (26,138,418 )     162,025,248  
Net Assets:                
Beginning of period     623,151,222       461,125,974  
End of period   $ 597,012,804     $ 623,151,222  
Share Transactions:                
Issued     563,599       1,000,119  
Issued in-kind (a)           808,358  
Reinvested     307,232       53,597  
Redeemed     (1,560,561 )     (863,743 )
Redeemed in-kind (a)           (118,834 )
Change in shares     (689,730 )     879,497  

 

 

(a) See Note 3 in Notes to Financial Statements.

 

See Notes to Financial Statements

 

11 

 

 

Financial Statements   Boston Trust Asset Management Fund

 

Financial Highlights                                  
Selected data for a share outstanding throughout the years indicated.                              

 

                            For the nine        
    For the year     For the year     For the year     For the year     months     For the year  
    ended     ended     ended     ended     ended     ended  
    December     December     December     December     December     March 31,  
    31, 2020     31, 2019     31, 2018     31, 2017     31, 2016     2016  
Net Asset Value, Beginning of Period   $ 55.17     $ 44.27     $ 46.88     $ 41.33     $ 40.92     $ 41.80  
Investment Activities:                                                
Operations:                                                
Net investment income     0.53       0.48       0.52       0.49       0.35       0.55  
Net realized/unrealized gains (losses) from investments     3.74       10.93       (1.20 )     6.22       2.18       0.92  
Total from investment activities     4.27       11.41       (0.68 )     6.71       2.53       1.47  
Dividends:                                                
Net investment income     (0.53 )     (0.48 )     (0.52 )     (0.49 )     (0.46 )     (0.57 )
Net realized gains from investments     (2.62 )     (0.03 )     (1.41 )     (0.67 )     (1.66 )     (1.78 )
Total dividends     (3.15 )     (0.51 )     (1.93 )     (1.16 )     (2.12 )     (2.35 )
Net Asset Value, End of Period   $ 56.29     $ 55.17     $ 44.27     $ 46.88     $ 41.33     $ 40.92  
Total Return     7.83 %     25.81 %     (1.61 )%     16.23 %     6.19 %(a)     3.65 %
Ratios/Supplemental Data:                                                
Net assets at end of period (000’s)   $ 597,013     $ 623,151     $ 461,126     $ 496,710     $ 403,969     $ 354,405  
Ratio of net expenses to average net assets     0.88 %     0.90 %     0.93 %     0.92 %     0.95 %(b)     0.94 %
Ratio of net investment income to average net assets     0.96 %     1.02 %     1.05 %     1.13 %     1.15 %(b)     1.32 %
Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment adviser) to average net assets     0.88 %     0.90 %     0.93 %     0.92 %     0.95 %(b)     0.94 %
Portfolio turnover rate     12.18 %     5.76 %(c)     2.53 %     6.96 %     8.42 %(a)     11.64 %

 

 

(a)       Not annualized for periods less than one year.

(b)       Annualized for periods less than one year.

(c)       Excludes impact of in-kind transactions.

 

See Notes to Financial Statements

 

12 

 

 

Schedule of Portfolio Investments   Boston Trust Equity Fund
December 31, 2020

 

Security Description     Shares       Fair Value ($)  
Common Stocks (99.4%)                
Communication Services (10.8%)                
Alphabet, Inc., Class A (a)     750       1,314,480  
Alphabet, Inc., Class C (a)     5,250       9,197,370  
Comcast Corp., Class A     65,000       3,406,000  
Facebook, Inc., Class B (a)     10,000       2,731,600  
Omnicom Group, Inc.     5,000       311,850  
Verizon Communications, Inc.     20,000       1,175,000  
              18,136,300  
Consumer Discretionary (7.5%)                
Autoliv, Inc.     10,000       921,000  
Lowe’s Cos., Inc.     10,000       1,605,100  
NIKE, Inc., Class B     30,000       4,244,100  
Ross Stores, Inc.     7,000       859,670  
Starbucks Corp.     40,000       4,279,200  
The Home Depot, Inc.     3,000       796,860  
              12,705,930  
Consumer Staples (9.1%)                
Church & Dwight Co., Inc.     15,000       1,308,450  
Costco Wholesale Corp.     15,000       5,651,700  
Diageo PLC, Sponsored ADR     7,500       1,191,075  
McCormick & Co., Inc.     14,000       1,338,400  
PepsiCo, Inc.     10,000       1,483,000  
Procter & Gamble Co. (The)     10,000       1,391,400  
Sysco Corp.     20,000       1,485,200  
The Hershey Co.     10,000       1,523,300  
              15,372,525  
Energy (1.8%)                
Chevron Corp.     7,500       633,375  
Exxon Mobil Corp.     17,500       721,350  
Schlumberger NV     75,000       1,637,250  
              2,991,975  
Financials (12.3%)                
American Express Co.     15,000       1,813,650  
Berkshire Hathaway, Inc., Class B (a)     10,000       2,318,700  
Chubb Ltd.     10,000       1,539,200  
Cincinnati Financial Corp.     20,000       1,747,400  
Commerce Bancshares, Inc.     2,625       172,463  
JPMorgan Chase & Co.     30,000       3,812,100  
Moody’s Corp.     1,500       435,360  
Northern Trust Corp.     22,500       2,095,650  
PNC Financial Services Group, Inc.     17,500       2,607,500  
T. Rowe Price Group, Inc.     20,000       3,027,800  
U.S. Bancorp     25,000       1,164,750  
              20,734,573  
Health Care (12.5%)                
Becton, Dickinson & Co.     15,000       3,753,300  
Dentsply Sirona, Inc.     25,000       1,309,000  
Edwards Lifesciences Corp. (a)     22,500       2,052,675  
Henry Schein, Inc. (a)     2,500       167,150  
Johnson & Johnson     17,500       2,754,150  
Medtronic PLC     10,000       1,171,400  
Merck & Co., Inc.     12,500       1,022,500  
Mettler-Toledo International, Inc. (a)     1,500       1,709,520  
Stryker Corp.     12,000       2,940,480  
UnitedHealth Group, Inc.     12,000       4,208,160  
              21,088,335  
Industrials (13.6%)                
3M Co.     10,000       1,747,900  
Deere & Co.     10,000       2,690,500  
Donaldson Co., Inc.     15,000       838,200  
Honeywell International, Inc.     10,000       2,127,000  
Hubbell, Inc.     15,000       2,351,850  
Illinois Tool Works, Inc.     15,000       3,058,200  
Union Pacific Corp.     22,500       4,684,950  
United Parcel Service, Inc., Class B     15,000       2,526,000  
W.W. Grainger, Inc.     7,000       2,858,380  
              22,882,980  
Information Technology (28.0%)                
Accenture PLC, Class A     25,000       6,530,250  
Apple, Inc.     110,000       14,595,900  
Automatic Data Processing, Inc.     20,000       3,524,000  
Cisco Systems, Inc.     20,000       895,000  
Intuit, Inc.     2,000       759,700  
Microsoft Corp.     55,000       12,233,100  
Oracle Corp.     40,000       2,587,600  
Visa, Inc., Class A     28,000       6,124,440  
              47,249,990  
Materials (2.5%)                
Air Products & Chemicals, Inc.     5,000       1,366,100  
AptarGroup, Inc.     10,000       1,368,900  
PPG Industries, Inc.     10,000       1,442,200  
              4,177,200  
Utilities (1.3%)                
Eversource Energy     25,000       2,162,750  
              2,162,750  
TOTAL COMMON STOCKS (Cost $54,818,821)             167,502,558  
                 
Investment Companies (0.6%)                
JPMorgan U.S. Government Money Market Fund, Capital Shares, 0.03% (b)     947,755       947,755  
TOTAL INVESTMENT COMPANIES (Cost $947,755)             947,755  
                 
Total Investments (Cost $55,766,576) — 100.0% (c)             168,450,313  
Other assets in excess of liabilities — 0.0%             36,976  
NET ASSETS — 100.0%             $ 168,487,289  

 

 

(a) Non-income producing security.

(b) Rate disclosed is the seven day yield as of December 31, 2020.

(c) See Federal Tax Information listed in the Notes to the Financial Statements.

 

ADR American Depositary Receipt

PLC Public Limited Company

 

See Notes to Financial Statements

 

13 

 

 

Financial Statements Boston Trust Equity Fund

 

Statement of Assets and Liabilities

December 31, 2020

 

Assets:    
Investments, at fair value (cost $55,766,576) $ 168,450,313
Dividends receivable   144,542
Receivable for capital shares issued   10,003
Prepaid expenses   5,575
Total Assets   168,610,433
Liabilities:    
Accrued expenses and other liabilities:    
Investment adviser   105,759
Administration and accounting   5,994
Chief compliance officer   740
Custodian   1,366
Shareholder servicing fees   247
Transfer agent   2,864
Trustee   1,981
Other   4,193
Total Liabilities   123,144
Net Assets $ 168,487,289
Composition of Net Assets:    
Paid in capital $ 54,128,202
Total distributable earnings/(loss)   114,359,087
Net Assets $ 168,487,289
Shares outstanding (par value $0.01, unlimited number of shares authorized)   5,123,449
Net Asset Value, Offering Price and Redemption price per share $ 32.89

 

Statement of Operations

For the year ended December 31, 2020

 

Investment Income:    
Dividends $ 2,724,630
Total Investment Income   2,724,630
Expenses:    
Investment adviser   1,116,954
Administration and accounting   86,673
Chief compliance officer   11,246
Custodian   20,429
Shareholder servicing   3,580
Transfer agency   35,164
Trustee   9,878
Other   50,935
Total expenses   1,334,859
Net Expenses   1,334,859
Net Investment Income   1,389,771
Net Realized/Unrealized Gains (Losses) from    
Investments:    
Net realized gains from investment transactions   4,210,057
Change in unrealized appreciation/depreciation on investments   14,438,744
Net realized/unrealized gains (losses) on investments   18,648,801
Change in Net Assets Resulting from Operations $ 20,038,572

 

See Notes to Financial Statements

 

14 

 

 

Financial Statements Boston Trust Equity Fund

 

Statements of Changes in Net Assets

 

  For the year ended   For the year ended
  December 31, 2020   December 31, 2019
Investment Activities:          
Operations:          
Net investment income $ 1,389,771   $ 1,280,402
Net realized gains from investment transactions   4,210,057     1,332,110
Change in unrealized appreciation/depreciation on investments   14,438,744     36,580,729
Change in Net Assets Resulting from Operations   20,038,572     39,193,241
Distributions to shareholders:          
Total Distributions   (4,722,166 )     (1,442,463 )
Change in Net Assets Resulting from distributions to shareholders   (4,722,166 )     (1,442,463 )
Capital Share Transactions:          
Proceeds from shares issued   2,383,276     1,613,063
Dividends reinvested   2,304,416     651,454
Cost of shares redeemed   (11,167,756 )     (6,208,577 )
Change in Net Assets Resulting from Capital Share Transactions   (6,480,064 )     (3,944,060 )
Change in Net Assets   8,836,342     33,806,718
Net Assets:          
Beginning of period   159,650,947     125,844,229
End of period $ 168,487,289   $ 159,650,947
Share Transactions:          
Issued   86,983     58,549
Reinvested   71,588     22,675
Redeemed   (437,884 )     (237,992 )
Change in shares   (279,313 )     (156,768 )

 

See Notes to Financial Statements

 

15 

 

 

Financial Statements Boston Trust Equity Fund

 

Financial Highlights                                    
Selected data for a share outstanding throughout the years indicated.                          
                                               
      For the year       For the year       For the year       For the year       For the nine
months
      For the year  
      ended       ended       ended       ended       ended       ended  
      December       December       December       December       December       March 31,  
      31, 2020       31, 2019       31, 2018       31, 2017       31, 2016       2016  
Net Asset Value, Beginning of Period   $ 29.55     $ 22.64     $ 23.63     $ 20.09     $ 19.70     $ 20.66  
Investment Activities:                                                
Operations:                                                
Net investment income     0.27       0.24       0.22       0.23       0.16       0.23  
Net realized/unrealized gains (losses) from                                                
investments     4.00       6.94       (0.80 )     3.92       1.58       0.27  
Total from investment activities     4.27       7.18       (0.58 )     4.15       1.74       0.50  
Dividends:                                                
Net investment income     (0.27 )     (0.24 )     (0.23 )     (0.23 )     (0.20 )     (0.24 )
Net realized gains from investments     (0.66 )     (0.03 )     (0.18 )     (0.38 )     (1.15 )     (1.22 )
Total dividends     (0.93 )     (0.27 )     (0.41 )     (0.61 )     (1.35 )     (1.46 )
Net Asset Value, End of Period   $ 32.89     $ 29.55     $ 22.64     $ 23.63     $ 20.09     $ 19.70  
Total Return     14.53 %     31.74 %     (2.55 )%     20.67 %     8.82 %(a)     2.59 %
Ratios/Supplemental Data:                                                
Net assets at end of period (000’s)   $ 168,487     $ 159,651     $ 125,844     $ 134,006     $ 118,824     $ 10,831  
Ratio of net expenses to average net assets     0.90 %     0.91 %     0.92 %     0.93 %     0.96 %(b)     0.95 %
Ratio of net investment income to average net assets     0.93 %     0.88 %     0.91 %     1.02 %     1.01 %(b)     1.14 %
Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment adviser) to average net assets (c)     0.90 %     0.91 %     0.92 %     0.93 %     0.96 %(b)     0.96 %
Portfolio turnover rate     9.30 %     2.61 %     1.67 %     9.00 %     6.65 %(a)     18.04 %

 

 

(a) Not annualized for periods less than one year.

(b) Annualized for periods less than one year.

(c) During the periods ended March 31, 2016 and December 31, 2016, certain fees were reduced. If such fee reduction had not occurred, the ratio would have been as indicated.

 

See Notes to Financial Statements

 

16 

 

 

Schedule of Portfolio Investments   Boston Trust Midcap Fund
December 31, 2020

 

Security Description     Shares       Fair Value ($)  
Common Stocks (98.8%)                
Communication Services (2.8%)                
Electronic Arts, Inc.     14,450       2,075,020  
Omnicom Group, Inc.     29,300       1,827,441  
              3,902,461  
Consumer Discretionary (10.7%)                
AutoZone, Inc. (a)     1,450       1,718,888  
Carter’s, Inc.     24,850       2,337,640  
eBay, Inc.     45,000       2,261,250  
Hyatt Hotels Corp., Class A     23,450       1,741,163  
O’Reilly Automotive, Inc. (a)     3,100       1,402,967  
Ross Stores, Inc.     18,525       2,275,054  
Service Corporation International     29,325       1,439,858  
Tractor Supply Co.     12,550       1,764,279  
              14,941,099  
Consumer Staples (5.1%)                
Church & Dwight Co., Inc.     14,125       1,232,124  
Lancaster Colony Corp.     6,125       1,125,346  
Sysco Corp.     16,225       1,204,869  
The Hershey Co.     13,125       1,999,331  
The JM Smucker Co.     13,280       1,535,168  
              7,096,838  
Energy (1.1%)                
Baker Hughes Co.     76,575       1,596,589  
              1,596,589  
Financials (12.0%)                
Brown & Brown, Inc.     25,675       1,217,252  
CBOE Global Markets, Inc.     17,450       1,624,944  
Everest Re Group Ltd.     5,525       1,293,347  
FactSet Research Systems, Inc.     6,725       2,236,062  
M&T Bank Corp.     20,475       2,606,468  
Northern Trust Corp.     25,625       2,386,712  
SEI Investments Co.     36,425       2,093,345  
Signature Bank     8,400       1,136,436  
T. Rowe Price Group, Inc.     14,325       2,168,662  
              16,763,228  
Health Care (13.6%)                
Agilent Technologies, Inc.     16,250       1,925,463  
Cerner Corp.     22,300       1,750,104  
Henry Schein, Inc. (a)     18,375       1,228,553  
Hill-Rom Holdings, Inc.     21,450       2,101,456  
Laboratory Corp. of America Holdings (a)     5,900       1,200,945  
Mettler-Toledo International, Inc. (a)     1,235       1,407,505  
Steris PLC     11,150       2,113,370  
Teleflex, Inc.     3,450       1,419,917  
The Cooper Companies., Inc.     5,150       1,871,098  
Waters Corp. (a)     10,000       2,474,199  
Zimmer Biomet Holdings, Inc.     9,475       1,460,003  
              18,952,613  
Industrials (14.8%)                
AMETEK, Inc.     17,875       2,161,802  
AO Smith Corp.     25,750       1,411,615  
Cummins, Inc.     7,700       1,748,670  
Donaldson Co., Inc.     35,875       2,004,694  
Expeditors International of Washington, Inc.     17,950       1,707,225  
Hubbell, Inc.     11,325       1,775,647  
Lincoln Electric Holdings, Inc.     12,750       1,482,188  
Masco Corp.     22,725       1,248,284  
Nordson Corp.     6,525       1,311,199  
Snap-on, Inc.     10,275       1,758,463  
The Middleby Corp. (a)     9,000       1,160,280  
Verisk Analytics, Inc.     6,925       1,437,561  
W.W. Grainger, Inc.     3,450       1,408,773  
              20,616,401  
Information Technology (20.4%)                
Akamai Technologies, Inc. (a)     14,375       1,509,231  
Amdocs Ltd.     20,450       1,450,519  
Amphenol Corp., Class A     16,450       2,151,167  
ANSYS, Inc. (a)     3,875       1,409,725  
Aspen Technology, Inc. (a)     18,275       2,380,318  
Broadridge Finance Solutions, Inc.     11,525       1,765,629  
CDK Global, Inc.     25,600       1,326,848  
Check Point Software Technologies Ltd.  (a)     12,450       1,654,730  
Citrix Systems, Inc.     17,025       2,214,952  
Cognizant Technology Solutions Corp., Class A     17,500       1,434,125  
Dolby Laboratories, Inc., Class A     20,525       1,993,593  
F5 Networks, Inc. (a)     11,475       2,018,912  
IPG Photonics Corp. (a)     8,025       1,795,915  
Paychex, Inc.     34,175       3,184,426  
TE Connectivity Ltd.     19,175       2,321,517  
              28,611,607  
Materials (5.9%)                
AptarGroup, Inc.     14,175       1,940,416  
Avery Dennison Corp.     15,375       2,384,816  
Packaging Corporation of America     13,800       1,903,158  
RPM International, Inc.     21,575       1,958,579  
              8,186,969  
Real Estate (6.2%)                
Alexandria Real Estate Equities, Inc.     7,475       1,332,195  
AvalonBay Communities, Inc.     7,525       1,207,236  
Camden Property Trust     12,375       1,236,510  
CyrusOne, Inc.     15,950       1,166,743  
Jones Lang LaSalle, Inc. (a)     15,375       2,281,189  
Realty Income Corp.     23,900       1,485,862  
              8,709,735  
Utilities (6.2%)                
Atmos Energy Corp.     16,750       1,598,453  
Consolidated Edison, Inc.     25,175       1,819,397  
Eversource Energy     34,925       3,021,362  
ONE Gas, Inc.     29,600       2,272,392  
              8,711,604  
TOTAL COMMON STOCKS (Cost $94,481,661)             138,089,144  
                 
Investment Companies (1.1%)                
JPMorgan U.S. Government Money Market Fund, Capital Shares, 0.03% (b)     1,487,845       1,487,845  
TOTAL INVESTMENT COMPANIES (Cost $1,487,845)             1,487,845  
                 
Total Investments (Cost $95,969,506) — 99.9% (c)             139,576,989  
Other assets in excess of liabilities — 0.1%             145,901  
NET ASSETS — 100.0%           $ 139,722,890  

 

 

(a) Non-income producing security.

(b) Rate disclosed is the seven day yield as of December 31, 2020.

(c) See Federal Tax Information listed in the Notes to the Financial Statements.

 

PLC Public Limited Company

 

See Notes to Financial Statements

 

17 

 

 

Financial Statements Boston Trust Midcap Fund

 

Statement of Assets and Liabilities

December 31, 2020

 

Assets:    
Investments, at fair value (cost $95,969,506) $ 139,576,989
Dividends receivable   142,758
Receivable for capital shares issued   109,092
Prepaid expenses   14,598
Total Assets   139,843,437
Liabilities:    
Payable for capital shares redeemed   2,282
Accrued expenses and other liabilities:    
Investment adviser   87,967
Administration and accounting   5,197
Chief compliance officer   634
Custodian   1,165
Shareholder servicing fees   12,720
Transfer agent   3,485
Trustee   1,681
Other   5,416
Total Liabilities   120,547
Net Assets $ 139,722,890
Composition of Net Assets:    
Paid in capital $ 96,013,042
Total distributable earnings/(loss)   43,709,848
Net Assets $ 139,722,890
Shares outstanding (par value $0.01, unlimited number of shares authorized)   6,647,927
Net Asset Value, Offering Price and Redemption price per share $ 21.02


 

Statement of Operations

For the year ended December 31, 2020

 

Investment Income:      
Dividends $ 2,039,397  
Less: Foreign tax withholding   (538 )
Total Investment Income   2,038,859  
Expenses:      
Investment adviser   960,313  
Administration and accounting   77,819  
Chief compliance officer   10,229  
Custodian   18,382  
Shareholder servicing   160,958  
Transfer agency   41,089  
Trustee   9,010  
Interest fees   183  
Other   71,527  
Total expenses before fee reductions   1,349,510  
Fees contractually reduced by the investment adviser   (68,764 )
Net Expenses   1,280,746  
Net Investment Income   758,113  
Net Realized/Unrealized Gains (Losses) from Investments:      
Net realized gains from investment transactions   620,497  
Change in unrealized appreciation/depreciation on investments   6,536,438  
Net realized/unrealized gains (losses) on investments   7,156,935  
Change in Net Assets Resulting from Operations $ 7,915,048  

 

See Notes to Financial Statements

 

18 

 

 

Financial Statements Boston Trust Midcap Fund

 

Statements of Changes in Net Assets

 

    For the year ended     For the year ended  
    December 31, 2020     December 31, 2019  
Investment Activities:                
Operations:                
Net investment income   $ 758,113     $ 741,000  
Net realized gains from investment transactions     620,497       3,967,963  
Change in unrealized appreciation/depreciation on investments     6,536,438       20,892,329  
Change in Net Assets Resulting from Operations     7,915,048       25,601,292  
Distributions to shareholders:                
Total Distributions     (1,650,010 )     (5,145,785 )
Change in Net Assets Resulting from distributions to shareholders     (1,650,010 )     (5,145,785 )
Capital Share Transactions:                
Proceeds from shares issued     38,228,874       60,147,066  
Dividends reinvested     1,347,943       4,094,485  
Cost of shares redeemed     (51,423,640 )     (14,255,219 )
Change in Net Assets Resulting from Capital Share Transactions     (11,846,823 )     49,986,332  
Change in Net Assets     (5,581,785 )     70,441,839  
Net Assets:                
Beginning of period     145,304,675       74,862,836  
End of period   $ 139,722,890     $ 145,304,675  
Share Transactions:                
Issued     2,120,345       3,233,471  
Reinvested     64,805       214,483  
Redeemed     (2,969,777 )     (759,976 )
Change in shares     (784,627 )     2,687,978  

 

See Notes to Financial Statements

 

19 

 

 

Financial Statements Boston Trust Midcap Fund

 

Financial Highlights                                    
Selected data for a share outstanding throughout the years indicated.          
                                             
      For the year       For the year       For the year       For the year       For the nine
months
      For the year  
      ended       ended       ended       ended       ended       ended  
      December       December       December       December       December       March 31,  
      31, 2020       31, 2019       31, 2018       31, 2017       31, 2016       2016  
Net Asset Value, Beginning of Period   $ 19.55     $ 15.78     $ 17.26     $ 15.34     $ 15.29     $ 16.12  
Investment Activities:                                                
Operations:                                                
Net investment income     0.12       0.10       0.08       0.08       0.12       0.09  
Net realized/unrealized gains (losses) from investments     1.60       4.39       (0.62 )     2.98       1.01       0.05  
Total from investment activities     1.72       4.49       (0.54 )     3.06       1.13       0.14  
Dividends:                                                
Net investment income     (0.12 )     (0.09 )     (0.08 )     (0.08 )     (0.13 )     (0.09 )
Net realized gains from investments     (0.13 )     (0.63 )     (0.86 )     (1.06 )     (0.95 )     (0.88 )
Total dividends     (0.25 )     (0.72 )     (0.94 )     (1.14 )     (1.08 )     (0.97 )
Net Asset Value, End of Period   $ 21.02     $ 19.55     $ 15.78     $ 17.26     $ 15.34     $ 15.29  
Total Return     8.81 %     28.59 %     (3.36 )%     20.01 %     7.29 %(a)     1.07 %
Ratios/Supplemental Data:                                                
Net assets at end of period (000’s)   $ 139,723     $ 145,305     $ 74,863     $ 61,548     $ 50,495     $ 47,941  
Ratio of net expenses to average net assets     1.00 %     1.00 %     0.98 %     1.00 %     1.00 %(b)     1.00 %
Ratio of net investment income to average net assets     0.59 %     0.67 %     0.54 %     0.46 %     0.99 %(b)     0.58 %
Ratio of expenses (before fee reductions or recoupment  of fees previously reimbursed by the investment adviser) to average net assets (c)     1.05 %     1.04 %     0.98 %     0.98 %     1.02 %(b)     1.03 %
Portfolio turnover rate     38.33 %     18.46 %     19.34 %     23.22 %     14.53 %(a)     21.02 %

 

 
(a) Not annualized for periods less than one year.

(b) Annualized for periods less than one year.

(c) During the periods, certain fees were reduced or recouped by the investment adviser. If such fee reductions/recoupments had not occurred, the ratio would have been as indicated.

 

See Notes to Financial Statements

 

20 

 

 

Financial Statements   Boston Trust SMID Cap Fund
December 31, 2020

 

Security Description     Shares       Fair Value ($)  
Common Stocks (98.8%)                
Communication Services (2.8%)                
Interpublic Group of Cos., Inc.     158,654       3,731,542  
Omnicom Group, Inc.     40,589       2,531,536  
              6,263,078  
Consumer Discretionary (9.8%)                
Carter’s, Inc.     31,083       2,923,978  
Choice Hotels International, Inc.     15,345       1,637,772  
Columbia Sportswear Co.     27,134       2,370,969  
Dorman Products, Inc. (a)     29,392       2,551,813  
Service Corporation International     71,268       3,499,259  
Texas Roadhouse, Inc.     29,803       2,329,402  
TopBuild Corp. (a)     6,922       1,274,202  
Tractor Supply Co.     16,941       2,381,566  
Williams Sonoma, Inc.     31,367       3,194,415  
              22,163,376  
Consumer Staples (4.4%)                
Flowers Foods, Inc.     112,987       2,556,896  
Lamb Weston Holdings, Inc.     22,776       1,793,382  
Lancaster Colony Corp.     10,365       1,904,361  
The JM Smucker Co.     31,774       3,673,075  
              9,927,714  
Energy (1.7%)                
Baker Hughes Co.     97,148       2,025,536  
Helmerich & Payne, Inc.     75,832       1,756,269  
              3,781,805  
Financials (13.8%)                
American Financial Group, Inc.     21,160       1,854,039  
Brown & Brown, Inc.     43,067       2,041,807  
CBOE Global Markets, Inc.     23,888       2,224,451  
Cohen & Steers, Inc.     30,682       2,279,673  
East West Bancorp, Inc.     45,510       2,307,812  
FactSet Research Systems, Inc.     8,949       2,975,543  
M&T Bank Corp.     36,681       4,669,491  
SEI Investments Co.     80,535       4,628,345  
Signature Bank     20,401       2,760,051  
SVB Financial Group (a)     9,126       3,539,337  
UMB Financial Corp.     26,718       1,843,275  
              31,123,824  
Health Care (18.3%)                
Charles River Laboratories International, Inc. (a)     17,563       4,388,291  
Chemed Corp.     6,790       3,616,422  
Dentsply Sirona, Inc.     32,548       1,704,213  
Henry Schein, Inc. (a)     23,315       1,558,841  
Hill-Rom Holdings, Inc.     34,849       3,414,157  
Masimo Corp. (a)     5,901       1,583,710  
Medpace Holdings, Inc. (a)     37,141       5,170,027  
PerkinElmer, Inc.     34,173       4,903,826  
Steris PLC     24,921       4,723,526  
The Cooper Companies., Inc.     13,812       5,018,177  
Waters Corp. (a)     21,880       5,413,550  
              41,494,740  
Industrials (13.3%)                
AO Smith Corp.     49,751       2,727,350  
Applied Industrial Technologies, Inc.     32,739       2,553,315  
C.H. Robinson Worldwide, Inc.     19,534       1,833,657  
Donaldson Co., Inc.     56,687       3,167,670  
Expeditors International of Washington, Inc.     34,771       3,307,069  
Hubbell, Inc.     26,365       4,133,768  
Lincoln Electric Holdings, Inc.     23,324       2,711,415  
Masco Corp.     46,695       2,564,956  
Nordson Corp.     9,243       1,857,381  
The Middleby Corp. (a)     17,064       2,199,891  
UniFirst Corp.     14,488       3,066,965  
              30,123,437  
Information Technology (17.3%)                
Akamai Technologies, Inc. (a)     31,656       3,323,563  
Amdocs Ltd.     21,160       1,500,879  
Aspen Technology, Inc. (a)     33,111       4,312,708  
Broadridge Finance Solutions, Inc.     15,673       2,401,104  
CDK Global, Inc.     37,998       1,969,436  
Citrix Systems, Inc.     35,789       4,656,148  
Dolby Laboratories, Inc., Class A     26,287       2,553,256  
F5 Networks, Inc. (a)     16,422       2,889,287  
IPG Photonics Corp. (a)     18,809       4,209,266  
Jack Henry & Associates, Inc.     9,596       1,554,456  
Manhattan Associates, Inc. (a)     34,066       3,583,062  
NetApp, Inc.     41,669       2,760,155  
Progress Software Corp.     78,836       3,562,599  
              39,275,919  
Materials (6.2%)                
AptarGroup, Inc.     22,556       3,087,691  
Avery Dennison Corp.     21,488       3,333,003  
Packaging Corporation of America     23,804       3,282,810  
RPM International, Inc.     47,067       4,272,742  
              13,976,246  
Real Estate (6.6%)                
Camden Property Trust     23,520       2,350,118  
CoreSite Realty Corp.     22,237       2,785,851  
CubeSmart     46,695       1,569,419  
CyrusOne, Inc.     17,852       1,305,874  
Jones Lang LaSalle, Inc. (a)     24,294       3,604,501  
Lamar Advertising Co., Class A     25,861       2,152,152  
STAG Industrial, Inc.     33,968       1,063,878  
              14,831,793  
Utilities (4.6%)                
Atmos Energy Corp.     44,276       4,225,259  
New Jersey Resources Corp.     48,008       1,706,684  
ONE Gas, Inc.     57,907       4,445,520  
              10,377,463  
TOTAL COMMON STOCKS (Cost $174,619,714)             223,339,395  
                 
Investment Companies (1.2%)                
JPMorgan U.S. Government Money Market Fund, Capital Shares, 0.03% (b)     2,752,352       2,752,352  
TOTAL INVESTMENT COMPANIES (Cost $2,752,352)             2,752,352  
                 
Total Investments (Cost $177,372,066) — 100.0% (c)             226,091,747  
Liabilities in excess of other assets — 0.0%             (16,610 )  
NET ASSETS — 100.0%             $ 226,075,137  

 

 
(a) Non-income producing security.

(b) Rate disclosed is the seven day yield as of December 31, 2020.

(c) See Federal Tax Information listed in the Notes to the Financial Statements.

 

PLC Public Limited Company

 

See Notes to Financial Statements

 

21 

 

 

Financial Statements Boston Trust SMID Cap Fund

 

Statement of Assets and Liabilities

December 31, 2020

 

Assets:    
Investments, at fair value (cost $177,372,066) $ 226,091,747
Dividends receivable   229,007
Receivable for capital shares issued   72,073
Prepaid expenses   14,681
Total Assets   226,407,508
Liabilities:    
Payable for capital shares redeemed   194,089
Accrued expenses and other liabilities:    
Investment adviser   109,451
Administration and accounting   8,595
Chief compliance officer   1,071
Custodian   1,447
Transfer agent   2,935
Trustee   2,768
Other   12,015
Total Liabilities   332,371
Net Assets $ 226,075,137
Composition of Net Assets:    
Paid in capital $ 180,657,670
Total distributable earnings/(loss)   45,417,467
Net Assets $ 226,075,137
Shares outstanding (par value $0.01, unlimited number of shares authorized)   11,753,606
Net Asset Value, Offering Price and Redemption price per share $ 19.23


 

Statement of Operations

For the year ended December 31, 2020

 

Investment Income:      
Dividends   $ 2,617,462  
Total Investment Income     2,617,462  
Expenses:        
Investment adviser     1,201,015  
Administration and accounting     90,135  
Chief compliance officer     11,630  
Custodian     22,537  
Transfer agency     35,786  
Trustee     10,508  
Interest fees     152  
Other     81,719  
Total expenses before fee reductions     1,453,482  
Fees contractually reduced by the investment adviser     (251,750 )
Net Expenses     1,201,732  
Net Investment Income     1,415,730  
Net Realized/Unrealized Gains (Losses) from        
Investments:        
Net realized (losses) from investment transactions     (3,117,108 )
Net realized gains from redemptions in-kind     4,664  
Change in unrealized appreciation/depreciation on        
investments     32,345,630  
Net realized/unrealized gains (losses) on investments     29,233,186  
Change in Net Assets Resulting from Operations   $ 30,648,916  

 

See Notes to Financial Statements

 

22 

 

 

Financial Statements Boston Trust SMID Cap Fund

 

Statements of Changes in Net Assets

 

    For the year ended     For the year ended  
    December 31, 2020     December 31, 2019  
Investment Activities:                
Operations:                
Net investment income   $ 1,415,730     $ 743,711  
Net realized gains/(losses) from investment transactions     (3,112,444 )     2,407,151  
Change in unrealized appreciation/depreciation on investments     32,345,630       16,700,103  
Change in Net Assets Resulting from Operations     30,648,916       19,850,965  
Distributions to shareholders:                
Total Distributions     (1,697,179 )     (3,234,772 )
Return of capital     (46,102 )      
Change in Net Assets Resulting from distributions to shareholders     (1,743,281 )     (3,234,772 )
Capital Share Transactions:                
Proceeds from shares issued     114,366,780       43,659,409  
Dividends reinvested     1,716,616       3,166,407  
Cost of shares redeemed     (40,626,345 )     (11,365,725 )
Cost of in-kind shares redeemed (a)     (4,663,238 )      
Change in Net Assets Resulting from Capital Share Transactions     70,793,813       35,460,091  
Change in Net Assets     99,699,448       52,076,284  
Net Assets:                
Beginning of period     126,375,689       74,299,405  
End of period   $ 226,075,137     $ 126,375,689  
Share Transactions:                
Issued     7,221,313       2,472,566  
Reinvested     89,828       181,041  
Redeemed     (2,372,199 )     (672,234 )
Redeemed in-kind (a)     (244,533 )      
Change in shares     4,694,409       1,981,373  

 

 

(a)       See Note 3 in Notes to Financial Statements.

 

See Notes to Financial Statements

 

23 

 

 

Financial Statements Boston Trust SMID Cap Fund

 

Financial Highlights                                    
Selected data for a share outstanding throughout the years indicated.                  
                                             
      For the year       For the year       For the year       For the year       For the nine
months
      For the year  
      ended       ended       ended       ended       ended       ended  
      December       December       December       December       December       March 31,  
      31, 2020       31, 2019       31, 2018       31, 2017       31, 2016       2016  
Net Asset Value, Beginning of Period   $ 17.90     $ 14.63     $ 15.79     $ 13.48     $ 12.49     $ 13.72  
Investment Activities:                                                
Operations:                                                
Net investment income     0.12       0.14       0.11       0.07       0.13       0.06  
Net realized/unrealized gains (losses) from investments     1.36       3.76       (0.98 )     2.41       1.72       (0.41 )
Total from investment activities     1.48       3.90       (0.87 )     2.48       1.85       (0.35 )
Dividends:                                                
Net investment income     (0.13 )     (0.12 )     (0.12 )     (0.08 )     (0.15 )     (0.04 )
Net realized gains from investments     (0.02 )     (0.51 )     (0.17 )     (0.09 )     (0.71 )     (0.84 )
Return of capital                                    
Total dividends     (0.15 )     (0.63 )     (0.29 )     (0.17 )     (0.86 )     (0.88 )
Net Asset Value, End of Period   $ 19.23     $ 17.90     $ 14.63     $ 15.79     $ 13.48     $ 12.49  
Total Return     8.26 %     26.74 %     (5.62 )%     18.39 %     14.67 %(a)     (2.34 )%
Ratios/Supplemental Data:                                                
Net assets at end of period (000’s)   $ 226,075     $ 126,376     $ 74,299     $ 56,443     $ 6,510     $ 5,589  
Ratio of net expenses to average net assets     0.75 %     0.75 %     0.75 %     0.75 %     0.75 %(b)     0.79 %(c)
Ratio of net investment income to average net assets     0.89 %     0.85 %     0.77 %     0.85 %     1.31 %(b)     0.49 %
Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment adviser) to average net assets (d)     0.91 %     0.95 %     0.98 %     1.04 %     1.61 %(b)     1.73 %
Portfolio turnover rate     51.26 %(e)     24.08 %     14.98 %     37.44 %     22.69 %(a)     50.15 %

 

 

(a) Not annualized for periods less than one year.

(b) Annualized for periods less than one year.

(c) The net expense ratio shown for the period presented represents the blended ratio of the current expense limit in effect as of June 1, 2015 and the higher expense limit in effect prior to that date.

(d) During the periods, certain fees were reduced. If such fee reduction had not occurred, the ratio would have been as indicated.

(e) Excludes impact of in-kind transactions.

 

Amounts designated as “-” are $0.00 or have been rounded to $0.00.

 

See Notes to Financial Statements

 

24 

 

 

 

 

Read our 2020 Annual ESG Impact Report online

 

We invite you to read our Annual ESG Impact Report online, which provides an in-depth view of the ways in which Boston Trust Walden Company promotes business sustainability and achieve impact on behalf of clients.

 

The report can be found at: www.bostontrustwalden.com/insights/annual-esg-impact-report-2020/

 

Included in this report:

 

 

 

25 

 

 

Boston Trust Walden Balanced Fund 

(formerly known as the Walden Balanced Fund)

 

Boston Trust Walden Equity Fund

(formerly known as the Walden Equity Fund)

December 31, 2020

 

William H. Apfel, CFA

Portfolio Manager

 

Boston Trust Walden Inc.

 

Balanced Fund Objective

The Fund seeks long-term capital growth and income through an actively managed portfolio of stocks, bonds and money market instruments.

 

Equity Fund Objective

The Fund seeks long-term growth of capital through an actively managed portfolio of stocks.

 

Investment Concerns

Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities. The net asset value per share of these Funds will fluctuate as the value of the securities in the portfolio changes.

 

Foreign investing involves risks not typically associated with U.S. investments, including adverse political, social and economic developments and differing auditing and legal standards. These risks are magnified in emerging markets.

 

Small- to mid-capitalization companies typically have a higher risk of failure and historically have experienced a greater degree of volatility.

 

Bonds offer a relatively stable level of income, although bond prices will fluctuate, providing the potential for principal gain or loss. Intermediate term, higher quality bonds generally offer less risk than longer-term bonds and a lower rate of return.

 

Cash equivalents offer low risk and low return potential.

 

Manager Commentary (Unaudited)

 

Management Discussion of Fund Performance

The Boston Trust Walden Balanced Fund and the Boston Trust Walden Equity Fund returned 8.26% and 13.28%, respectively for the 12-month period ended December 31, 2020. The relevant market indices, the S&P 500 Index and the Bloomberg Barclays Government/Credit Bond Index, returned 18.40% and 8.93%, respectively, for the year. Both Funds’ equity segments underperformed the S&P 500 Index benchmark, and the Balanced Fund’s fixed income segment underperformed the bond benchmark as well. The Balanced Fund’s relative returns were further negatively impacted by asset allocation. To begin the year, the Balanced Fund’s equity allocation was at the upper end of its range, a stance that had positively aided the Balanced Fund’s returns for much of the last decade. However, as the pandemic caused stocks to sell off sharply in February and March, this significantly detracted from the Balanced Fund’s performance. Though asset allocation decisions in the latter parts of the year were additive, asset allocation on balance was a detractor relative to a static blended benchmark.

 

That the S&P 500 Index rose more than 18% in 2020 is a remarkable outcome in its own right, but it is more striking when considering the Index declined by one third during the year’s first quarter. Investor confidence oscillated throughout the year, highlighting the tension between economic uncertainty, above average valuations, fiscal and monetary policy intervention, and already low interest rates. The Funds’ relative equity performance tended to follow the shifts in investors’ attitude toward risk, albeit with a more muted degree of protection compared to previous downturns given the unique nature of the pandemic.

 

According to our analysis of full year returns, the stocks of businesses that had, on average, track records of good fundamental performance regardless of economic conditions fared moderately better on average than their lower quality counterparts. Furthermore, for much of the year the market was especially focused on companies perceived to be capable of delivering improving growth rates, regardless of the challenges presented by the pandemic.

 

In contrast, our valuation discipline proved to be a substantial headwind for much of 2020, a challenge that was most pronounced in the earlier stages of the recovery from the March market lows. Through much of the spring, investor sentiment seemed to entail a near total suspension of the normal concern regarding extreme valuations. As 2020 neared its end, there was some evidence that valuation was again getting its due consideration. Whether that was exclusively related to optimism about more cyclical parts of the economy or a renewed sensitivity to risk management remains to be seen.

 

At the sector level, positions in technology and consumer discretionary detracted most from relative results, with a pronounced headwind due to our valuation discipline. Meanwhile, industrial sector holdings contributed positively, as did the absence of investments in the real estate sector.

 

Outlook

After gaining 55% in value over the last two years, stocks are no longer cheap. But current prices, in our view, still allow for further appreciation. With continued support from the Fed and Congress, and a vast pool of pent up consumer demand, prospects for the economy appear bright. We anticipate that corporate profits will rise substantially in 2021. This includes continued momentum for those companies who either benefited from or were unaffected by the stay-at-home policies, and a rebound for the more economically sensitive companies that saw sharp declines in earnings in 2020. Accordingly, we favor stocks. We remain steadfast in identifying financially strong companies with sustainable business models and reasonable valuations. These stocks should participate in the above tailwinds, but also provide a measure of protection relative to those with riskier businesses and/or shares that imply an unsustainable level of future growth.

 

Alternatives to stocks have limited appeal. Courtesy of the Fed’s actions, yields on cash and money market funds are effectively zero. Longer dated bonds aren’t much better with the 10-year US Treasury yielding roughly 1%. (Indeed, so-called “real” bond yields – the amount earned after subtracting anticipated inflation – are negative!) But even at these levels, bonds still have a place in the Balanced Fund. Even under the most optimistic forecasts, the path toward full economic recovery is unlikely to be smooth. Stock prices will be volatile, subject to changes in sentiment as well as economic conditions. In contrast, high quality bonds should provide some ballast to the Balanced Fund’s portfolio if equity market conditions worsen. As such, we continue to retain an allocation to bonds.*

 

 

* Portfolio composition is subject to change.

 

26 

 

 

Investment Performance (Unaudited) Boston Trust Walden Balanced Fund
  Boston Trust Walden Equity Fund
  December 31, 2020

 

    For the periods ended 12/31/20
    Average Annual Total Returns  
                                                      Since  
                                                      Inception  
      1 Year       3 Years       5 Years       10 Years       15 Years       20 Years       (06/20/99)
Boston Trust Walden Balanced Fund1     8.26 %     9.52 %     10.48 %     9.01 %     7.11 %     6.05 %     6.01 %
Boston Trust Walden Equity Fund1     13.28 %     13.46 %     14.55 %     12.19 %     9.35 %     7.73 %     7.41 %
S&P 500 Index     18.40 %     14.18 %     15.22 %     13.88 %     9.88 %     7.47 %     6.92 %
Bloomberg Barclays U.S. Government/Credit Bond Index     8.93 %     5.97 %     4.98 %     4.19 %     4.64 %     5.01 %     5.21 %
FTSE 3 Month US T-Bill Index     0.58 %     1.56 %     1.16 %     0.60 %     1.16 %     1.43 %     1.73 %

 

Hypothetical Growth of a $100,000 Investment

 

 

 

The above charts represent a 10-year hypothetical $100,000 investment in the Boston Trust Walden Balanced Fund and Boston Trust Walden Equity Fund, and includes the reinvestment of dividends and capital gains in the Funds. The returns shown on the table and the graphs do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

 

The Boston Trust Walden Balanced Fund is measured against a combination of equity and fixed income indices. The Boston Trust Walden Equity Fund is measured against the Standard & Poor’s 500 Index (“S&P 500”), which is widely regarded as a gauge of the U.S. equities market. This index includes 500 leading companies in leading industries of the U.S. economy. Although the S&P 500 focuses on the large-cap segment of the market, with approximately 75% coverage of U.S. equities, it is also widely viewed as a proxy for the total market. The Bloomberg Barclays U.S. Government/Credit Bond Index includes Treasuries (i.e., public obligations of the U.S. Treasury that have remaining maturities of more than one year), government-related issues (i.e., agency, sovereign, supranational, and local authority debt), and USD Corporates. The Bloomberg Barclays U.S. Government/Credit Bond Index is a component of the Bloomberg Barclays U.S. Aggregate Bond Index. The FTSE 3 Month US T-Bill Index reflects monthly return equivalents of yield averages that are not marked to the market. The index is an average of the last three-month treasury bill issues. The three-month treasury bills are the short-term debt obligations of the U.S. Government. The indexes are unmanaged and their performance does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Funds’ performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 

Boston Trust Walden Balanced Fund

 

Fund Net Asset Value:   $ 21.82  
Gross Expense Ratio1:     1.02 %

 

Boston Trust Walden Equity Fund

 

Fund Net Asset Value:   $ 28.82  
Gross Expense Ratio1:     1.07 %

 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

 

 

1 The Gross Expense Ratio is from each Fund’s most recent prospectus, dated May 1, 2020. The contractual fee limit under each Fund’s expense limitation agreement is 1.00% of each Fund’s average annual net assets, subject to certain limitations as described in each Fund’s prospectus. Please see each Fund’s most recent prospectus for details. Additional information pertaining to each Fund’s expense ratio as of December 31, 2020 can be found in the financial highlights included in this report. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through May 1, 2021 and may be renewed thereafter.

 

27 

 

 

Boston Trust Walden Midcap Fund

(formerly Known as the Walden Midcap Fund)

December 31, 2020

 

Stephen J. Amyouny, CFA

Lead Portfolio Manager

 

Richard Q. Williams, CFA

Portfolio Manager

 

Mark Zagata, CFA

Portfolio Manager

 

Boston Trust Walden Inc.

 

Fund Objective

The Fund seeks long-term capital growth through an actively managed portfolio of stocks of middle capitalization (“mid cap”) companies.

 

Investment Concerns

Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.

 

Mid cap funds typically carry additional risks since smaller companies generally have a higher risk of failure.

 

Manager Commentary (Unaudited)

 

Management Discussion of Fund Performance

The fourth quarter performance capped off a strong year for the Russell Midcap® Index (“Index”), which finished the year 17% higher than where it started in 2020, even with the 27.07% decline in the first quarter. Indeed, from the market trough in late March, the Index advanced nearly 90%. Even though the Boston Trust Walden Midcap Fund outperformed the Index return (-24.05% versus -27.07%) during the first quarter decline, the Fund’s total return of 8.76% for the 12-month period ended December 31, 2020 trailed the Index by a wide margin.

 

It should perhaps not be surprising that the Fund failed to keep up in the strong market rally of the second, third, and fourth quarters of 2020. In contrast to the fourth quarter where our emphasis on quality and value detracted from results, the Fund’s full year underperformance stemmed primarily from maintaining our valuation discipline. That said, despite the in-line performance of high-quality stocks in general, it is worth highlighting the relative outperformance of loss making entities over profitable peers, which was stunning: loss-makers1 outperformed profitable companies by more than 60%. Loss-making entities also now comprise 10% of Index value. Given the Fund is entirely invested in stocks of profitable companies, avoiding the loss-making cohort explains much of the relative underperformance.

 

Outlook

Entering 2021, we can point to several reasons for the optimism that propelled Index to new all-time highs in the fourth quarter. Among them included: the success in clinical trials and initial distribution of several Coronavirus (COVID-19) vaccines; continued economic recovery supported by significant monetary and fiscal stimuli; somewhat less political uncertainty following the presidential election; and historically low interest rates. However, we also continue to see risk in the current environment: a surge of COVID-19 case counts that is leading to new restrictions on economic activity; a fragile economic recovery still dependent on monetary and fiscal support; and continuing evidence of speculative activity among investors. We believe valuation risk in the market overall to be elevated.

 

While we do not seek to gain an edge through market timing, we continue to believe that over the long term stock prices ultimately reflect company fundamentals. We do not believe investors will perpetually favor as a group companies that cannot consistently generate profits or free cash flow and yet trade at elevated valuation multiples of sales. Of course, some of these individual companies will emerge as high-quality industry leaders. However, not all, or even a majority of them will succeed. As such, we continue to emphasize in our research and portfolio management activities those companies that have a demonstrated history of profitability, stability, and growth, have sustainable business models, high quality of earnings, and that are trading at reasonable valuations. As of December 31, 2020, the Fund exhibited strong financial characteristics and a more reasonable valuation profile than the Index. As a result, we continue to believe the Fund may provide favorable risk-adjusted returns over the long term.*

 

 

* Portfolio composition is subject to change. 

1 Loss-makers are defined as companies with five-year cumulative EBIT (earnings before interest and taxes) less than $0

 

28 

 

 

Investment Performance (Unaudited) Boston Trust Walden Midcap Fund
      December 31, 2020

 

    For the periods ended 12/31/20  
    Average Annual Total Returns  
                              Since  
                              Inception  
      1 Year       3 Years       5 Years       (08/1/11)
Boston Trust Walden Midcap Fund     8.76 %     10.42 %     12.55 %     11.59 %
Russell Midcap® Index     17.10 %     11.61 %     13.40 %     13.54 %

 

Hypothetical Growth of a $100,000 Investment

 

 

 

The above chart represents a hypothetical $100,000 investment in the Boston Trust Walden Midcap Fund from August 1, 2011 to December 31, 2020, and includes the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

 

The Boston Trust Walden Midcap Fund is measured against the Russell Midcap® Index, which is an unmanaged index that tracks the performance of the mid-cap segment of the U.S. equity universe. The Russell Midcap® Index is a subset of the Russell 1000® Index. It includes approximately 800 of the smallest securities based on a combination of their market capitalization and current index membership. The Russell Midcap® Index represents approximately 31% of the total market capitalization of the Russell 1000 companies. Russell Investment Group is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of Russell Investment Group. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 

Fund Net Asset Value:   $ 19.71  
Gross Expense Ratio1:     1.00 %

 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. Returns less than one year are not annualized. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

 

 

1 The Gross Expense Ratio is from the Fund’s most recent prospectus, dated May 1, 2020. The contractual fee limit under the Fund’s expense limitation agreement is 1.00% of the Fund’s average annual net assets, subject to certain limitations as described in the Fund’s prospectus. Additional information pertaining to the Fund’s expense ratio as of December 31, 2020 can be found in the financial highlights included in this report. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through May 1, 2021 and may be renewed thereafter.

 

29 

 

 

Boston Trust Walden SMID Cap Fund

(formerly known as the Walden SMID Cap Fund)

December 31, 2020

 

Kenneth P. Scott, CFA

Lead Portfolio Manager

 

Richard Q. Williams, CFA

Portfolio Manager

 

Leanne Moore

Portfolio Manager

 

Boston Trust Walden Inc.

 

Fund Objective

The Fund seeks long-term capital growth through an actively managed portfolio of stocks of small and middle capitalization (“smid cap”) companies.

 

Investment Concerns

Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.

 

Smid cap companies typically have a higher risk of failure and historically have experienced a greater degree of volatility.

 

Manager Commentary (Unaudited)

 

Management Discussion of Fund Performance

The fourth quarter performance capped off a year of superlatives for the Russell 2500™ Index (“Index”), which finished the year 20% higher than where it started in 2020, despite the 29.72% decline in the first quarter. Indeed, from the market trough in late March, the Index doubled in value. Even with the outperformance of the Fund during the first quarter drawdown (-25.03% versus -29.72%), the Fund’s total return of 9.13% for the 12-month period ended December 31, 2020 underperformed the Index by a wide margin.

 

It should perhaps not be surprising that the Fund failed to keep up in the strong market rally of the second, third, and fourth quarters of 2020. But to reiterate a theme consistent throughout the year, the underperformance was largely due to style: stocks of higher quality companies, particularly the more reasonably valued cohort, underperformed the overall index by a wide margin, and the Fund performed similarly. The performance gap between stocks of profitable and unprofitable companies was stunning: loss-makers1 outperformed by more than 65%. Loss-making entities also now comprise 18% of the index’s value. Given the Fund is entirely invested in stocks of profitable companies, the “allocation” effect of avoiding the loss-making cohort presented headwinds too strong to overcome, even with execution of our approach that was consistent with expectations.

 

Outlook

Entering 2021, we can point to several reasons for the optimism that has propelled the Index to new all-time highs in the fourth quarter. Among them included: the success in clinical trials and initial distribution of several Coronavirus (COVID-19) vaccines; continued economic recovery; somewhat less political uncertainty following the U.S. presidential election; and historically low interest rates. However, we also continue to see some risks in the current environment: a new surge of COVID-19 case counts that is leading to new restrictions on economic activity; a fragile economic recovery still dependent on monetary and fiscal support; and continuing evidence of speculative activity among investors. We believe valuation risk in the market overall to be elevated.

 

While we do not seek to gain an edge through market timing, we continue to believe that over the long term stock prices ultimately reflect company fundamentals. We do not believe investors will perpetually favor as a group companies that cannot consistently generate profits or free cash flow and yet trade at elevated valuation multiples of sales. Of course, some of these individual companies will emerge as high-quality industry leaders. However, not all, or even a majority of them will succeed. As such, we continue to emphasize in our research and portfolio management activities those companies that have a demonstrated history of profitability, stability, and growth, have sustainable business models, high quality of earnings, and that are trading at reasonable valuations. As of December 31, 2020, the Fund exhibited strong financial characteristics and a more reasonable valuation profile than the Index. As a result, we continue to believe the Fund may provide favorable risk-adjusted returns over the long term.*

 

 

* Portfolio composition is subject to change.

 1 Loss-makers are defined as companies with five-year cumulative EBIT (earnings before interest and taxes) less than $0.

 

30 

 

 

Investment Performance (Unaudited) Boston Trust Walden SMID Cap Fund
      December 31, 2020

 

    For the periods ended 12/31/20  
    Average Annual Total Returns  
                              Since  
                              Inception  
      1 Year       3 Years       5 Years       (06/28/12)
Boston Trust Walden SMID Cap Fund1     9.13 %     9.12 %     12.79 %     12.16 %
Russell 2500TM Index     19.99 %     11.33 %     13.64 %     13.24 %

 

Hypothetical Growth of a $100,000 Investment

 

 

 

The above chart represents a hypothetical $100,000 investment in the Boston Trust Walden SMID Cap Fund from June 28, 2012 to December 31, 2020, and includes the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and the graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

 

The Boston Trust Walden SMID Cap Fund is measured against the Russell 2500™ Index, which is an unmanaged index that tracks the performance of the small- to mid-cap segment of the U.S. equity universe, commonly referred to as “smid” cap. The Russell 2500™ is a subset of the Russell 3000® Index. It includes approximately 2500 of the smallest securities based on a combination of their market cap and current index membership. Russell Investment Group is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of Russell Investment Group. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 

Fund Net Asset Value:   $ 19.40  
Gross Expense Ratio1:     1.07 %

 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

 

 

1 The Gross Expense Ratio is from the Fund’s most recent prospectus, dated May 1, 2020. The contractual fee limit under the Fund’s expense limitation agreement is 1.00% of the Fund’s average annual net assets, subject to certain limitations as described in the Fund’s prospectus. Please see the Fund’s most recent prospectus for details. Additional information pertaining to the Fund’s expense ratio as of December 31, 2020 can be found in the financial highlights included in this report. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through May 1, 2021 and may be renewed thereafter.

 

31 

 

 

Boston Trust Walden Small Cap Fund

December 31, 2020

 

Kenneth P. Scott, CFA

Lead Portfolio Manager

 

Richard Q. Williams, CFA

Portfolio Manager

 

Leanne Moore

Portfolio Manager

 

Boston Trust Walden Inc.

 

Fund Objective

The Fund seeks long-term capital growth through an actively managed portfolio of stocks of small capitalization (“small cap”) companies.

 

Investment Concerns

Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.

 

Small cap funds typically carry additional risks since smaller companies generally have a higher risk of failure, and historically, their stocks have experienced a greater degree of market volatility than stocks on average.

 

Manager Commentary (Unaudited)

 

Management Discussion of Fund Performance

The fourth quarter performance capped off a year of superlatives for the Russell 2000® Index (“Index”), which finished the year 20% higher than where it started in 2020, despite the 30.61% decline in the first quarter. Indeed, from the market trough in late March, the Index doubled in value. Even with the outperformance of the Fund during the first quarter drawdown (-26.16% versus -30.61%), the Fund’s total return of 8.17% for the 12-month period ended December 31, 2020 underperformed the Index by a wide margin.

 

It should perhaps not be surprising that the Fund failed to keep up in the strong market rally of the second, third, and fourth quarters. But to reiterate a theme consistent throughout the year, the underperformance was largely due to style: stocks of higher quality companies, particularly the more reasonably valued cohort, underperformed the overall index by a wide margin, and the Fund performed similarly. The performance divide between stocks of profitable and unprofitable companies was stunning: loss-makers1 outperformed by more than 50%. Loss-making entities now comprise 23% of the Index’s value. Given the Fund is entirely invested in stocks of profitable companies, the “allocation” effect of avoiding the loss-making cohort presented headwinds too strong to overcome, even with execution of our approach that was consistent with expectations.

 

Outlook 

Entering 2021, we can point to several reasons for the optimism that have propelled the Index to new all-time highs in the fourth quarter. Among them included: the success in clinical trials and initial distribution of several Coronavirus (COVID-19) vaccines; continued economic recovery; somewhat less political uncertainty following the presidential election; and historically low interest rates. However, we also continue to see risk in the current environment: a new surge of COVID-19 case counts that is leading to new restrictions on economic activity; a fragile economic recovery still dependent on monetary and fiscal support; and continuing evidence of speculative activity among investors. We believe valuation risk in the market overall to be elevated.

 

While we do not seek to gain an edge through market timing, we continue to believe that over the long term stock prices ultimately reflect company fundamentals. We do not believe investors will perpetually favor, as a group, companies that cannot consistently generate profits or free cash flow and yet trade at elevated valuation multiples of sales. Of course, some of these individual companies will emerge as high-quality industry leaders. However, not all, or even a majority of them will succeed. As such, we continue to emphasize in our research and portfolio management activities those companies that have a demonstrated history of profitability, stability, and growth, have sustainable business models, high quality of earnings, and that are trading at reasonable valuations. As of December 31, 2020, the Fund exhibits strong financial characteristics and a more reasonable valuation profile than the Index. As a result, we continue to believe the strategy may provide favorable risk-adjusted returns over the long term.*

 

 

* Portfolio composition is subject to change.

 

1 Loss-makers are defined as companies with five-year cumulative EBIT (earnings before interest and taxes) less than $0.

 

32 

 

 

Investment Performance (Unaudited) Boston Trust Walden Small Cap Fund
        December 31, 2020

 

    For the periods ended 12/31/20  
    Average Annual Total Returns  
                                              Since  
                                              Inception  
      1 Year       3 Years       5 Years       10 Years       15 Years       (12/31/94)
Boston Trust Walden Small Cap Fund1     8.17 %     9.71 %     12.82 %     9.93 %     9.32 %     10.90 %
Russell 2000® Index     19.96 %     10.25 %     13.26 %     11.20 %     8.91 %     9.74 %

 

Hypothetical Growth of a $100,000 Investment

 

 

 

The above chart represents a 10-year hypothetical $100,000 investment in the Boston Trust Walden Small Cap Fund and includes the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

 

The Boston Trust Walden Small Cap Fund is measured against the Russell 2000® Index, which is an unmanaged index that tracks the performance of the small-cap segment of the U.S. equity universe. The Russell 2000® Index is a subset of the Russell 3000® Index representing approximately 10% of the total market capitalization of that index. It includes approximately 2,000 of the smallest securities based on a combination of their market cap and current index membership. Russell Investment Group is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of Russell Investment Group. The performance of an index does not reflect the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 

Fund Net Asset Value:   $ 15.31  
Gross Expense Ratio1:     1.07 %

 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

 

 

1 The Gross Expense Ratio is from the Fund’s most recent prospectus, dated May 1, 2020. The contractual fee limit under the Fund’s expense limitation agreement is 1.00% of the Fund’s average annual net assets, subject to certain limitations as described in the Fund’s prospectus. Please see the Fund’s most recent prospectus for details. Additional information pertaining to the Fund’s expense ratio as of December 31, 2020 can be found in the financial highlights included in this report. The investment performance may reflect fee reductions. If such fee reductions had not occurred, the quoted performance would have been lower. The contractual fee waiver continues through May 1, 2021 and may be renewed thereafter.

 

33 

 

 

Boston Trust Walden International Equity Fund

(formerly known as the Walden International Equity Fund)

December 31, 2020

 

William H. Apfel, CFA 

Lead Portfolio Manager

 

Nathaniel J. Riley, CFA

Portfolio Manager

 

David A. Sandell, CFA

Portfolio Manager

 

Boston Trust Walden Inc.

 

Fund Objective

The Fund seeks long-term capital growth through an actively managed portfolio of equities of international companies.

 

Investment Concerns

Foreign investing involves risks not typically associated with U.S. investments, including adverse political, regulatory, social and economic developments and differing auditing and legal standards. These risks are magnified in emerging markets.

 

Equity securities (stocks) are more volatile and carry more risk and return potential than other forms of investments, including investments in high-grade fixed income securities.

 

Mid-capitalization funds typically carry additional risks since smaller companies generally have a higher risk of failure.

 

Manager Commentary (Unaudited)

 

Management Discussion of Fund Performance

For the 12-month period ended December 31, 2020, the Boston Trust Walden International Equity Fund posted a total return of 7.16%. The Fund’s return trailed that of its primary benchmark, the MSCI World ex-USA Index (net) (“Index”), which posted a return of 7.59% for the year.

 

Global equity markets declined sharply in the first quarter of 2020 as economies slowed when the Coronavirus (COVID-19) pandemic took hold and government policies, along with fear of contagion, compelled people to stay home as much as possible. This led to lower spending on the part of consumers and businesses, and corporate earnings estimates for the year declined. Deterioration in fundamentals and rising volatility in financial markets led many investors to sell stocks; at its trough on March 23, 2020, the Index was down 34.21% year-to-date.

 

Governments around the globe answered with fiscal and monetary policy moves that quickly reversed the rout in financial markets. As the pandemic waned in the summer, economic activity in many parts of the world increased to near-normal levels, and stocks rose commensurately. In the fall, COVID-19 cases increased in many developed markets, but promising vaccine results and their initial rollout, along with continued government support of economies around the globe, propelled the equity market ever-higher through the remainder of the year.

 

Certain market segments fared better than others did. Most geographies performed well; of the 22 countries represented in the Index, all but six achieved a positive return for 2020. Of the decliners, most were smaller and less diversified equity markets; the only one of significant size was the UK, which grappled with the effects of an impending Brexit and a worse pandemic than many other countries. Most sectors also posted positive returns for the year, though there was a notable gap between the best performers and the worst. Certain sectors, like Information Technology, benefited from the stay-at-home lifestyle, while others, like Energy, suffered from lower use of their products worldwide.

 

Turning to other market factors, quality was a slight tailwind for the year. Stocks that appear to be high quality, as measured by the Adviser’s proprietary quality metric, outperformed lower quality stocks for the year. All the outperformance came in the first quarter as more stable companies with lower levels of debt were rewarded during the economic and market downturn; during the following nine months of the year higher quality stocks underperformed slightly. The Fund was overweight higher quality stocks relative to its benchmark throughout 2020, so this provided a modest performance benefit.

 

Expensive stocks, as measured by the Adviser’s proprietary valuation metric, outperformed the broader market for the year. This negatively affected the Fund’s performance, as it was underweight that segment of the market. This was offset, however, by an underweight position in the cheapest stocks relative to its benchmark, which underperformed the market during the year.*

 

 

* Portfolio composition is subject to change.

 

34 

 

 

Investment Performance (Unaudited) Boston Trust Walden International Equity Fund
        December 31, 2020

 

    For the periods ended 12/31/20  
    Average Annual Total Returns  
                              Since  
                              Inception  
      1 Year       3 Years       5 Years       (06/9/15)
Boston Trust Walden International Equity Fund     7.16 %     5.10 %     6.95 %     5.26 %
MSCI World ex-USA Index (Net)     7.59 %     4.22 %     7.64 %     5.26 %
FTSE All-World Developed ex-US Index     10.24 %     5.12 %     8.69 %     6.31 %

 

Hypothetical Growth of a $1,000,000 Investment

 

 

 

The above chart represents a hypothetical $1,000,000 investment in the Boston Trust Walden International Equity Fund from June 9, 2015 to December 31, 2020, and includes the reinvestment of dividends and capital gains in the Fund. The returns shown on the table and the graph do not reflect the deduction of taxes a shareholder would pay on Fund distributions or the redemption of Fund shares.

 

The Boston Trust Walden International Equity Fund is measured against the MSCI World ex-USA Index, which captures large and mid cap representation across 22 of 23 Developed Markets countries (excluding the United States) and the FTSE All World Developed ex-US Index, which represents the largest securities in developed countries equity markets (excluding the United States) based on all investable equity securities. Index returns reflect neither the deduction of expenses associated with a mutual fund, such as investment management and fund accounting fees. The Fund’s performance reflects the deduction of fees for these services. Investors cannot invest directly in an index.

 

Fund Net Asset Value:   $ 12.29  
Gross Expense Ratio1:     1.04 %

 

Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost. To obtain performance information current to the most recent month-end, please call 1-800-282-8782 ext. 7050.

 

 

1 The Gross Expense Ratio is from the Fund’s prospectus, dated May 1, 2020. Please see the Fund’s most recent prospectus for details. Additional information pertaining to the Fund’s expense ratio as of December 31, 2020 can be found in the financial highlights included in this report.

 

35 

 

 

Schedule of Portfolio Investments   Boston Trust Walden Balanced Fund
December 31, 2020

 

Security Description     Shares       Fair Value ($)  
Common Stocks (68.0%)                
Communication Services (7.3%)                
Alphabet, Inc., Class A (a)     1,000       1,752,640  
Alphabet, Inc., Class C (a)     2,450       4,292,106  
Charter Communications, Inc., Class A (a)     2,445       1,617,490  
Comcast Corp., Class A     26,000       1,362,400  
Electronic Arts, Inc.     7,000       1,005,200  
The Walt Disney Co. (a)     8,500       1,540,030  
Verizon Communications, Inc.     22,000       1,292,500  
              12,862,366  
Consumer Discretionary (6.4%)                
AutoZone, Inc. (a)     800       948,352  
Dollar General Corp.     7,000       1,472,100  
Lowe’s Cos., Inc.     4,500       722,295  
McDonald’s Corp.     5,500       1,180,190  
NIKE, Inc., Class B     17,000       2,404,990  
Ross Stores, Inc.     13,000       1,596,530  
Starbucks Corp.     18,000       1,925,640  
The Home Depot, Inc.     4,000       1,062,480  
              11,312,577  
Consumer Staples (5.3%)                
Church & Dwight Co., Inc.     6,000       523,380  
Colgate-Palmolive Co.     15,000       1,282,650  
Costco Wholesale Corp.     6,500       2,449,070  
Estee Lauder Cos., Inc., Class A     6,000       1,597,140  
PepsiCo, Inc.     12,000       1,779,600  
Procter & Gamble Co. (The)     6,000       834,840  
The Hershey Co.     6,500       990,145  
              9,456,825  
Energy (1.1%)                
ConocoPhillips     49,000       1,959,510  
              1,959,510  
Financials (7.9%)                
American Express Co.     11,000       1,330,010  
Chubb Ltd.     6,500       1,000,480  
Cincinnati Financial Corp.     13,500       1,179,495  
Commerce Bancshares, Inc.     11,550       758,835  
JPMorgan Chase & Co.     20,000       2,541,400  
Moody’s Corp.     2,500       725,600  
Northern Trust Corp.     20,000       1,862,800  
PNC Financial Services Group, Inc.     11,500       1,713,500  
T. Rowe Price Group, Inc.     10,000       1,513,900  
U.S. Bancorp     30,500       1,420,995  
              14,047,015  
Health Care (10.7%)                
Amgen, Inc.     4,000       919,680  
Becton, Dickinson & Co.     7,250       1,814,095  
Cerner Corp.     11,000       863,280  
Danaher Corp.     4,500       999,630  
Intuitive Surgical, Inc. (a)     1,700       1,390,770  
Johnson & Johnson     8,250       1,298,385  
Medtronic PLC     17,000       1,991,380  
Merck & Co., Inc.     15,000       1,227,000  
Mettler-Toledo International, Inc. (a)     1,400       1,595,552  
Stryker Corp.     9,250       2,266,620  
The Cooper Companies., Inc.     2,600       944,632  
UnitedHealth Group, Inc.     6,750       2,367,090  
Waters Corp. (a)     5,500       1,360,810  
              19,038,924  
Industrials (7.6%)                
3M Co.     8,500       1,485,715  
Cummins, Inc.     5,500       1,249,050  
Deere & Co.     6,000       1,614,300  
Donaldson Co., Inc.     22,000       1,229,360  
Hubbell, Inc.     9,500       1,489,505  
Illinois Tool Works, Inc.     5,000       1,019,400  
Lincoln Electric Holdings, Inc.     5,000       581,250  
Union Pacific Corp.     9,500       1,978,090  
United Parcel Service, Inc., Class B     9,500       1,599,800  
W.W. Grainger, Inc.     3,000       1,225,020  
              13,471,490  
Information Technology (17.9%)                
Accenture PLC, Class A     12,000       3,134,520  
Akamai Technologies, Inc. (a)     9,500       997,405  
Analog Devices, Inc.     7,500       1,107,975  
Apple, Inc.     66,000       8,757,540  
Automatic Data Processing, Inc.     13,000       2,290,600  
Cisco Systems, Inc.     39,000       1,745,250  
Intel Corp.     25,000       1,245,500  
Intuit, Inc.     2,000       759,700  
Microsoft Corp.     30,000       6,672,601  
Oracle Corp.     32,000       2,070,080  
Visa, Inc., Class A     13,500       2,952,855  
              31,734,026  
Materials (2.2%)                
Air Products & Chemicals, Inc.     5,000       1,366,100  
AptarGroup, Inc.     10,500       1,437,345  
PPG Industries, Inc.     8,000       1,153,760  
              3,957,205  
Utilities (1.6%)                
Atmos Energy Corp.     8,000       763,440  
Eversource Energy     24,000       2,076,240  
              2,839,680  
TOTAL COMMON STOCKS (Cost $53,525,965)             120,679,618  

 

    Principal          
      Amount ($)          
Certificate of Deposit (0.1%)                
Certificate of Deposit (0.1%)                
Self-Help Federal Credit Union, 1.90%, 12/20/21 (b)     200,000       203,625  
TOTAL CERTIFICATE OF DEPOSIT (Cost $200,000)             203,625  
Corporate Bonds (4.1%)                
Communication Services (0.3%)                
Comcast Corp., 3.30%, 4/1/27, Callable 2/1/27 @ 100     250,000       284,590  
Comcast Corp., 3.95%, 10/15/25, Callable 8/15/25 @ 100     250,000       287,404  
              571,994  
Consumer Discretionary (0.5%)                
NIKE, Inc., 2.75%, 3/27/27, Callable 1/27/27 @ 100     500,000       553,729  

 

See Notes to Financial Statements

 

36 

 

 

Schedule of Portfolio Investments   Boston Trust Walden Balanced Fund
December 31, 2020

 

      Principal          
Security Description     Amount ($)       Fair Value ($)  
Corporate Bonds, Continued                
Consumer Discretionary, continued                
Starbucks Corp., 2.45%, 6/15/26, Callable 3/15/26 @ 100     350,000       378,465  
              932,194  
Financials (0.8%)                
American Express Co., 2.65%, 12/2/22     287,000       299,666  
John Deere Capital Corp., 2.80%, 7/18/29     350,000       390,209  
John Deere Capital Corp., 2.95%, 4/1/22, MTN     150,000       155,026  
JPMorgan Chase & Co., 2.95%, 10/1/26, Callable 7/1/26 @ 100     500,000       555,005  
              1,399,906  
Health Care (0.6%)                
Abbott Laboratories, 2.95%, 3/15/25, Callable 12/15/24 @ 100     100,000       109,784  
Healthcare Corp., 1.15%, 6/15/25, Callable 5/15/25 @ 100     100,000       102,099  
Kaiser Foundation Hospitals, 3.15%, 5/1/27, Callable 2/1/27 @ 100     250,000       282,731  
Merck & Co., Inc., 3.88%, 1/15/21     150,000       150,101  
Pfizer, Inc., 3.40%, 5/15/24     100,000       109,997  
Stryker Corp., 3.50%, 3/15/26, Callable 12/15/25 @ 100     300,000       339,335  
              1,094,047  
Industrials (0.6%)                
3M Co., 3.00%, 8/7/25     250,000       277,770  
Emerson Electric Co., 2.63%, 2/15/23, Callable 11/15/22 @ 100     200,000       208,690  
Hubbell, Inc., 3.35%, 3/1/26, Callable 12/1/25 @ 100     145,000       159,578  
Hubbell, Inc., 3.50%, 2/15/28, Callable 11/15/27 @ 100     150,000       163,456  
Hubbell, Inc., 3.63%, 11/15/22     75,000       79,241  
United Parcel Service, Inc., 2.40%, 11/15/26, Callable 8/15/26 @ 100     200,000       218,598  
              1,107,333  
Information Technology (1.2%)                
Apple, Inc., 2.20%, 9/11/29, Callable 6/11/29 @ 100     350,000       378,197  
Apple, Inc., 2.85%, 2/23/23, Callable 12/23/22 @ 100     150,000       157,565  
Apple, Inc., 3.00%, 6/20/27, Callable 3/20/27 @ 100     200,000       224,167  
Mastercard, Inc., 2.95%, 11/21/26, Callable 8/21/26 @ 100     100,000       111,918  
Mastercard, Inc., 3.30%, 3/26/27, Callable 1/26/27 @ 100     150,000       171,275  
Oracle Corp., 2.50%, 4/1/25, Callable 3/1/25 @ 100     200,000       215,122  
Oracle Corp., 3.40%, 7/8/24, Callable 4/8/24 @ 100     300,000       328,518  
Visa, Inc., 3.15%, 12/14/25, Callable 9/14/25 @ 100     275,000       308,712  
              1,895,474  
Utilities (0.1%)                
Midamerican Energy Co., 3.10%, 5/1/27,Callable 2/1/27 @ 100     200,000       224,514  
                 
TOTAL CORPORATE BONDS (Cost $6,770,858)             7,225,462  
                 
Municipal Bonds (2.4%)                
                 
Georgia (0.2%)                
State of Georgia, GO, 1.40%, 8/1/33, Callable 8/1/30 @ 100     350,000       348,688  
                 
Hawaii (0.3%)                
State of Hawaii, GO, 1.87%, 8/1/33, Callable 8/1/30 @ 100     500,000       507,580  
                 
Massachusetts (1.7%)                
Commonwealth of Massachusetts, GO, Series D, 3.00%, 5/1/35, Callable 5/1/29 @ 100 (b)     1,150,000       1,301,697  
Commonwealth of Massachusetts, GO, Series D, 3.00%, 5/1/36, Callable 5/1/29 @ 100 (b)     1,500,000       1,689,614  
              2,991,311  
New York (0.1%)                
New York State Environmental Facilities Corp., Series C, 1.89%, 7/15/22     190,000       194,180  
                 
Wisconsin (0.1%)                
Wisconsin State, Build America Bonds, GO, 4.60%, 5/1/26, Callable 5/1/21 @ 100     250,000       253,473  
                 
TOTAL MUNICIPAL BONDS (Cost $4,034,411)             4,295,232  
                 
U.S. Government & U.S. Government Agency Obligations (23.4%)                
                 
Federal Farm Credit Bank (0.8%)                
2.60%, 10/6/22     150,000       156,485  
2.75%, 7/16/27     250,000       282,379  
2.85%, 3/2/28     750,000       857,512  
              1,296,376  
Federal Home Loan Bank (3.6%)                
2.13%, 3/10/23     1,000,000       1,043,455  
2.50%, 3/11/22     200,000       205,685  
2.88%, 6/14/24     1,000,000       1,091,932  
2.88%, 9/13/24     1,000,000       1,097,071  
3.25%, 6/9/23     850,000       913,146  
5.25%, 8/15/22     1,000,000       1,082,638  
5.50%, 7/15/36     700,000       1,082,734  
              6,516,661  
Federal National Mortgage Association (3.4%)                
1.88%, 9/24/26     1,000,000       1,081,840  
2.13%, 4/24/26     1,250,000       1,362,561  
2.63%, 9/6/24     3,250,000       3,536,019  
              5,980,420  
Government National Mortgage Association (0.0%) (c)                
4.00%, 9/15/40     18,105       19,601  
4.00%, 9/15/41     67,915       73,416  
6.50%, 5/15/32     1,251       1,389  
              94,406  

 

See Notes to Financial Statements

 

37 

 

 

Schedule of Portfolio Investments   Boston Trust Walden Balanced Fund
December 31, 2020

 

U.S. Government & U.S. Government Agency Obligations, Continued

 

      Principal          
Security Description     Amount ($)       Fair Value ($)  
Housing & Urban Development (0.3%)                
2.70%, 8/1/22     491,000       497,892  
U.S. Treasury Inflation Index Note (1.0%)                
0.25%, 7/15/29     1,017,950       1,153,211  
0.75%, 7/15/28     518,660       603,618  
              1,756,829  
U.S. Treasury Note (14.3%)                
0.63%, 8/15/30     1,500,000       1,462,734  
1.63%, 8/15/29     5,000,000       5,349,608  
1.75%, 5/15/23     2,500,000       2,595,605  
2.13%, 11/30/23     2,000,000       2,114,766  
2.13%, 5/15/25     3,500,000       3,778,633  
2.50%, 2/28/26     750,000       831,621  
2.63%, 12/31/23     1,000,000       1,073,516  
2.75%, 8/31/23     1,500,000       1,603,594  
2.75%, 11/15/23     1,500,000       1,611,797  
2.75%, 2/28/25     3,500,000       3,858,545  
2.88%, 9/30/23     1,000,000       1,074,453  
              25,354,872  
TOTAL U.S. GOVERNMENT & U.S. GOVERNMENT AGENCY OBLIGATIONS (Cost $38,865,939)             41,497,456  
                 
Yankee Dollar (0.2%)                
Financials (0.2%)                
The Toronto-Dominion Bank, 3.50%, 7/19/23, MTN     350,000       378,950  
TOTAL YANKEE DOLLAR (Cost $354,212)             378,950  
                 

Investment Companies (1.6%)     Shares          
JPMorgan U.S. Government Money  Market Fund, Capital Shares, 0.03% (d)     2,795,394       2,795,394  
TOTAL INVESTMENT COMPANIES (Cost $2,795,394)             2,795,394  
Total Investments (Cost $106,546,779) — 99.8% (e)             177,075,737  
Other assets in excess of liabilities — 0.2%             307,273  
NET ASSETS — 100.0%           $ 177,383,010  

 

 
(a) Non-income producing security.

(b) These securities have been deemed illiquid and represents 1.80% of the Fund’s net assets.

(c) Represents less than 0.05%.

(d) Rate disclosed is the seven day yield as of December 31, 2020.

(e) See Federal Tax Information listed in the Notes to the Financial Statements.

 

GO General Obligation

MTN Medium Term Note

PLC Public Limited Company

 

See Notes to Financial Statements

 

38 

 

 

Financial Statements Boston Trust Walden Balanced Fund

 

Statement of Assets and Liabilities

December 31, 2020

 

Assets:    
Investments, at fair value (cost $106,546,779) $ 177,075,737
Interest and dividends receivable   419,941
Receivable for capital shares issued   23,045
Prepaid expenses   15,560
Total Assets   177,534,283
Liabilities:    
Payable for capital shares redeemed   4,355
Accrued expenses and other liabilities:    
Investment adviser   110,966
Administration and accounting   7,051
Chief compliance officer   812
Custodian   1,608
Shareholder servicing fees   15,533
Transfer agent   3,096
Trustee   2,194
Other   5,658
Total Liabilities   151,273
Net Assets $ 177,383,010
Composition of Net Assets:    
Paid in capital $ 105,948,728
Total distributable earnings/(loss)   71,434,282
Net Assets $ 177,383,010
Shares outstanding (par value $0.01, unlimited number of shares authorized)   8,128,169
Net Asset Value, Offering Price and Redemption price per share $ 21.82


 

Statement of Operations

For the year ended December 31, 2020

 

Investment Income:    
Interest $ 1,002,130
Dividends   1,936,774
Total Investment Income   2,938,904
Expenses:    
Investment adviser   1,198,883
Administration and accounting   99,005
Chief compliance officer   12,179
Custodian   22,489
Shareholder servicing   178,114
Transfer agency   37,310
Trustee   10,739
Other   73,290
Total expenses before fee reductions   1,632,009
Fees contractually reduced by the investment adviser   (33,272 )
Net Expenses   1,598,737
Net Investment Income   1,340,167
Net Realized/Unrealized Gains (Losses) from Investments:    
Net realized gains from investment transactions   4,321,388
Change in unrealized appreciation/depreciation on investments   8,652,006
Net realized/unrealized gains (losses) on investments   12,973,394
Change in Net Assets Resulting from Operations $ 14,313,561

 

See Notes to Financial Statements

 

39 

 

 

Financial Statements Boston Trust Walden Balanced Fund

 

Statements of Changes in Net Assets

 

    For the year ended     For the year ended  
    December 31, 2020     December 31, 2019  
Investment Activities:                
Operations:                
Net investment income   $ 1,340,167     $ 1,453,834  
Net realized gains from investment transactions     4,321,388       1,420,529  
Change in unrealized appreciation/depreciation on investments     8,652,006       27,075,874  
Change in Net Assets Resulting from Operations     14,313,561       29,950,237  
Distributions to shareholders:                
Total Distributions     (5,142,308 )     (2,514,243 )
Change in Net Assets Resulting from distributions to shareholders     (5,142,308 )     (2,514,243 )
Capital Share Transactions:                
Proceeds from shares issued     28,024,694       17,881,885  
Dividends reinvested     4,213,462       2,015,907  
Cost of shares redeemed     (21,918,263 )     (13,937,371 )
Change in Net Assets Resulting from Capital Share Transactions     10,319,893       5,960,421  
Change in Net Assets     19,491,146       33,396,415  
Net Assets:                
Beginning of period     157,891,864       124,495,449  
End of period   $ 177,383,010     $ 157,891,864  
Share Transactions:                
Issued     1,413,309       943,180  
Reinvested     195,884       99,208  
Redeemed     (1,088,200 )     (732,434 )
Change in shares     520,993       309,954  

 

See Notes to Financial Statements

 

40 

 

 

Financial Statements Boston Trust Walden Balanced Fund

 

Financial Highlights                                    
Selected data for a share outstanding throughout the years indicated.                
                                             
      For the year       For the year       For the year       For the year       For the nine
months
      For the year  
      ended       ended       ended       ended       ended       ended  
      December       December       December       December       December       March 31,  
      31, 2020       31, 2019       31, 2018       31, 2017       31, 2016       2016  
Net Asset Value, Beginning of Period   $ 20.76     $ 17.06     $ 17.76     $ 15.74     $ 15.32     $ 15.96  
Investment Activities:                                                
Operations:                                                
Net investment income     0.17       0.19       0.19       0.18       0.13       0.20  
Net realized/unrealized gains (losses) from                                                
investments     1.54       3.85       (0.52 )     2.16       0.77       0.27  
Total from investment activities     1.71       4.04       (0.33 )     2.34       0.90       0.47  
Dividends:                                                
Net investment income     (0.17 )     (0.20 )     (0.18 )     (0.18 )     (0.17 )     (0.21 )
Net realized gains from investments     (0.48 )     (0.14 )     (0.19 )     (0.14 )     (0.31 )     (0.90 )
Total dividends     (0.65 )     (0.34 )     (0.37 )     (0.32 )     (0.48 )     (1.11 )
Net Asset Value, End of Period   $ 21.82     $ 20.76     $ 17.06     $ 17.76     $ 15.74     $ 15.32  
Total Return     8.26 %     23.70 %     (1.90 )%     14.88 %     5.87 %(a)     3.10 %
Ratios/Supplemental Data:                                                
Net assets at end of period (000’s)   $ 177,383     $ 157,892     $ 124,495     $ 121,356     $ 101,126     $ 86,891  
Ratio of net expenses to average net assets     1.00 %     1.00 %     1.00 %     1.00 %     1.00 %(b)     1.00 %
Ratio of net investment income to average net assets     0.84 %     1.01 %     1.02 %     1.08 %     1.13 %(b)     1.29 %
Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment adviser) to average net assets (c)     1.02 %     1.02 %     1.04 %     1.03 %     1.05 %(b)     1.06 %
Portfolio turnover rate     18.73 %     12.99 %     8.47 %     8.40 %     10.18 %(a)     15.56 %

 

 

(a) Not annualized for periods less than one year.

(b) Annualized for periods less than one year.

(c) During the periods, certain fees were reduced. If such fee reduction had not occurred, the ratio would have been as indicated.

 

See Notes to Financial Statements

 

41 

 

 

Schedule of Portfolio Investments   Boston Trust Walden Equity Fund
December 31, 2020

 

Security Description     Shares     Fair Value ($)  
Common Stocks (98.7%)                
Communication Services (10.7%)                
Alphabet, Inc., Class A (a)     2,700       4,732,128  
Alphabet, Inc., Class C (a)     4,700       8,233,836  
Charter Communications, Inc., Class A (a)     4,879       3,227,702  
Comcast Corp., Class A     66,725       3,496,390  
Electronic Arts, Inc.     14,000       2,010,400  
The Walt Disney Co. (a)     19,000       3,442,420  
Verizon Communications, Inc.     54,500       3,201,875  
              28,344,751  
Consumer Discretionary (8.4%)                
Dollar General Corp.     18,000       3,785,400  
McDonald’s Corp.     10,250       2,199,445  
NIKE, Inc., Class B     41,000       5,800,270  
Ross Stores, Inc.     32,500       3,991,325  
Starbucks Corp.     39,000       4,172,220  
The Home Depot, Inc.     7,000       1,859,340  
The TJX Cos., Inc.     5,000       341,450  
              22,149,450  
Consumer Staples (8.1%)                
Church & Dwight Co., Inc.     9,000       785,070  
Colgate-Palmolive Co.     30,000       2,565,300  
Costco Wholesale Corp.     16,500       6,216,870  
Estee Lauder Cos., Inc., Class A     12,500       3,327,375  
PepsiCo, Inc.     30,000       4,449,000  
Procter & Gamble Co. (The)     6,500       904,410  
The Clorox Co.     5,500       1,110,560  
The Hershey Co.     14,000       2,132,620  
              21,491,205  
Energy (1.2%)                
ConocoPhillips     77,000       3,079,230  
              3,079,230  
Financials (12.0%)                
American Express Co.     24,375       2,947,181  
Chubb Ltd.     20,000       3,078,400  
Cincinnati Financial Corp.     17,550       1,533,344  
Discover Financial Services     2,000       181,060  
JPMorgan Chase & Co.     45,000       5,718,150  
M&T Bank Corp.     5,000       636,500  
Marsh & McLennan Cos., Inc.     17,000       1,989,000  
Moody’s Corp.     5,000       1,451,200  
Northern Trust Corp.     40,500       3,772,170  
PNC Financial Services Group, Inc.     29,500       4,395,500  
T. Rowe Price Group, Inc.     20,000       3,027,800  
U.S. Bancorp     66,000       3,074,940  
              31,805,245  
Health Care (16.1%)                
Amgen, Inc.     7,000       1,609,440  
Becton, Dickinson & Co.     16,500       4,128,630  
Cerner Corp.     22,000       1,726,560  
Danaher Corp.     11,000       2,443,540  
Dentsply Sirona, Inc.     15,000       785,400  
Intuitive Surgical, Inc. (a)     4,000       3,272,400  
Johnson & Johnson     18,000       2,832,840  
Medtronic PLC     33,000       3,865,620  
Merck & Co., Inc.     33,000       2,699,400  
Mettler-Toledo International, Inc. (a)     3,000       3,419,040  
Stryker Corp.     21,000       5,145,840  
The Cooper Companies., Inc.     5,000       1,816,600  
UnitedHealth Group, Inc.     17,000       5,961,560  
Waters Corp. (a)     11,700       2,894,814  
              42,601,684  
Industrials (11.1%)                
3M Co.     19,500       3,408,405  
Cummins, Inc.     11,000       2,498,100  
Deere & Co.     13,300       3,578,365  
Donaldson Co., Inc.     41,450       2,316,226  
Hubbell, Inc.     22,500       3,527,775  
Illinois Tool Works, Inc.     15,500       3,160,140  
Union Pacific Corp.     23,300       4,851,526  
United Parcel Service, Inc., Class B     20,500       3,452,200  
W.W. Grainger, Inc.     6,500       2,654,210  
              29,446,947  
Information Technology (25.9%)                
Accenture PLC, Class A     27,000       7,052,670  
Akamai Technologies, Inc. (a)     22,000       2,309,780  
Analog Devices, Inc.     18,000       2,659,140  
Apple, Inc.     145,000       19,240,050  
Automatic Data Processing, Inc.     25,850       4,554,770  
Cisco Systems, Inc.     74,000       3,311,500  
Intel Corp.     42,500       2,117,350  
Microsoft Corp.     74,000       16,459,080  
Oracle Corp.     60,000       3,881,400  
Visa, Inc., Class A     30,000       6,561,900  
              68,147,640  
Materials (3.0%)                
Air Products & Chemicals, Inc.     8,000       2,185,760  
AptarGroup, Inc.     26,000       3,559,140  
PPG Industries, Inc.     16,000       2,307,520  
              8,052,420  
Utilities (2.2%)                
Atmos Energy Corp.     15,000       1,431,450  
Eversource Energy     51,500       4,455,265  
              5,886,715  
TOTAL COMMON STOCKS (Cost $104,601,594)             261,005,287  
                 
Investment Companies (1.2%)                
JPMorgan U.S. Government Money Market Fund, Capital Shares, 0.03% (b)     3,267,571       3,267,571  
TOTAL INVESTMENT COMPANIES (Cost $3,267,571)             3,267,571  
                 
Total Investments (Cost $107,869,165) — 99.9% (c)             264,272,858  
Other assets in excess of liabilities — 0.1%             145,269  
NET ASSETS — 100.0%           $ 264,418,127  

 

 

(a) Non-income producing security.

(b) Rate disclosed is the seven day yield as of December 31, 2020.

(c) See Federal Tax Information listed in the Notes to the Financial Statements.

 

PLC Public Limited Company

 

See Notes to Financial Statements

 

42 

 

 

Financial Statements Boston Trust Walden Equity Fund

 

Statement of Assets and Liabilities

December 31, 2020

 

Assets:    
Investments, at fair value (cost $107,869,165) $ 264,272,858
Dividends receivable   229,912
Receivable for capital shares issued   171,054
Prepaid expenses   14,908
Total Assets   264,688,732
Liabilities:    
Payable for capital shares redeemed   53,102
Accrued expenses and other liabilities:    
Investment adviser   157,133
Administration and accounting   9,439
Chief compliance officer   1,166
Custodian   2,171
Shareholder servicing fees   31,823
Transfer agent   3,232
Trustee   3,137
Other   9,402
Total Liabilities   270,605
Net Assets $ 264,418,127
Composition of Net Assets:    
Paid in capital $ 106,724,327
Total distributable earnings/(loss)   157,693,800
Net Assets $ 264,418,127
Shares outstanding (par value $0.01, unlimited number of shares authorized)   9,173,301
Net Asset Value, Offering Price and Redemption price per share $ 28.82


 

Statement of Operations

For the year ended December 31, 2020

 

Investment Income:      
Dividends   $ 4,197,381  
Total Investment Income     4,197,381  
Expenses:        
Investment adviser     1,726,719  
Administration and accounting     135,719  
Chief compliance officer     17,733  
Custodian     32,088  
Shareholder servicing     377,651  
Transfer agency     39,195  
Trustee     15,610  
Other     101,361  
Total expenses before fee reductions     2,446,076  
Fees contractually reduced by the investment adviser     (143,297 )
Net Expenses     2,302,779  
Net Investment Income     1,894,602  
Net Realized/Unrealized Gains (Losses) from        
Investments:        
Net realized gains from investment transactions     7,022,165  
Change in unrealized appreciation/depreciation on        
investments     20,925,528  
Net realized/unrealized gains (losses) on investments     27,947,693  
Change in Net Assets Resulting from Operations   $ 29,842,295  

 

See Notes to Financial Statements

 

43 

 

 

Financial Statements Boston Trust Walden Equity Fund

 

Statements of Changes in Net Assets

 

  For the year ended   For the year ended
  December 31, 2020   December 31, 2019
Investment Activities:          
Operations:          
Net investment income $ 1,894,602   $ 1,866,744
Net realized gains from investment transactions   7,022,165     7,908,081
Change in unrealized appreciation/depreciation on investments   20,925,528     51,904,859
Change in Net Assets Resulting from Operations   29,842,295     61,679,684
Distributions to shareholders:          
Total Distributions   (10,053,152)     (7,360,570)
Change in Net Assets Resulting from distributions to shareholders   (10,053,152)     (7,360,570)
Capital Share Transactions:          
Proceeds from shares issued   38,832,045     32,110,753
Dividends reinvested   7,984,924     6,014,991
Cost of shares redeemed   (50,717,437)     (36,513,094)
Change in Net Assets Resulting from Capital Share Transactions   (3,900,468)     1,612,650
Change in Net Assets   15,888,675     55,931,764
Net Assets:          
Beginning of period   248,529,452     192,597,688
End of period $ 264,418,127   $ 248,529,452
Share Transactions:          
Issued   1,564,906     1,327,796
Reinvested   282,952     233,773
Redeemed   (2,061,965)     (1,509,693)
Change in shares   (214,107)     51,876

 

See Notes to Financial Statements

 

44 

 

 

Financial Statements Boston Trust Walden Equity Fund

 

Financial Highlights                                    
Selected data for a share outstanding throughout the years indicated.                        
                                             
      For the year       For the year       For the year       For the year       For the nine
months
      For the year  
      ended       ended       ended       ended       ended       ended  
      December       December       December       December       December       March 31,  
      31, 2020       31, 2019       31, 2018       31, 2017       31, 2016       2016  
Net Asset Value, Beginning of Period   $ 26.47     $ 20.63     $ 21.61     $ 18.82     $ 17.88     $ 18.55  
Investment Activities:                                                
Operations:                                                
Net investment income     0.21       0.20       0.19       0.20       0.14       0.23  
Net realized/unrealized gains (losses) from                                                
investments     3.28       6.44       (0.72 )     3.70       1.44       0.29  
Total from investment activities     3.49       6.64       (0.53 )     3.90       1.58       0.52  
Dividends:                                                
Net investment income     (0.21 )     (0.20 )     (0.18 )     (0.20 )     (0.18 )     (0.24 )
Net realized gains from investments     (0.93 )     (0.60 )     (0.27 )     (0.91 )     (0.46 )     (0.95 )
Total dividends     (1.14 )     (0.80 )     (0.45 )     (1.11 )     (0.64 )     (1.19 )
Net Asset Value, End of Period   $ 28.82     $ 26.47     $ 20.63     $ 21.61     $ 18.82     $ 17.88  
Total Return     13.28 %     32.30 %     (2.54 )%     20.77 %     8.80 %(a)     2.92 %
Ratios/Supplemental Data:                                                
Net assets at end of period (000’s)   $ 264,418     $ 248,529     $ 192,598     $ 197,439     $ 181,830     $ 164,566  
Ratio of net expenses to average net assets     1.00 %     1.00 %     1.00 %     1.00 %     1.00 %(b)     1.00 %
Ratio of net investment income to average net assets     0.82 %     0.83 %     0.82 %     0.93 %     1.00 %(b)     1.21 %
Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment adviser) to average net assets (c)     1.06 %     1.07 %     1.08 %     1.07 %     1.09 %(b)     1.10 %
Portfolio turnover rate     14.96 %     10.57 %     6.51 %     9.88 %     9.94 %(a)     17.78 %

 

 

(a) Not annualized for periods less than one year.

(b) Annualized for periods less than one year.

(c) During the periods, certain fees were reduced. If such fee reduction had not occurred, the ratio would have been as indicated.

 

See Notes to Financial Statements

 

45 

 

 

Schedule of Portfolio Investments   Boston Trust Walden Midcap Fund
December 31, 2020

 

Security Description   Shares     Fair Value ($)  
Common Stocks (98.8%)            
Communication Services (2.8%)                
Electronic Arts, Inc.     8,475       1,217,010  
Omnicom Group, Inc.     17,400       1,085,238  
              2,302,248  
Consumer Discretionary (9.8%)                
AutoZone, Inc. (a)     850       1,007,624  
Carter’s, Inc.     14,600       1,373,422  
eBay, Inc.     26,975       1,355,494  
Hyatt Hotels Corp., Class A     15,225       1,130,456  
O’Reilly Automotive, Inc. (a)     1,925       871,197  
Ross Stores, Inc.     11,000       1,350,910  
Tractor Supply Co.     7,575       1,064,894  
              8,153,997  
Consumer Staples (5.3%)                
Church & Dwight Co., Inc.     8,700       758,901  
Lancaster Colony Corp.     3,575       656,835  
Sysco Corp.     11,150       827,999  
The Hershey Co.     8,100       1,233,873  
The JM Smucker Co.     8,075       933,470  
              4,411,078  
Energy (1.1%)                
Baker Hughes Co.     45,075       939,814  
              939,814  
Financials (12.4%)                
Brown & Brown, Inc.     14,800       701,668  
CBOE Global Markets, Inc.     10,350       963,792  
Everest Re Group Ltd.     3,250       760,793  
FactSet Research Systems, Inc.     4,125       1,371,563  
M&T Bank Corp.     10,825       1,378,022  
Northern Trust Corp.     15,150       1,411,070  
SEI Investments Co.     22,750       1,307,443  
Signature Bank     7,050       953,795  
T. Rowe Price Group, Inc.     9,350       1,415,496  
              10,263,642  
Health Care (13.0%)                
Agilent Technologies, Inc.     9,700       1,149,353  
Cerner Corp.     13,425       1,053,594  
Henry Schein, Inc. (a)     11,625       777,248  
Hill-Rom Holdings, Inc.     12,700       1,244,219  
Mettler-Toledo International, Inc. (a)     715       814,871  
Steris PLC     6,625       1,255,702  
Teleflex, Inc.     1,950       802,562  
The Cooper Companies., Inc.     3,275       1,189,873  
Waters Corp. (a)     6,350       1,571,117  
Zimmer Biomet Holdings, Inc.     6,225       959,210  
              10,817,749  
Industrials (15.4%)                
AMETEK, Inc.     10,425       1,260,799  
AO Smith Corp.     18,650       1,022,393  
Cummins, Inc.     4,350       987,885  
Donaldson Co., Inc.     22,750       1,271,269  
Expeditors International of Washington, Inc.     12,150       1,155,587  
Hubbell, Inc.     6,950       1,089,691  
Lincoln Electric Holdings, Inc.     8,650       1,005,562  
Masco Corp.     13,775       756,661  
Nordson Corp.     4,050       813,848  
Snap-on, Inc.     5,550       949,827  
The Middleby Corp. (a)     5,400       696,168  
Verisk Analytics, Inc.     4,200       871,878  
W.W. Grainger, Inc.     2,100       857,514  
              12,739,082  
Information Technology (19.7%)                
Akamai Technologies, Inc. (a)     8,425       884,541  
Amdocs Ltd.     12,175       863,573  
ANSYS, Inc. (a)     2,250       818,550  
Aspen Technology, Inc. (a)     10,725       1,396,930  
Broadridge Finance Solutions, Inc.     7,075       1,083,890  
CDK Global, Inc.     15,100       782,633  
Check Point Software Technologies Ltd. (a)     7,450       990,180  
Citrix Systems, Inc.     10,025       1,304,253  
Cognizant Technology Solutions Corp., Class A     12,525       1,026,424  
Dolby Laboratories, Inc., Class A     11,975       1,163,132  
F5 Networks, Inc. (a)     7,100       1,249,174  
IPG Photonics Corp. (a)     6,075       1,359,524  
Paychex, Inc.     21,575       2,010,358  
TE Connectivity Ltd.     11,725       1,419,546  
              16,352,708  
Materials (6.3%)                
AptarGroup, Inc.     8,525       1,166,987  
Avery Dennison Corp.     10,425       1,617,021  
Packaging Corporation of America     9,125       1,258,429  
RPM International, Inc.     12,625       1,146,098  
              5,188,535  
Real Estate (6.0%)                
Alexandria Real Estate Equities, Inc.     5,125       913,378  
AvalonBay Communities, Inc.     500       80,215  
Camden Property Trust     9,525       951,738  
CyrusOne, Inc.     9,750       713,213  
Jones Lang LaSalle, Inc. (a)     9,100       1,350,167  
Realty Income Corp.     15,325       952,754  
              4,961,465  
Utilities (7.0%)                
Atmos Energy Corp.     11,325       1,080,745  
Consolidated Edison, Inc.     16,750       1,210,523  
Eversource Energy     23,855       2,063,696  
ONE Gas, Inc.     18,975       1,456,710  
              5,811,674  
TOTAL COMMON STOCKS (Cost $55,634,886)             81,941,992  
                 
Investment Companies (1.0%)                
JPMorgan U.S. Government Money Market Fund, Capital Shares, 0.03% (b)     844,274       844,274  
TOTAL INVESTMENT COMPANIES (Cost $844,274)             844,274  
                 
Total Investments (Cost $56,479,160) — 99.8% (c)             82,786,266  
Other assets in excess of liabilities — 0.2%             161,742  
NET ASSETS — 100.0%           $ 82,948,008  

 

 

(a) Non-income producing security.

(b) Rate disclosed is the seven day yield as of December 31, 2020.

(c) See Federal Tax Information listed in the Notes to the Financial Statements.

 

PLC Public Limited Company

 

See Notes to Financial Statements

 

46 

 

 

Financial Statements Boston Trust Walden Midcap Fund

 

Statement of Assets and Liabilities

December 31, 2020

 

Assets:    
Investments, at fair value (cost $56,479,160) $ 82,786,266
Dividends receivable   80,829
Receivable for capital shares issued   140,312
Prepaid expenses   7,975
Total Assets   83,015,382
Liabilities:    
Payable for capital shares redeemed   28
Accrued expenses and other liabilities:    
Investment adviser   51,735
Administration and accounting   3,017
Chief compliance officer   366
Custodian   602
Shareholder servicing fees   4,701
Transfer agent   2,957
Trustee   964
Other   3,004
Total Liabilities   67,374
Net Assets $ 82,948,008
Composition of Net Assets:    
Paid in capital $ 56,130,198
Total distributable earnings/(loss)   26,817,810
Net Assets $ 82,948,008
Shares outstanding (par value $0.01, unlimited number of shares authorized)   4,208,594
Net Asset Value, Offering Price and Redemption price per share $ 19.71


 

Statement of Operations 

For the year ended December 31, 2020

 

Investment Income:    
Dividends $ 1,064,875
Less: Foreign tax withholding   (555 )
Total Investment Income   1,064,320
Expenses:    
Investment adviser   496,850
Administration and accounting   38,981
Chief compliance officer   5,050
Custodian   9,280
Shareholder servicing   48,318
Transfer agency   35,613
Trustee   4,448
Interest fees   109
Other   39,295
Total expenses before fee reductions   677,944
Fees contractually reduced by the investment adviser   (15,213 )
Net Expenses   662,731
Net Investment Income   401,589
Net Realized/Unrealized Gains (Losses) from Investments:    
Net realized gains from investment transactions   2,226,292
Change in unrealized appreciation/depreciation on investments   6,162,796
Net realized/unrealized gains (losses) on investments   8,389,088
Change in Net Assets Resulting from Operations $ 8,790,677

 

See Notes to Financial Statements

 

47 

 

 

Financial Statements Boston Trust Walden Midcap Fund

 

Statements of Changes in Net Assets

 

    For the year ended     For the year ended  
    December 31, 2020     December 31, 2019  
Investment Activities:                
Operations:                
Net investment income   $ 401,589     $ 370,355  
Net realized gains from investment transactions     2,226,292       3,543,017  
Change in unrealized appreciation/depreciation on investments     6,162,796       9,362,398  
Change in Net Assets Resulting from Operations     8,790,677       13,275,770  
Distributions to shareholders:                
Total Distributions     (2,575,502 )     (3,932,964 )
Change in Net Assets Resulting from distributions to shareholders     (2,575,502 )     (3,932,964 )
Capital Share Transactions:                
Proceeds from shares issued     25,455,556       10,311,717  
Dividends reinvested     2,228,870       3,313,873  
Cost of shares redeemed     (13,489,526 )     (6,249,705 )
Change in Net Assets Resulting from Capital Share Transactions     14,194,900       7,375,885  
Change in Net Assets     20,410,075       16,718,691  
Net Assets:                
Beginning of period     62,537,933       45,819,242  
End of period   $ 82,948,008     $ 62,537,933  
Share Transactions:                
Issued     1,548,805       567,958  
Reinvested     114,360       181,284  
Redeemed     (797,789 )     (349,003 )
Change in shares     865,376       400,239  

 

See Notes to Financial Statements

 

48 

 

 

Financial Statements Boston Trust Walden Midcap Fund

 

Financial Highlights                                    
Selected data for a share outstanding throughout the years indicated.              
                                             
      For the year       For the year       For the year       For the year       For the nine
months
      For the year  
      ended       ended       ended       ended       ended       ended  
      December       December       December       December       December       March 31,  
      31, 2020       31, 2019       31, 2018       31, 2017       31, 2016       2016  
Net Asset Value, Beginning of Period   $ 18.71     $ 15.57     $ 17.24     $ 14.90     $ 14.57     $ 15.18  
Investment Activities:                                                
Operations:                                                
Net investment income     0.10       0.12       0.09       0.07       0.11       0.09  
Net realized/unrealized gains (losses) from investments     1.53       4.27       (0.66 )     2.85       0.97       0.07  
Total from investment activities     1.63       4.39       (0.57 )     2.92       1.08       0.16  
Dividends:                                                
Net investment income     (0.09 )     (0.10 )     (0.09 )     (0.08 )     (0.12 )     (0.08 )
Net realized gains from investments     (0.54 )     (1.15 )     (1.01 )     (0.50 )     (0.63 )     (0.69 )
Total dividends     (0.63 )     (1.25 )     (1.10 )     (0.58 )     (0.75 )     (0.77 )
Net Asset Value, End of Period   $ 19.71     $ 18.71     $ 15.57     $ 17.24     $ 14.90     $ 14.57  
Total Return     8.76 %     28.38 %     (3.58 )%     19.62 %     7.36 %(a)     1.27 %
Ratios/Supplemental Data:                                                
Net assets at end of period (000’s)   $ 82,948     $ 62,538     $ 45,819     $ 46,562     $ 39,059     $ 35,543  
Ratio of net expenses to average net assets     1.00 %     1.00 %     1.00 %     1.00 %     1.00 %(b)     1.00 %
Ratio of net investment income to average net assets     0.61 %     0.68 %     0.54 %     0.45 %     0.97 %(b)     0.59 %
Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment adviser) to average net assets (c)     1.02 %     1.00 %     1.00 %     1.01 %     1.04 %(b)     1.07 %
Portfolio turnover rate     38.28 %     23.17 %     18.66 %     24.85 %     12.59 %(a)     20.10 %

 

 

(a) Not annualized for periods less than one year.

(b) Annualized for periods less than one year.

(c) During the periods, certain fees were reduced. If such fee reduction had not occurred, the ratio would have been as indicated.

 

See Notes to Financial Statements

 

49 

 

 

Schedule of Portfolio Investments   Boston Trust Walden SMID Cap Fund
December 31, 2020

 

Security Description   Shares     Fair Value ($)  
Common Stocks (98.6%)            
Communication Services (3.3%)                
Interpublic Group of Cos., Inc.     46,115       1,084,625  
Omnicom Group, Inc.     17,025       1,061,849  
              2,146,474  
Consumer Discretionary (10.2%)                
Carter’s, Inc.     8,780       825,934  
Choice Hotels International, Inc.     4,365       465,876  
Columbia Sportswear Co.     7,175       626,952  
Dorman Products, Inc. (a)     8,360       725,815  
Texas Roadhouse, Inc.     10,870       849,600  
TopBuild Corp. (a)     6,700       1,233,336  
Tractor Supply Co.     6,700       941,886  
Williams Sonoma, Inc.     9,135       930,308  
              6,599,707  
Consumer Staples (4.4%)                
Flowers Foods, Inc.     33,725       763,197  
Lamb Weston Holdings, Inc.     6,475       509,842  
Lancaster Colony Corp.     3,015       553,946  
The JM Smucker Co.     8,730       1,009,187  
              2,836,172  
Energy (1.7%)                
Baker Hughes Co.     28,070       585,260  
Helmerich & Payne, Inc.     22,350       517,626  
              1,102,886  
Financials (13.9%)                
American Financial Group, Inc.     6,175       541,054  
Brown & Brown, Inc.     13,135       622,730  
CBOE Global Markets, Inc.     6,855       638,338  
Cohen & Steers, Inc.     9,030       670,929  
East West Bancorp, Inc.     13,690       694,220  
FactSet Research Systems, Inc.     2,700       897,750  
M&T Bank Corp.     9,890       1,258,997  
SEI Investments Co.     22,055       1,267,500  
Signature Bank     6,000       811,740  
SVB Financial Group (a)     2,700       1,047,141  
UMB Financial Corp.     7,805       538,467  
              8,988,866  
Health Care (16.5%)                
Chemed Corp.     2,000       1,065,220  
Dentsply Sirona, Inc.     15,300       801,108  
Henry Schein, Inc. (a)     6,575       439,605  
Hill-Rom Holdings, Inc.     10,225       1,001,743  
Masimo Corp. (a)     2,285       613,248  
Medpace Holdings, Inc. (a)     10,100       1,405,920  
PerkinElmer, Inc.     9,600       1,377,600  
Steris PLC     6,600       1,250,964  
The Cooper Companies., Inc.     3,675       1,335,201  
Waters Corp. (a)     5,600       1,385,552  
              10,676,161  
Industrials (13.9%)                
AO Smith Corp.     14,835       813,255  
Applied Industrial Technologies, Inc.     9,590       747,924  
C.H. Robinson Worldwide, Inc.     7,415       696,046  
Donaldson Co., Inc.     16,875       942,974  
Expeditors International of Washington, Inc.     10,200       970,122  
Hubbell, Inc.     6,700       1,050,493  
Lincoln Electric Holdings, Inc.     6,730       782,363  
Masco Corp.     14,115       775,337  
Nordson Corp.     2,655       533,522  
The Middleby Corp. (a)     4,905       632,353  
UniFirst Corp.     4,830       1,022,463  
              8,966,852  
Information Technology (17.8%)                
Akamai Technologies, Inc. (a)     9,200       965,909  
Amdocs Ltd.     6,140       435,510  
Aspen Technology, Inc. (a)     9,500       1,237,374  
Broadridge Finance Solutions, Inc.     4,300       658,760  
CDK Global, Inc.     11,120       576,350  
Citrix Systems, Inc.     9,800       1,274,979  
Dolby Laboratories, Inc., Class A     9,565       929,048  
F5 Networks, Inc. (a)     5,600       985,264  
IPG Photonics Corp. (a)     5,275       1,180,493  
Jack Henry & Associates, Inc.     2,755       446,282  
Manhattan Associates, Inc. (a)     9,275       975,545  
NetApp, Inc.     12,740       843,898  
Progress Software Corp.     23,445       1,059,480  
              11,568,892  
Materials (5.9%)                
AptarGroup, Inc.     6,490       888,416  
Avery Dennison Corp.     6,300       977,194  
Packaging Corporation of America     5,775       796,430  
RPM International, Inc.     12,485       1,133,388  
              3,795,428  
Real Estate (6.5%)                
Camden Property Trust     6,700       669,464  
CoreSite Realty Corp.     6,500       814,319  
CubeSmart     13,815       464,322  
CyrusOne, Inc.     5,225       382,209  
Jones Lang LaSalle, Inc. (a)     6,415       951,794  
Lamar Advertising Co., Class A     7,555       628,727  
STAG Industrial, Inc.     9,915       310,538  
              4,221,373  
Utilities (4.5%)                
Atmos Energy Corp.     12,360       1,179,515  
New Jersey Resources Corp.     14,385       511,387  
ONE Gas, Inc.     16,105       1,236,380  
              2,927,282  
TOTAL COMMON STOCKS (Cost $44,050,524)             63,830,093  
                 
Investment Companies (1.4%)                
JPMorgan U.S. Government Money Market Fund, Capital Shares, 0.03% (b)     878,077       878,077  
TOTAL INVESTMENT COMPANIES (Cost $878,077)             878,077  
                 
Total Investments (Cost $44,928,601) — 100.0% (c)             64,708,170  
Other assets in excess of liabilities — 0.0%             26,233  
NET ASSETS — 100.0%           $ 64,734,403  

 

 

(a) Non-income producing security.

(b) Rate disclosed is the seven day yield as of December 31, 2020.

(c) See Federal Tax Information listed in the Notes to the Financial Statements.

 

PLC Public Limited Company

 

See Notes to Financial Statements

 

50 

 

 

Financial Statements Boston Trust Walden SMID Cap Fund

 

Statement of Assets and Liabilities

December 31, 2020

 

Assets:    
Investments, at fair value (cost $44,928,601) $ 64,708,170
Dividends receivable   69,148
Receivable for capital shares issued   1,570
Prepaid expenses   9,702
Total Assets   64,788,590
Liabilities:    
Payable for capital shares redeemed   233
Accrued expenses and other liabilities:    
Investment adviser   41,261
Administration and accounting   2,367
Chief compliance officer   284
Custodian   504
Shareholder servicing fees   3,553
Transfer agent   3,073
Trustee   760
Other   2,152
Total Liabilities   54,187
Net Assets $ 64,734,403
Composition of Net Assets:    
Paid in capital $ 44,534,690
Total distributable earnings/(loss)   20,199,713
Net Assets $ 64,734,403
Shares outstanding (par value $0.01, unlimited number of shares authorized)   3,337,682
Net Asset Value, Offering Price and Redemption price per share $ 19.40


 

Statement of Operations 

For the year ended December 31, 2020

 

Investment Income:      
Dividends   $ 895,276  
Total Investment Income     895,276  
Expenses:        
Investment adviser     416,412  
Administration and accounting     32,981  
Chief compliance officer     4,259  
Custodian     7,684  
Shareholder servicing     42,701  
Transfer agency     36,223  
Trustee     3,753  
Interest fees     54  
Other     41,771  
Total expenses before fee reductions     585,838  
Fees contractually reduced by the investment adviser     (30,484 )
Net Expenses     555,354  
Net Investment Income     339,922  
Net Realized/Unrealized Gains (Losses) from        
Investments:        
Net realized gains from investment transactions     1,041,519  
Change in unrealized appreciation/depreciation on investments     3,152,893  
Net realized/unrealized gains (losses) on investments     4,194,412  
Change in Net Assets Resulting from Operations   $ 4,534,334  

 

See Notes to Financial Statements

 

51 

 

 

Financial Statements Boston Trust Walden SMID Cap Fund

 

Statements of Changes in Net Assets

 

  For the year ended     For the year ended  
  December 31, 2020     December 31, 2019  
Investment Activities:              
Operations:              
Net investment income $ 339,922     $ 338,685  
Net realized gains from investment transactions   1,041,519       2,742,242  
Change in unrealized appreciation/depreciation on investments   3,152,893       9,402,172  
Change in Net Assets Resulting from Operations   4,534,334       12,483,099  
Distributions to shareholders:              
Total Distributions   (1,133,962 )     (3,068,662 )
Change in Net Assets Resulting from distributions to shareholders   (1,133,962 )     (3,068,662 )
Capital Share Transactions:              
Proceeds from shares issued   10,653,961       8,038,546  
Dividends reinvested   805,985       2,312,967  
Cost of shares redeemed   (11,707,864 )     (5,804,826 )
Change in Net Assets Resulting from Capital Share Transactions   (247,918 )     4,546,687  
Change in Net Assets   3,152,454       13,961,124  
Net Assets:              
Beginning of period   61,581,949       47,620,825  
End of period $ 64,734,403     $ 61,581,949  
Share Transactions:              
Issued   628,131       459,149  
Reinvested   41,782       130,529  
Redeemed   (734,546 )     (337,040 )
Change in shares   (64,633 )     252,638  

 

See Notes to Financial Statements

 

52 

 

 

Financial Statements Boston Trust Walden SMID Cap Fund

 

Financial Highlights                                    
Selected data for a share outstanding throughout the years indicated.                  
                                             
      For the year       For the year       For the year       For the year       For the nine
months
      For the year  
      ended       ended       ended       ended       ended       ended  
      December       December       December       December       December       March 31,  
      31, 2020       31, 2019       31, 2018       31, 2017       31, 2016       2016  
Net Asset Value, Beginning of Period   $ 18.10     $ 15.12     $ 16.69     $ 14.60     $ 13.40     $ 14.70  
Investment Activities:                                                
Operations:                                                
Net investment income     0.09       0.10       0.09       0.07       0.12       0.04  
Net realized/unrealized gains (losses) from investments     1.55       3.83       (0.99 )     2.40       1.87       (0.44 )
Total from investment activities     1.64       3.93       (0.90 )     2.47       1.99       (0.40 )
Dividends:                                                
Net investment income     (0.10 )     (0.10 )     (0.09 )     (0.09 )     (0.14 )     (0.02 )
Net realized gains from investments     (0.25 )     (0.85 )     (0.58 )     (0.29 )     (0.65 )     (0.88 )
Total dividends     (0.35 )     (0.95 )     (0.67 )     (0.38 )     (0.79 )     (0.90 )
Net Asset Value, End of Period   $ 19.40     $ 18.10     $ 15.12     $ 16.69     $ 14.60     $ 13.40  
Total Return     9.13 %     26.12 %     (5.59 )%     16.94 %     14.73 %(a)     (2.47 )%
Ratios/Supplemental Data:                                                
Net assets at end of period (000’s)   $ 64,734     $ 61,582     $ 47,621     $ 45,632     $ 38,128     $ 32,452  
Ratio of net expenses to average net assets     1.00 %     1.00 %     1.00 %     1.00 %     1.00 %(b)     1.00 %
Ratio of net investment income to average net assets     0.61 %     0.61 %     0.52 %     0.48 %     1.12 %(b)     0.30 %
Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment adviser) to average net assets (c)     1.05 %     1.07 %     1.08 %     1.08 %     1.12 %(b)     1.15 %
Portfolio turnover rate     38.70 %     29.75 %     18.61 %     31.92 %     20.85 %(a)     43.24 %

 

 

(a) Not annualized for periods less than one year.

(b) Annualized for periods less than one year.

(c) During the periods, certain fees were reduced. If such fee reduction had not occurred, the ratio would have been as indicated.

 

See Notes to Financial Statements

 

53 

 

 

Schedule of Portfolio Investments   Boston Trust Walden Small Cap Fund
December 31, 2020

 

Security Description   Shares     Fair Value ($)  
Common Stocks (98.3%)            
Consumer Discretionary (10.9%)                
Carter’s, Inc.     99,620       9,371,253  
Choice Hotels International, Inc.     49,400       5,272,462  
Columbia Sportswear Co.     105,000       9,174,900  
Dorman Products, Inc. (a)     76,560       6,646,939  
Monro, Inc.     83,435       4,447,086  
Nordstrom, Inc.     181,000       5,649,010  
Texas Roadhouse, Inc.     93,000       7,268,880  
TopBuild Corp. (a)     61,500       11,320,920  
Williams Sonoma, Inc.     64,600       6,578,864  
              65,730,314  
Consumer Staples (2.6%)                
Flowers Foods, Inc.     362,800       8,210,164  
Lancaster Colony Corp.     40,900       7,514,557  
              15,724,721  
Energy (1.4%)                
Cactus, Inc., Class A     122,375       3,190,316  
Helmerich & Payne, Inc.     222,810       5,160,280  
              8,350,596  
Financials (14.3%)                
1st Source Corp.     83,500       3,365,050  
Bank of Hawaii Corp.     49,355       3,781,580  
Bank of Marin Bancorp     34,000       1,167,560  
Camden National Corp.     61,095       2,185,979  
Cathay General Bancorp     148,335       4,774,904  
Cohen & Steers, Inc.     123,000       9,138,900  
East West Bancorp, Inc.     105,220       5,335,706  
First Hawaiian, Inc.     181,000       4,267,980  
German American Bancorp     63,000       2,084,670  
Green Dot Corp., Class A (a)     90,640       5,057,712  
Independent Bank Corp.     73,265       5,351,276  
Lakeland Financial Corp.     107,400       5,754,492  
Morningstar, Inc.     35,900       8,313,363  
Selective Insurance Group, Inc.     68,595       4,594,493  
Signature Bank     52,880       7,154,135  
Tompkins Financial Corp.     55,500       3,918,300  
UMB Financial Corp.     85,945       5,929,346  
Washington Trust Bancorp, Inc.     94,300       4,224,640  
              86,400,086  
Health Care (22.5%)                
Anika Therapeutics, Inc. (a)     108,000       4,888,080  
Atrion Corp.     7,600       4,881,024  
Bruker Corp.     226,000       12,233,380  
Cantel Medical Corp.     192,855       15,208,544  
Corcept Therapeutics, Inc. (a)     121,900       3,188,904  
CorVel Corp. (a)     98,160       10,404,960  
Ensign Group, Inc.     57,500       4,192,900  
Globus Medical, Inc., Class A (a)     145,850       9,512,337  
Haemonetics Corp. (a)     68,500       8,134,375  
Hill-Rom Holdings, Inc.     106,000       10,384,820  
HMS Holdings Corp. (a)     317,350       11,662,613  
ICU Medical, Inc. (a)     30,950       6,638,466  
Medpace Holdings, Inc. (a)     90,745       12,631,704  
Premier, Inc.     256,815       9,014,207  
U.S. Physical Therapy, Inc.     107,800       12,962,949  
              135,939,263  
Industrials (16.9%)                
Applied Industrial Technologies, Inc.     122,020       9,516,340  
Donaldson Co., Inc.     173,870       9,715,856  
Douglas Dynamics, Inc.     94,640       4,047,753  
4,73Forward Air Corp.     105,180       8,082,031  
Franklin Electric Co., Inc.     97,340       6,736,901  
Insperity, Inc.     35,880       2,921,350  
Landstar System, Inc.     71,000       9,560,860  
Lincoln Electric Holdings, Inc.     89,280       10,378,800  
Tennant Co.     74,000       5,192,580  
The Middleby Corp. (a)     62,310       8,033,005  
UniFirst Corp.     51,500       10,902,035  
Valmont Industries, Inc.     42,000       7,347,060  
Watts Water Technologies, Inc., Class A     76,870       9,355,079  
              101,789,650  
Information Technology (16.2%)                
Badger Meter, Inc.     85,230       8,016,734  
CDK Global, Inc.     86,200       4,467,746  
Coherent, Inc. (a)     31,600       4,740,632  
CSG Systems International, Inc.     206,195       9,293,209  
ExlService Holdings, Inc. (a)     87,000       7,406,310  
InterDigital, Inc.     117,300       7,117,764  
Manhattan Associates, Inc. (a)     111,500       11,727,570  
NETGEAR, Inc. (a)     127,000       5,160,010  
NIC, Inc.     468,000       12,088,440  
Power Integrations, Inc.     174,340       14,271,472  
Progress Software Corp.     191,030       8,632,646  
Teradata Corp. (a)     214,000       4,808,580  
              97,731,113  
Materials (3.8%)                
Minerals Technologies, Inc.     97,340       6,046,761  
Sensient Technologies Corp.     114,270       8,429,698  
Silgan Holdings, Inc.     222,555       8,252,339  
              22,728,798  
Real Estate (4.9%)                
CoreSite Realty Corp.     75,250       9,427,320  
CubeSmart     162,230       5,452,550  
Jones Lang LaSalle, Inc. (a)     48,800       7,240,456  
Physicians Realty Trust     205,000       3,649,000  
STAG Industrial, Inc.     112,000       3,507,840  
              29,277,166  
Utilities (4.8%)                
Chesapeake Utilities Corp.     72,230       7,816,008  
IDACORP, Inc.     43,790       4,205,154  
New Jersey Resources Corp.     123,200       4,379,760  
ONE Gas, Inc.     107,710       8,268,897  
Unitil Corp.     101,000       4,471,270  
              29,141,089  
TOTAL COMMON STOCKS (Cost $441,271,461)             592,812,796  
Investment Companies (1.4%)                
JPMorgan U.S. Government Money Market Fund, Capital Shares, 0.03% (b)     8,548,575       8,548,575  
TOTAL INVESTMENT COMPANIES (Cost $8,548,575)             8,548,575  
Total Investments (Cost $449,820,036) — 99.7% (c)             601,361,371  
Other assets in excess of liabilities — 0.3%             1,616,332  
NET ASSETS — 100.0%           $ 602,977,703  

 

 

(a) Non-income producing security.

(b) Rate disclosed is the seven day yield as of December 31, 2020.

(c) See Federal Tax Information listed in the Notes to the Financial Statements.

 

See Notes to Financial Statements

 

54 

 

 

Financial Statements Boston Trust Walden Small Cap Fund

 

Statement of Assets and Liabilities

December 31, 2020

 

Assets:    
Investments, at fair value (cost $449,820,036) $ 601,361,371
Dividends receivable   449,856
Receivable for capital shares issued   2,338,054
Prepaid expenses   25,033
Total Assets   604,174,314
Liabilities:    
Payable for investments purchased   480,998
Payable for capital shares redeemed   260,566
Accrued expenses and other liabilities:    
Investment adviser   321,308
Administration and accounting   21,651
Chief compliance officer   2,604
Custodian   4,026
Shareholder servicing fees   65,248
Transfer agent   5,979
Trustee   6,762
Other   27,469
Total Liabilities   1,196,611
Net Assets $ 602,977,703
Composition of Net Assets:    
Paid in capital $ 447,663,031
Total distributable earnings/(loss)   155,314,672
Net Assets $ 602,977,703
Shares outstanding (par value $0.01, unlimited number of shares authorized)   39,378,471
Net Asset Value, Offering Price and Redemption price per share $ 15.31


 

Statement of Operations

For the year ended December 31, 2020

 

Investment Income:      
Dividends   $ 6,648,371  
Total Investment Income     6,648,371  
Expenses:        
Investment adviser     3,021,382  
Administration and accounting     230,649  
Chief compliance officer     30,031  
Custodian     58,341  
Shareholder servicing     675,170  
Transfer agency     61,536  
Trustee     25,643  
Other     175,613  
Total expenses before fee reductions     4,278,365  
Fees contractually reduced by the investment adviser     (247,032 )
Net Expenses     4,031,333  
Net Investment Income     2,617,038  
Net Realized/Unrealized Gains (Losses) from Investments:        
Net realized gains from investment transactions (a)     10,924,392  
Change in unrealized appreciation/depreciation on investments     104,324,721  
Net realized/unrealized gains (losses) on investments     115,249,113  
Change in Net Assets Resulting from Operations   $ 117,866,151  

 

 

(a)       Includes Class Action related litigation gains of $270,322.

 

See Notes to Financial Statements

 

55 

 

 

Financial Statements Boston Trust Walden Small Cap Fund

 

Statements of Changes in Net Assets

 

  For the year ended   For the year ended  
  December 31, 2020   December 31, 2019  
Investment Activities:            
Operations:            
Net investment income   $ 2,617,038     $ 1,407,401  
Net realized gains from investment transactions     10,924,392       55,008,647  
Change in unrealized appreciation/depreciation on investments     104,324,721       9,542,517  
Change in Net Assets Resulting from Operations     117,866,151       65,958,565  
Distributions to shareholders:                
Total Distributions     (10,155,733 )     (15,569,783 )
Change in Net Assets Resulting from distributions to shareholders     (10,155,733 )     (15,569,783 )
Capital Share Transactions:                
Proceeds from shares issued     258,244,300       80,119,024  
Proceeds from merger (b)     103,030,710        
Dividends reinvested     9,187,705       14,461,506  
Cost of shares redeemed     (110,664,229 )     (31,775,419 )
Cost of in-kind shares redeemed (a)           (119,901,316 )
Change in Net Assets Resulting from Capital Share Transactions     259,798,486       (57,096,205 )
Change in Net Assets     367,508,904       (6,707,423 )
Net Assets:                
Beginning of period     235,468,799       242,176,222  
End of period   $ 602,977,703     $ 235,468,799  
Share Transactions:                
Issued     20,922,885       5,601,029  
Issued from merger (b)     10,376,826        
Reinvested     721,349       1,010,587  
Redeemed     (8,746,308 )     (2,272,358 )
Redeemed in-kind (a)           (8,413,292 )
Change in shares     23,274,752       (4,074,034 )

 

 

(a) See Note 3 in Notes to Financial Statements.

(b) See Note 7 in Notes to Financial Statements.

 

See Notes to Financial Statements

 

56 

 

 

Financial Statements Boston Trust Walden Small Cap Fund

 

Financial Highlights                                    
Selected data for a share outstanding throughout the years indicated.            
                                             
      For the year       For the year       For the year       For the year       For the nine
months
      For the year  
      ended       ended       ended       ended       ended       ended  
      December       December       December       December       December       March 31,  
      31, 2020       31, 2019       31, 2018       31, 2017       31, 2016       2016  
Net Asset Value, Beginning of Period   $ 14.62     $ 12.00     $ 14.73     $ 14.33     $ 12.74     $ 15.20  
Investment Activities:                                                
Operations:                                                
Net investment income     0.08       0.09       0.07       0.07       0.12       0.06  
Net realized/unrealized gains (losses) from                                                
investments     1.00       3.47       (0.86 )     1.67       1.92       (0.25 )
Total from investment activities     1.08       3.56       (0.79 )     1.74       2.04       (0.19 )
Dividends:                                                
Net investment income     (0.08 )     (0.06 )     (0.07 )     (0.08 )     (0.14 )     (0.06 )
Net realized gains from investments     (0.31 )     (0.88 )     (1.87 )     (1.26 )     (0.31 )     (2.21 )
Total dividends     (0.39 )     (0.94 )     (1.94 )     (1.34 )     (0.45 )     (2.27 )
Net Asset Value, End of Period   $ 15.31     $ 14.62     $ 12.00     $ 14.73     $ 14.33     $ 12.74  
Total Return     8.17 %     29.88 %     (6.00 )%     12.26 %     15.94 %(a)     (0.52 )%
Ratios/Supplemental Data:                                                
Net assets at end of period (000’s)   $ 602,978     $ 235,469     $ 242,176     $ 366,113     $ 327,593     $ 338,656  
Ratio of net expenses to average net assets     1.00 %     1.00 %     1.00 %     1.00 %     1.00 %(b)     1.00 %
Ratio of net investment income to average net assets     0.64 %     0.58 %     0.39 %     0.46 %     1.21 %(b)     0.44 %
Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment adviser) to average net assets (c)     1.06 %     1.07 %     1.09 %     1.02 %     1.06 %(b)     1.08 %
Portfolio turnover rate     39.89 %(d)     23.23 %(e)     24.60 %     23.78 %     51.92 %(a)     37.42 %

 

 

(a) Not annualized for periods less than one year.

(b) Annualized for periods less than one year.

(c) During the periods, certain fees were reduced or recouped by the investment adviser. If such fee reductions/recoupments had not occurred, the ratio would have been as indicated.

(d) Excludes impact of merger transaction.

(e) Excludes impact of in-kind transactions.

 

See Notes to Financial Statements

 

57 

 

 

Schedule of Portfolio Investments   Boston Trust Walden International Equity Fund
December 31, 2020

 

Security Description     Shares       Fair Value ($)  
Common Stocks (97.9%)                
Australia (5.4%)                
Brambles Ltd.     87,777‌       718,999‌  
CSL Ltd.     5,211‌       1,138,424‌  
Origin Energy Ltd.     181,339‌       666,338‌  
Telstra Corp. Ltd.     314,337‌       722,620‌  
Woodside Petroleum Ltd.     40,322‌       707,030‌  
              3,953,411‌  
                 
Belgium (0.6%)                
Colruyt SA     7,585‌       449,354‌  
              449,354‌  
                 
Canada (8.8%)                
Bank of Montreal     10,978‌       834,801‌  
BCE, Inc.     11,100‌       474,718‌  
Canadian National Railway Co.     5,074‌       557,913‌  
Great-West Lifeco, Inc.     19,284‌       459,864‌  
Intact Financial Corp.     4,300‌       509,229‌  
Magna International, Inc.     9,900‌       700,942‌  
Metro, Inc.     15,206‌       678,637‌  
Royal Bank of Canada     6,484‌       532,853‌  
The Bank of Nova Scotia     15,028‌       812,388‌  
The Toronto-Dominion Bank     15,933‌       900,369‌  
              6,461,714‌  
                 
Denmark (2.4%)                
Novo Nordisk A/S     17,517‌       1,225,437‌  
Novozymes A/S     9,400‌       539,562‌  
              1,764,999‌  
                 
Finland (0.8%)                
Kone OYJ     7,661‌       621,608‌  
              621,608‌  
France (9.9%)                
Air Liquide SA     5,794‌       950,840‌  
Danone SA     13,126‌       862,608‌  
Dassault Systemes     3,556‌       722,285‌  
EssilorLuxottica SA     3,331‌       519,423‌  
Imerys SA     13,978‌       660,533‌  
Legrand SA     6,214‌       554,548‌  
L’Oreal SA     2,400‌       911,779‌  
Publicis Groupe SA     13,743‌       684,772‌  
Schneider Electric SE     6,500‌       940,074‌  
Societe BIC SA     8,443‌       477,282‌  
              7,284,144‌  
Germany (8.4%)                
Allianz SE     2,118‌       518,150‌  
Beiersdorf AG     3,165‌       364,855‌  
Deutsche Boerse AG     3,056‌       518,751‌  
Fresenius SE & Co. KGaA     12,955‌       598,549‌  
Fuchs Petrolub SE     7,320‌       415,470‌  
Hannover Rueck SE     2,400‌       381,308‌  
Henkel AG & Co. KGaA     4,900‌       471,625‌  
Hugo Boss AG     17,301‌       576,880‌  
Merck KGaA     3,586‌       614,610‌  
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen     1,600‌       473,797‌  
SAP AG     9,606‌       1,262,149‌  
              6,196,144‌  
                 
Hong Kong (3.2%)                
Hang Lung Properties Ltd.     178,400‌       472,187‌  
Hang Seng Bank Ltd.     41,020‌       708,820‌  
MTR Corp. Ltd.     83,900‌       469,326‌  
Sino Land Co. Ltd.     548,000‌       714,236‌  
              2,364,569‌  
Ireland (0.7%)                
Experian PLC     14,071‌       536,096‌  
              536,096‌  
Israel (1.6%)                
Check Point Software Technologies Ltd. (a)     3,600‌       478,476‌  
Nice Ltd. (a)     2,574‌       727,721‌  
              1,206,197‌  
Italy (1.3%)                
Snam SpA     90,171‌       506,299‌  
Terna Rete Elettrica Nazionale SpA     62,748‌       478,688‌  
              984,987‌  
Japan (22.9%)                
Astellas Pharma, Inc.     37,300‌       576,722‌  
Benesse Holdings, Inc.     14,760‌       288,187‌  
Central Japan Railway Co.     5,215‌       740,834‌  
Chugai Pharmaceutical Co. Ltd.     12,900‌       688,817‌  
Daiwa House Industry Co. Ltd.     18,590‌       554,986‌  
Denso Corp.     8,900‌       529,976‌  
East Japan Railway Co.     7,900‌       528,898‌  
Fast Retailing Co. Ltd.     805‌       722,468‌  
INPEX Corp.     71,800‌       388,064‌  
JSR Corp.     24,500‌       684,419‌  
Kao Corp.     10,400‌       804,192‌  
Kurita Water Industries Ltd.     13,000‌       497,681‌  
Mitsubishi Estate Co. Ltd.     29,300‌       473,245‌  
Nippon Telegraph & Telephone Corp.     35,000‌       897,574‌  
Nitto Denko Corp.     8,200‌       736,410‌  
Nomura Research Institute Ltd.     19,564‌       699,145‌  
Oracle Corporation Japan     5,100‌       663,726‌  
Oriental Land Co. Ltd.     3,765‌       622,399‌  
Sumitomo Mitsui Financial Group, Inc.     27,600‌       854,153‌  
Sysmex Corp.     5,900‌       709,662‌  
Terumo Corp.     15,200‌       635,827‌  
The Chiba Bank Ltd.     82,800‌       456,703‌  
The Hachijuni Bank Ltd.     104,900‌       351,215‌  
Tokio Marine Holdings, Inc.     8,300‌       430,028‌  
Tokyo Gas Co. Ltd.     19,000‌       441,747‌  
Toyota Motor Corp.     9,340‌       716,286‌  
Trend Micro, Inc.     10,800‌       621,862‌  
Yamato Holdings Co. Ltd.     19,500‌       498,175‌  
              16,813,401‌  
                 
Luxembourg (0.7%)                
Tenaris SA     62,086‌       501,500‌  
              501,500‌  
                 
Netherlands (3.1%)                
Koninklijke Ahold Delhaize NV     30,583‌       863,559‌  
Koninklijke Vopak NV     11,512       603,592  
Wolters Kluwer NV     9,875‌       833,373‌  
              2,300,524‌  
Norway (0.7%)                
Equinor ASA     32,025‌       532,207‌  
              532,207‌  

 

See Notes to Financial Statements

 

58 

 

 

Schedule of Portfolio Investments   Boston Trust Walden International Equity Fund
December 31, 2020

 

Security Description   Shares     Fair Value ($)  
Common Stocks, Continued            
Singapore (1.3%)                
ComfortDelGro Corp. Ltd.     354,550       448,543  
Singapore Exchange Ltd.     77,200       543,469  
              992,012  
Spain (2.2%)                
Enagas SA     15,598       342,463  
Gas Natural SDG SA     22,135       516,488  
Industria de Diseno Textil SA     24,813       789,993  
              1,648,944  
Sweden (2.9%)                
Assa Abloy AB, Class B     16,750       412,181  
Atlas Copco AB, Class A     10,300       526,993  
Hennes & Mauritz AB (a)     32,624       681,776  
Svenska Handelsbanken AB (a)     54,726       549,357  
              2,170,307  
Switzerland (8.8%)                
ABB Ltd.     18,018       504,158  
Cie Financiere Richemont SA     9,344       844,632  
Givaudan SA     191       804,818  
Nestle SA     8,100       953,928  
Roche Holding AG     4,859       1,695,919  
SGS SA     175       527,742  
Sonova Holding AG (a)     2,653       683,227  
Zurich Insurance Group AG     1,200       508,781  
              6,523,205  
United Kingdom (12.2%)                
Admiral Group PLC     16,782       667,048  
Compass Group PLC     28,893       539,075  
Croda International PLC     9,274       837,743  
ITV PLC (a)     329,444       481,518  
Johnson Matthey PLC     15,576       517,034  
London Stock Exchange Group PLC     4,980       613,768  
Marks & Spencer Group PLC (a)     318,860       595,374  
National Grid PLC     47,157       561,584  
Next PLC (a)     5,512       534,430  
Reckitt Benckiser Group PLC     5,600       500,765  
RELX PLC     19,100       469,731  
Sage Group PLC     88,106       701,678  
Schroders PLC     8,337       380,742  
Smith & Nephew PLC     25,431       530,971  
Unilever PLC     9,200       553,733  
WPP PLC     37,770       410,311  
              8,895,505  
TOTAL COMMON STOCKS (Cost $60,636,260)             72,200,828  
Investment Companies (0.4%)                
JPMorgan U.S. Government Money Market Fund, Capital Shares, 0.03% (b)     291,309       291,309  
TOTAL INVESTMENT COMPANIES (Cost $291,309)             291,309  
Total Investments (Cost $60,927,569) — 98.3%(c)             72,492,137  
Other assets in excess of liabilities — 1.7%             1,227,680  
NET ASSETS — 100.0%           $ 73,719,817  

 

 

(a) Non-income producing security.

(b) Rate disclosed is the seven day yield as of December 31, 2020.

(c) See Federal Tax Information listed in the Notes to the Financial Statements.

 

PLC Public Limited Company

 

The Fund invested, as a percentage of net assets at value, in the following industries as of December 31, 2020:

 

    Percentage of  
Industry   Total Net Assets  
Financials     16.4 %
Industrials     14.7  
Health Care     12.9  
Consumer Discretionary     11.0  
Consumer Staples     10.1  
Materials     8.5  
Information Technology     7.9  
Energy     5.8  
Communication Services     4.9  
Real Estate     3.0  
Utilities     2.7  
Investment Companies     0.4  
Other net assets     1.7  
Total     100.0 %

 

See Notes to Financial Statements

 

59 

 

 

Financial Statements Boston Trust Walden International Equity Fund

 

Statement of Assets and Liabilities

December 31, 2020

 

Assets:    
Investments, at fair value (cost $60,927,569) $ 72,492,137
Cash   631,672
Foreign currency, at fair value (cost $624,794)   628,820
Dividends receivable   60,424
Receivable for investments sold   556,730
Receivable for capital shares issued   95,000
Receivable for tax reclaims   134,455
Prepaid expenses   3,663
Total Assets   74,602,901
Liabilities:    
Payable for investments purchased   824,946
Accrued expenses and other liabilities:    
Investment adviser   45,405
Administration and accounting   5,742
Chief compliance officer   327
Custodian   1,720
Shareholder servicing fees   599
Transfer agent   2,462
Trustee   853
Other   1,030
Total Liabilities   883,084
Net Assets $ 73,719,817
Composition of Net Assets:    
Paid in capital $ 62,968,363
Total distributable earnings/(loss)   10,751,454
Net Assets $ 73,719,817
Shares outstanding (par value $0.01, unlimited number of shares authorized)   5,999,972
Net Asset Value, Offering Price and Redemption price per share $ 12.29


 

Statement of Operations

For the year ended December 31, 2020

 

Investment Income:      
Dividends   $ 1,542,736  
Less: Foreign tax withholding     (162,706 )
Total Investment Income     1,380,030  
Expenses:        
Investment adviser     428,918  
Administration and accounting     52,979  
Chief compliance officer     4,243  
Custodian     25,147  
Shareholder servicing     6,236  
Transfer agency     28,766  
Trustee     3,708  
Other     23,074  
Total expenses     573,071  
Net Expenses     573,071  
Net Investment Income     806,959  
Net Realized/Unrealized Gains (Losses) from Investments:        
Net realized (losses) from investment securities and foreign currency transactions     (723,614 )
Change in unrealized appreciation/depreciation on investment securities and foreign currency translations     4,982,128  
Net realized/unrealized gains (losses) on investments     4,258,514  
Change in Net Assets Resulting from Operations   $ 5,065,473  

 

See Notes to Financial Statements

 

60 

 

 

Financial Statements Boston Trust Walden International Equity Fund

 

Statements of Changes in Net Assets

 

    For the year ended     For the year ended  
    December 31, 2020     December 31, 2019  
Investment Activities:                
Operations:                
Net investment income   $ 806,959     $ 951,745  
Net realized gains/(losses) from investment securities and foreign currency transactions     (723,614 )     156,236  
Change in unrealized appreciation/depreciation on investment securities and foreign currency translations     4,982,128       7,758,251  
Change in Net Assets Resulting from Operations     5,065,473       8,866,232  
Distributions to shareholders:                
Total Distributions     (804,178 )     (929,213 )
Change in Net Assets Resulting from distributions to shareholders     (804,178 )     (929,213 )
Capital Share Transactions:                
Proceeds from shares issued     14,880,095       10,921,617  
Dividends reinvested     576,531       611,610  
Cost of shares redeemed     (2,957,779 )     (1,566,941 )
Change in Net Assets Resulting from Capital Share Transactions     12,498,847       9,966,286  
Change in Net Assets     16,760,142       17,903,305  
Net Assets:                
Beginning of period     56,959,675       39,056,370  
End of period   $ 73,719,817     $ 56,959,675  
Share Transactions:                
Issued     1,335,777       1,010,684  
Reinvested     47,925       54,029  
Redeemed     (292,056 )     (148,651 )
Change in shares     1,091,646       916,062  

 

See Notes to Financial Statements

 

61 

 

 

Financial Statements Boston Trust Walden International Equity Fund

 

Financial Highlights                                    
Selected data for a share outstanding throughout the years indicated.                    
                                          Period  
      For the year       For the year       For the year       For the year       For the nine
months
      June 9, 2015  
      ended       ended       ended       ended       ended       through  
      December       December       December       December       December       March 31,  
      31, 2020       31, 2019       31, 2018       31, 2017       31, 2016       2016(a)  
Net Asset Value, Beginning of Period   $ 11.60     $ 9.78     $ 11.07     $ 9.34     $ 9.45     $ 10.00  
Investment Activities:                                                
Operations:                                                
Net investment income     0.15       0.20       0.17       0.13       0.12       0.08  
Net realized/unrealized gains (losses) from investments     0.69       1.81       (1.29 )     1.73       (0.06 )     (0.59 )
Total from investment activities     0.84       2.01       (1.12 )     1.86       0.06       (0.51 )
Dividends:                                                
Net investment income     (0.14 )     (0.19 )     (0.17 )     (0.13 )     (0.17 )     (0.04 )
Net realized gains from investments                                    
Total dividends     (0.14 )     (0.19 )     (0.17 )     (0.13 )     (0.17 )     (0.04 )
Net Asset Value, End of Period   $ 12.29     $ 11.60     $ 9.78     $ 11.07     $ 9.34     $ 9.45  
Total Return     7.16 %     20.62 %     (10.18 )%     19.92 %     0.62 %(b)     (5.09 )%(b)
Ratios/Supplemental Data:                                                
Net assets at end of period (000’s)   $ 73,720     $ 56,960     $ 39,056     $ 41,234     $ 14,713     $ 12,786  
Ratio of net expenses to average net assets     1.00 %     1.04 %     1.15 %     1.15 %     1.15 %(c)     1.15 %(c)
Ratio of net investment income to average net assets     1.41 %     1.93 %     1.57 %     1.57 %     1.87 %(c)     1.22 %(c)
Ratio of expenses (before fee reductions or recoupment of fees previously reimbursed by the investment adviser) to average net assets (d)     1.00 %     1.02 %     1.17 %     1.31 %     1.86 %(c)     2.21 %(c)
Portfolio turnover rate     8.38 %     10.70 %     3.44 %     10.16 %     4.90 %(b)     5.11 %(b)

 

 

(a) Commencement of operations on June 9, 2015.

(b) Not annualized for periods less than one year.

(c) Annualized for periods less than one year.

(d) During the periods, certain fees were reduced. If such fee reduction had not occurred, the ratio would have been as indicated.

 

See Notes to Financial Statements

 

62 

 

 

Notes to the Financial Statements December 31, 2020

 

1. Organization:

 

The Boston Trust Walden Funds (the “Trust”) was organized on January 8, 1992 as a Massachusetts business trust and is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust contains the following funds (individually a “Fund”, collectively the “Funds”), each of which are registered as a diversified Fund under the 1940 Act:

 

Fund Short Name
Boston Trust Asset Management Fund Asset Management Fund
Boston Trust Equity Fund Equity Fund
Boston Trust Midcap Fund Midcap Fund
Boston Trust SMID Cap Fund SMID Cap Fund
Boston Trust Walden Balanced Fund (formerly Walden Balanced Fund)* BTW Balanced Fund
Boston Trust Walden Equity Fund (formerly Walden Equity Fund)* BTW Equity Fund
Boston Trust Walden Midcap Fund (formerly Walden Midcap Fund)* BTW Midcap Fund
Boston Trust Walden SMID Cap Fund (formerly Walden SMID Cap Fund)* BTW SMID Cap Fund
Boston Trust Walden Small Cap Fund BTW Small Cap Fund
Boston Trust Walden International Equity Fund (formerly Walden International Equity Fund)* BTW International Equity Fund

 

 

* The Fund changed its name effective September 30, 2020.

 

The investment objective of the Asset Management Fund and BTW Balanced Fund is to seek long-term capital growth and income through an actively managed portfolio of stocks, bonds and money market instruments. The investment objective of the Equity Fund and BTW Equity Fund is to seek long-term capital growth through an actively managed portfolio of stocks. The investment objective of the Midcap Fund and BTW Midcap Fund is to seek long-term capital growth through an actively managed portfolio of stocks of middle capitalization companies. The investment objective of the SMID Cap Fund and BTW SMID Cap Fund is to seek long-term capital growth through an actively managed portfolio of stocks of small to middle capitalization companies. The investment objective of the BTW Small Cap Fund is to seek long-term capital growth through an actively managed portfolio of stocks of small capitalization companies. The investment objective of the BTW International Equity Fund is to seek long-term capital growth through an actively managed portfolio of equities of international companies.

 

Under the Trust’s organizational documents, its officers and trustees are indemnified against certain liabilities arising out of the performance of their duties to the Trust. In addition, in the normal course of business, the Trust may enter into contracts with its vendors and others that provide for general indemnifications. Each Fund’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Funds. However, based on experience, the Funds expect risk of loss to be remote.

 

2. Significant Accounting Policies:

 

The following is a summary of significant accounting policies followed by the Funds in the preparation of their financial statements. The policies are in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results may differ from those estimates.

 

The Funds are investment companies and accordingly follow the investment company accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946, “Financial Services - Investment Companies”.

 

Security Valuation:

The Funds record their investments at fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The valuation techniques used to determine fair value are further described below.

 

The value of each equity security, including common stocks, is based either on the last sale price on a national securities exchange, or in the absence of recorded sales, at the closing bid price on such exchanges, or at the quoted bid price in the over-the-counter market. Equity securities traded on the NASDAQ stock market are valued at the NASDAQ official closing price. The prices for foreign securities are reported in local currency and converted to U.S dollars using currency exchange rates. Prices for most securities held in the Funds are provided daily by a recognized independent pricing service.

 

Bonds and other fixed income securities (other than short-term obligations but including listed issues) are provided by an independent pricing service, the use of which has been approved by the Board of Trustees (“Board”). In making such valuations, the pricing service utilizes both dealer-supplied valuations and electronic data processing techniques that take into account appropriate factors such as institutional-size trading in similar groups of securities, yield, quality, coupon rate, maturity, type of issue, and trading characteristics other than market data and without exclusive reliance upon quoted prices or exchanges or over-the-counter prices, since such valuations are believed to reflect more accurately the fair value of such securities. All debt portfolio securities with a remaining maturity of 60 days or less may be valued at amortized cost, which approximates fair value.

 

The Trust may use a pricing service to value certain portfolio securities where the prices provided are believed to reflect the fair value of such securities. If market prices are not readily available or, in the opinion of the Adviser, market prices do not reflect fair value, or if an event occurs after the close of trading on the exchange or market on which the security is principally traded (but prior to the time the NAV is calculated) that materially affects fair value, the Adviser will value the Funds’ assets at their fair value according to policies approved by the Board. The Adviser believes that foreign security values may be affected by volatility that occurs in global markets on a trading day after the close of any given foreign securities

 

63 

 

 

Notes to the Financial Statements December 31, 2020

 

markets. The fair valuation procedures, therefore, include a procedure whereby foreign security prices may be “fair valued” by an independent pricing service through the use of factors which take such volatility into account.

 

Investments in investment companies and money market funds are valued at NAV per share.

 

Fair Value Measurements:

The valuation techniques employed by the Funds, as described above in Security Valuation, maximize the use of observable inputs and minimize the use of unobservable inputs in determining fair value. The inputs used for valuing the Funds’ investments are summarized in the three broad levels listed below:

 

Level 1 — Quoted prices in active markets for identical assets

Level 2 — Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.)

Level 3 — Significant unobservable inputs (including the Funds’ own assumptions in determining the fair value of investments)

 

The inputs or methodology used to value investments are not necessarily an indication of the risk associated with investing in those investments.

 

Pursuant to the valuation techniques described above in Security Valuation, equity securities are generally categorized as Level 1 securities in the fair value hierarchy (unless there is a fair valuation event, in which case affected securities are generally categorized as Level 2 securities). Fixed income securities, including those with a remaining maturity of 60 days or less, are generally categorized as Level 2 securities in the fair value hierarchy.

 

Open-ended investment companies and money market funds are generally categorized as Level 1 securities in the fair value hierarchy.

 

Investments for which there are no quotations available, or for which quotations do not appear reliable, are valued at fair value as determined in good faith by the Adviser under the direction of the Board. These valuations are typically categorized as Level 2 or Level 3 in the fair value hierarchy.

 

The Funds did not hold any Level 3 investments during the year ended December 31, 2020

 

The following is a summary of the valuation inputs used as of December 31, 2020 in valuing the Funds’ investments based on the three levels defined above:

 

          Level 2        
    Level 1     Other Significant     Total Investments  
Fund Name   Quoted Prices     Observable Inputs     in Securities  
Asset Management Fund                        
Investment Companies   $ 5,892,835     $     $ 5,892,835  
U.S. Government & U.S. Government Agency Obligations           116,512,092       116,512,092  
Municipal Bonds1           22,873,678       22,873,678  
Common Stocks2     433,982,500             433,982,500  
Corporate Bonds2           17,739,745       17,739,745  
Total     439,875,335       157,125,515       597,000,850  
                         
Equity Fund                        
Investment Companies     947,755             947,755  
Common Stocks2     167,502,558             167,502,558  
Total     168,450,313             168,450,313  
                         
Midcap Fund                        
Investment Companies     1,487,845             1,487,845  
Common Stocks2     138,089,144             138,089,144  
Total     139,576,989             139,576,989  
                         
SMID Cap Fund                        
Investment Companies     2,752,352             2,752,352  
Common Stocks2     223,339,395             223,339,395  
Total     226,091,747             226,091,747  
                         
BTW Balanced Fund                        
Investment Companies     2,795,394             2,795,394  
U.S. Government & U.S. Government Agency Obligations           41,497,456       41,497,456  
Municipal Bonds1           4,295,232       4,295,232  
Common Stocks2     120,679,618             120,679,618  
Certificate of Deposit           203,625       203,625  
Corporate Bonds2           7,225,462       7,225,462  
Yankee Dollar           378,950       378,950  
Total     123,475,012       53,600,725       177,075,737  
                         
BTW Equity Fund                        
Investment Companies     3,267,571             3,267,571  
Common Stocks2     261,005,287             261,005,287  
Total     264,272,858             264,272,858  

 

64 

 

 

Notes to the Financial Statements           December 31, 2020

 

          Level 2        
    Level 1     Other Significant     Total Investments  
Fund Name   Quoted Prices     Observable Inputs     in Securities  
BTW Midcap Fund                        
Investment Companies   $ 844,274     $     $ 844,274  
Common Stocks2     81,941,992             81,941,992  
Total     82,786,266             82,786,266  
                         
BTW SMID Cap Fund                        
Investment Companies     878,077             878,077  
Common Stocks2     63,830,093             63,830,093  
Total     64,708,170             64,708,170  
                         
BTW Small Cap Fund                        
Investment Companies     8,548,575             8,548,575  
Common Stocks2     592,812,796             592,812,796  
Total     601,361,371             601,361,371  
                         
BTW International Equity Fund                        
Investment Companies     291,309             291,309  
Common Stocks2     6,940,190       65,260,638       72,200,828  
Total     7,231,499       65,260,638       72,492,137  

 

 

1 For detailed State classifications, see the accompanying Schedules of Portfolio Investments.

2 For detailed industry descriptions, see the accompanying Schedules of Portfolio Investments.

 

Investment Transactions and Related Income:

Investment transactions are accounted for no later than one business day after trade date. However, for financial reporting purposes, investment transactions are accounted for on trade date. Investment gains and losses are calculated on an identified cost basis. Interest income is recognized on an accrual basis and includes, where applicable, the amortization or accretion of premium or discount based on effective yield. Dividend income is recorded on the ex-dividend date except in the case of certain foreign securities, in which case dividends are recorded as soon as such information becomes available.

 

Real Estate Investment Trusts:

The Funds may own shares of real estate investment trusts (“REITs”), which report information on the source of their distribution annually. Certain distributions received from REITs during the year, which are known to be return of capital, are recorded as a reduction to the cost of the individual REIT. These cost adjustments are typically based on estimates since actual return of capital amounts are not known at the time the annual report is prepared.

 

Expenses:

Expenses directly attributable to a Fund are charged directly to that Fund. Expenses relating to the Trust are allocated proportionately to each Fund within the Trust according to the relative net assets of each Fund or on another reasonable basis.

 

Distributions to Shareholders:

Distributions to shareholders are recorded on the ex-dividend date. Dividends to shareholders from net investment income, if any, are declared and paid annually by the Funds. Dividends to shareholders from net realized gains, if any, are declared and distributed at least annually by the Funds. The amounts of distributions to shareholders from net investment income and of distributions from net realized gains are determined in accordance with federal income tax regulations, which may differ from GAAP.

 

Federal Income Taxes:

Each Fund qualifies and intends to continue to qualify as a regulated investment company by complying with the provisions available to certain investment companies, as defined in Subchapter M of the Internal Revenue Code, and to make distributions from net investment income and from net realized capital gains sufficient to relieve it from all, or substantially all, federal income and excise taxes. Therefore, no federal income tax provision is required.

 

Management has reviewed tax positions taken in tax years that remain subject to examination by all major tax jurisdictions, including U.S. Federal (i.e., the last four tax year ends and the interim tax period since then, as applicable), and believes that there is no tax liability resulting from unrecognized tax benefits related to uncertain tax positions taken as of and during the year ended December 31, 2020. The Funds recognize interest and penalties, if any, related to unrecognized tax benefits, as income tax expense in the Statements of Operations as incurred. There is no income tax noted as due for the year ended December 31, 2020.

 

Foreign Currency Transactions:

The accounting records of the Funds are maintained in U.S. dollars. Non-U.S. dollar denominated amounts are translated into U.S. dollars as follows, with the resultant exchange gains and losses recorded in the Statements of Operations:

 

i) Value of investment securities and other assets and liabilities at the exchange rate on the valuation date; and

ii) Purchases and sales of Investment securities and income and expenses at the exchange rate prevailing on the respective date of such transactions.

 

65 

 

 

Notes to the Financial Statements December 31, 2020

 

The Funds do not isolate realized and unrealized gains and losses attributable to changes in the exchange rates from gains and losses that arise from changes in the value of investments. Such fluctuations are included with net realized and unrealized gain or loss from investments.

 

Investment income from non-U.S. sources received by a Fund is generally subject to non-U.S. withholding taxes at rates ranging up to 30%. Such withholding taxes may be reduced or eliminated under the terms of applicable U.S. income tax treaties. The Funds may be subject to foreign taxes on gains in investments or currency repatriation. The Funds accrue such taxes, as applicable, based on their current interpretation of tax rules in the foreign markets in which they invest.

 

3. Related Party Transactions and Other Service Arrangements:

 

Investment Adviser:

 

The Trust, with respect to the Funds, and the Adviser are parties to an Investment Advisory Agreement under which the Adviser is entitled to receive an annual fee, computed daily and paid monthly, equal to the average daily net assets of each Fund, at the following annual percentage rates before contractual waivers:

 

Fund   Fee Rate  
Asset Management Fund     0.72 %*
Equity Fund     0.75 %
Midcap Fund     0.75 %
SMID Cap Fund     0.75 %

 

Fund   Fee Rate  
BTW Balanced Fund     0.75 %
BTW Equity Fund     0.75 %
BTW Midcap Fund     0.75 %
BTW SMID Cap Fund     0.75 %
BTW Small Cap Fund     0.75 %
BTW International Equity Fund     0.75 %

 

 

* Effective rate for year ended December 31, 2020. The Asset Management Fund has an Investment Management Agreement with the Adviser under which the Fund pays: (a) 0.75% of the first $500 million of average daily net assets; (b) 0.50% of average daily net assets in excess of $500 million.

 

Additionally, two trustees of the Trust are officers of the Adviser or its affiliate, and an officer of the Trust is an officer of the Adviser. These persons are not paid directly by the Funds.

 

Administration and Fund Accounting: 

Citi Fund Services Ohio, Inc. (“Citi”) serves the Funds as administrator. Citi provides administrative and fund accounting services for a fee that is computed daily and paid monthly, based on the aggregate daily net assets of the Trust plus certain base fees.

 

Certain officers of the Trust are affiliated with Citi. Such persons were paid no fees directly by the Funds for serving as Officers of the Trust. Citi makes an employee available to serve as the Trust’s Chief Compliance Officer (“CCO”) under a Compliance Service Agreement between the Funds and Citi (the “CCO Agreement”). Under the CCO Agreement, Citi also provides infrastructure and support in implementing the written policies and procedures comprising the Trust’s compliance program, including support services to the CCO. For the services provided under the CCO Agreement, the Funds paid Citi $150,000 for the year ended December 31, 2020, plus certain out of pocket expenses. Citi pays the salary and other compensation earned by the CCO as an employee of Citi.

 

Distribution:

Foreside Financial Services, LLC (“Foreside”), which is not affiliated with Citi or the Adviser, serves as the Funds’ distribution agent. Fees for these services are paid monthly by the Adviser and not by the Funds.

 

Shareholder Services:

The Funds may enter into shareholder services agreements with investment advisers, banks, trust companies and other types of organizations (“Authorized Service Providers”), which may include affiliates of the Funds, for providing administrative services with respect to shares of the Funds attributable to or held in the name of the Authorized Service Provider for its clients or other parties with whom they have a servicing relationship. Fees paid by the Funds under shareholder services agreements may not exceed 0.25% of the average daily net assets of each Fund and are presented separately on the Statements of Operations. Affiliates of the Funds did not receive any fees during the year ended December 31, 2020.

 

Custodian and Transfer Agency:

Boston Trust Walden Company (“Boston Trust”), the parent company of the Adviser, acts as the Funds’ transfer agent. Under the transfer agency agreement, Boston Trust receives a fixed fee of $18,000 annually per fund, accrued daily and paid monthly for its services. Under a sub-transfer agency agreement, FIS Investor Services, LLC receives a fixed annual fee accrued daily and paid monthly, plus annual per account fees and certain out of pocket expenses for its services to the Trust. Expenses incurred under the transfer agency agreement and sub-transfer agency agreement are presented collectively as “Transfer Agency” expenses on the Statements of Operations.

 

Boston Trust acts as the custodian for all Funds except the BTW International Equity Fund. Under the custody agreement, Boston Trust receives an annual asset based fee of 0.014% of the value of securities held. Citibank, N.A. receives sub-custodian fees from Boston Trust for each Fund except the BTW International Equity Fund. Under a separate custody agreement, Citibank, N.A., an affiliate of Citi, serves as custodian for the BTW International Equity Fund and receives a fee based on a percentage of assets held on behalf of the BTW International Equity Fund, transaction fees and certain out of pocket expenses for its services. Such percentages vary by the jurisdiction in which the assets are held.

 

Fee Reductions:

The Adviser has agreed to reduce its fees payable by the Funds to the extent necessary, exclusive of brokerage costs, interest, taxes, dividends, litigation, indemnification, expenses associated with the investments in underlying investment companies and extraordinary expenses (as determined under GAAP) of each Fund, except the SMID Cap Fund , to 1.00% of the average daily net assets. The Adviser has agreed to reduce its fees payable by the SMID Cap Fund to the extent necessary, subject to certain exclusions, to limit the aggregate annual operating expenses to 0.75% of its average daily net assets. Prior to December 31, 2020, the contractual expense limitation for the BTW International Equity Fund was 1.10%. Any such

  

66 

 

 

Notes to the Financial Statements December 31, 2020

 

reductions made by the Adviser in its fees or in the payment or reimbursement of expenses that are a Fund’s obligation may be subject to repayment by the Fund within three years provided the Fund receiving the reduction, payment or reimbursement is able to effect such repayment and remain in compliance with applicable expense limitations. The expense limitation agreement shall automatically renew effective May 1 of every year until the Adviser provides written notice of non-renewal to the Trust.

 

Pursuant to its agreement, the Adviser reimbursed, and has yet to recoup, fees in the following amounts for the years ended December 31, 2018 (expiring 12/31/2021), December 31, 2019 (expiring 12/31/2022) and December 31, 2020 (expiring 12/31/2023):

 

Fund     Amount     Expires  
Midcap Fund     $ 42,703       12/31/2022  
        68,764       12/31/2023  
SMID Cap Fund       168,823       12/31/2021  
                   
        170,506       12/31/2022  
        251,750       12/31/2023  

 

Fund   Amount     Expires  
BTW Balanced Fund   $ 45,249       12/31/2021  
      34,853       12/31/2022  
      33,272       12/31/2023  
                 
BTW Equity Fund     166,166       12/31/2021  
      158,316       12/31/2022  
      143,297       12/31/2023  
                 
BTW Midcap Fund     15,213       12/31/2023  
                 
BTW SMID Cap Fund     42,347       12/31/2021  
      36,311       12/31/2022  
      30,485       12/31/2023  
                 
BTW Small Cap Fund     261,419       12/31/2021  
      168,952       12/31/2022  
      247,032       12/31/2023  
                 
BTW International Equity Fund     7,070       12/31/2021  

 

During the year ended December 31, 2020, the Funds did not recoup any waivers.

 

As of December 31, 2020, the Adviser may recoup amounts from the Funds as follows:

 

Total Potential Recoupment      
Asset Management Fund   $  
Equity Fund      
Midcap Fund     111,467  
SMID Cap Fund     591,079  


 

Total Potential Recoupment      
BTW Balanced Fund   $ 113,374  
BTW Equity Fund     467,779  
BTW Midcap Fund     15,213  
BTW SMID Cap Fund     109,143  
BTW Small Cap Fund     677,403  
BTW International Equity Fund     7,070  

 

In-Kind Subscriptions and Redemptions:

During the year ended December 31, 2020, the Funds delivered securities in exchange for the redemption of shares (redemptions in-kind) as follows:

 

            Fund Shares     Realized  
Fund     Fair Value     Redeemed     Gain/(Loss)  
SMID Cap Fund     $ 4,663,238       244,533     $ 4,664  

 

During the year ended December 31, 2019, the Asset Management Fund acquired securities and other assets from a common trust fund managed by an affiliate (Boston Trust Walden Company) of the Adviser, the Boston Trust Managed Growth Fund. The subscription proceeds were accomplished through an in-kind contribution of investments and other assets. The contribution was not a taxable event under the provisions of Section 584 of the Internal Revenue Code, and therefore the historical cost basis of those investments was carried forward. The Asset Management Fund issued 808,358 shares to the holders of Boston Trust Managed Growth Fund in exchange for investments and other assets valued at $43,771,772. The value and historical cost of the contributed investments was $43,613,987and $16,186,943, respectively, which was carried forward to align the ongoing reporting of realized and unrealized gains and losses for tax purposes.

 

During the year ended December 31, 2019, the Funds delivered securities in exchange for the redemption of shares (redemptions in-kind) as follows:

 

          Fund Shares     Realized  
Fund   Fair Value     Redeemed     Gain/(Loss)  
Asset Management Fund   $ 5,777,713       118,834     $ 5,029,044  
BTW Small Cap Fund     119,901,316       8,413,292       42,132,134  

 

Interfund Lending: 

Pursuant to an Exemptive Order issued by the Securities and Exchange Commission (“SEC”), the Funds may participate in an interfund lending program (the “Program”). The Program provides an alternative credit facility under which the Funds may lend to, or borrow from, one another, consistent with each Fund’s investment objectives, limitations and organization documents. The Program provides a borrowing Fund with a source of liquidity at a rate lower than the bank borrowing rate at times when the cash position of the Fund is insufficient to meet temporary cash requirements. In addition, Funds making short-term cash loans directly to other Funds would earn interest at a rate higher than they otherwise could obtain from investing their cash in repurchase agreements or certain other short-term money market instruments. Interfund loans have a maximum duration of seven days and may be called on one business day’s notice. Any open loans at period end are presented under the caption “Payable” for interfund lending in the Statements of

 

67 

 

 

Notes to the Financial Statements December 31, 2020

 

Assets and Liabilities. As of December 31, 2020, the Funds had no outstanding loans to or from another fund under the Program. The Funds’ activity in the Program during the period for which loans were outstanding was as follows:

 

        Weighted Average loan     Days     Weighted Average     Interest Income  
Fund   Borrower or Lender   Balance     Outstanding     Annualized Interest Rate     (Expense)  
Asset Management Fund   Lender   $ 637,090       12 *     2.36 %   $ 499  
Midcap Fund   Borrower     693,960       5       1.90       (184 )
SMID Cap   Borrower     640,314       3       2.86       (152 )
BTW Midcap Fund   Borrower     592,127       2       3.32       (109 )
BTW SMID Cap Fund   Borrower     535,042       2       1.81       (54 )
* Aggregate days Fund had loan outstanding as lender for all borrowers.

 

4. Purchases and Sales of Securities:

 

Cost of purchases and proceeds from sales and maturities of securities, excluding in-kinds, short-term securities and U.S. Government securities, for the Funds for the year ended December 31, 2020, totaled:

 

          Sales and  
Fund   Purchases     Maturities  
Asset Management Fund   $ 34,531,876     $ 121,284,221  
Equity Fund     13,657,607       23,636,828  
Midcap Fund     48,371,041       60,827,024  
SMID Cap Fund     155,543,256       81,295,780  
BTW Balanced Fund     24,439,675       27,073,663  
BTW Equity Fund     34,200,576       47,513,926  
BTW Midcap Fund     36,999,210       24,905,872  
BTW SMID Cap Fund     21,289,891       22,595,726  
BTW Small Cap Fund     305,697,643       155,780,175  
BTW International Equity Fund     16,103,387       4,723,655  

 

Cost of purchases and proceeds from sales and maturities of U.S. Government Securities, excluding short-term securities, for the Funds for the year ended December 31, 2020, totaled:

 

            Sales and  
Fund     Purchases     Maturities  
Asset Management Fund     $ 29,632,168   $ 6,281,758  
BTW Balanced Fund       10,533,340       1,550,674  

 

5. Federal Income Tax Information:

 

As of the tax year ended December 31, 2020, the cost, gross unrealized appreciation and gross unrealized depreciation on investments, for federal income tax purposes, were as follows:

 

                      Net Unrealized  
          Gross Tax Unrealized     Gross Tax Unrealized     Appreciation  
Fund   Tax Cost     Appreciation     (Depreciation)     (Depreciation)  
Asset Management Fund   $ 287,980,143     $ 309,123,882     $ (103,175   $ 309,020,707  
Equity Fund     55,919,392       112,683,737       (152,816 )     112,530,921  
Midcap Fund     96,553,206       44,547,354       (1,523,571 )     43,023,783  
SMID Cap Fund     180,454,897       48,916,416       (3,279,566 )     45,636,850  
BTW Balanced Fund     106,683,302       71,140,384       (747,949 )     70,392,435  
BTW Equity Fund     108,307,285       157,317,691       (1,352,118 )     155,965,573  
BTW Midcap Fund     56,583,399       26,448,251       (245,384 )     26,202,867  
BTW SMID Cap Fund     45,190,010       20,283,704       (765,544 )     19,518,160  
BTW Small Cap Fund     453,865,749       154,783,659       (7,288,037 )     147,495,622  
BTW International Equity Fund     60,927,592       14,617,687       (3,053,142 )     11,564,545  

 

68 

 

 

Notes to the Financial Statements December 31, 2020

 

The tax character of distributions paid during the fiscal year ended December 31, 2020 was as follows:

 

      Distributions paid from                        
      Ordinary     Net Long Term       Total Taxable       Return of       Total Distributions  
Fund     Income       Gains       Distributions       Capital       Paid    
Asset Management Fund   $ 5,477,265     $ 26,917,374     $ 32,394,639     $     $ 32,394,639  
Equity Fund     1,389,771       3,332,395       4,722,166             4,722,166  
Midcap Fund     911,395       738,615       1,650,010             1,650,010  
SMID Cap Fund     1,415,731       281,448       1,697,179       46,102       1,743,281  
BTW Balanced Fund     1,502,423       3,639,885       5,142,308             5,142,308  
BTW Equity Fund     2,025,655       8,027,497       10,053,152             10,053,152  
BTW Midcap Fund     419,577       2,155,925       2,575,502             2,575,502  
BTW SMID Cap Fund     340,093       793,869       1,133,962             1,133,962  
BTW Small Cap Fund     2,825,984       7,329,749       10,155,733             10,155,733  
BTW International Equity Fund     804,177             804,177             804,177  

 

The tax character of distributions paid during the fiscal year ended December 31, 2019 was as follows:

 

      Distributions paid from                          
Fund     Ordinary
Income
      Net Long Term
Gains
      Total Taxable
Distributions
      Return of
Capital
      Total Distributions
Paid
   
Asset Management Fund   $ 5,391,202       350,942     $ 5,742,144     $     $ 5,742,144  
Equity Fund     1,281,596       160,867       1,442,463             1,442,463  
Midcap Fund     1,776,041       3,369,743       5,145,784             5,145,784  
SMID Cap Fund     1,290,766       1,944,006       3,234,772             3,234,772  
BTW Balanced Fund     1,608,080       906,163       2,514,243             2,514,243  
BTW Equity Fund     2,122,863       5,237,707       7,360,570             7,360,570  
BTW Midcap Fund     559,523       3,373,441       3,932,964             3,932,964  
BTW SMID Cap Fund     462,200       2,606,462       3,068,662             3,068,662  
BTW Small Cap Fund     1,133,540       14,436,243       15,569,783             15,569,783  
BTW International Equity Fund     929,213             929,213             929,213  

 

As of December 31, 2020, the components of distributable earnings (deficit) on a tax basis were as follows: 

Fund      
  Undistributed
Ordinary Income
Undistributed
Long-Term
Capital Gains
Accumulated
Earnings
  Accumulated
Capital and

Other Losses1
Unrealized
Appreciation/

(Depreciation)
Total
Distributable
Earnings
(Deficit)
 
Asset Management Fund $ 20,468 $        3,620,901 $        3,641,369 $    $     309,020,707 $     312,662,076  
Equity Fund   1,828,166 1,828,166      112,530,921 114,359,087  
Midcap Fund   686,065 686,065   —   43,023,783 43,709,848  
SMID Cap Fund     (219,383)  45,636,850 45,417,467  
BTW Balanced Fund   37,116 1,004,731 1,041,847   —   70,392,435 71,434,282  
BTW Equity Fund   3,239 1,724,988 1,728,227   —   155,965,573 157,693,800  
BTW Midcap Fund   614,943 614,943   —   26,202,867 26,817,810  
BTW SMID Cap Fund   681,553 681,553   —   19,518,160 20,199,713  
BTW Small Cap Fund   3,049,853 4,769,197 7,819,050   —   147,495,622 155,314,672  
BTW International Equity Fund   1,202 1,202   (829,667)  11,579,919 10,751,454  
1 The differences between book-basis and tax-basis unrealized appreciation (depreciation) is attributable primarily to tax deferral of losses on wash sales and return of capital distributions from REIT securities and other investments.

 

As of the end of its tax year ended December 31, 2020, the following Funds have a net capital loss carry forwards (“CLCFs”) not subject to expiration as summarized in the tables below. The Board does not intend to authorize a distribution of any realized gain for the Fund until any applicable CLCF has been offset or expires.

 

    Short-Term     Long-Term        
Fund   Amount     Amount     Total  
SMID Cap Fund   $     $ 219,383     $ 219,383  
BTW International Equity Fund           829,667       829,667  

 

69 

 

 

Notes to the Financial Statements December 31, 2020

 

As of December 31, 2020, the following reclassifications have been made on the Statements of Assets and Liabilities to increase (decrease) such accounts with offsetting adjustments as indicated:

 

    Total Distributable        
Fund   Earnings     Paid in Capital  
SMID Cap Fund   $ 83,041     $ (83,041 )
BTW Midcap Fund     (34,628 )     34,628  
BTW SMID Cap Fund     (3,828 )     3,828  
BTW Small Cap Fund     (1,271,029 )     1,271,029  

 

These “book/tax” differences are either considered temporary or permanent in nature. To the extent these differences are permanent in nature (e.g. return of capital, distribution reclass, foreign currency reclass, and equalization), such amounts are reclassified within the composition of net assets based on their federal tax-basis treatment; temporary differences (e.g. wash sales and post October losses) do not require reclassification. To the extent dividends to shareholders exceed net investment income and net realized gains for tax purposes, they are reported as return of capital.

 

6. Control Ownership and Principal Holders:

 

The beneficial ownership, either directly or indirectly, of more than 25% of the voting securities of a Fund creates presumptions of control of the Fund under section 2 (a)(9) of the 1940 Act. As of December 31, 2020, the Funds had individual shareholder accounts and/or omnibus shareholder accounts (comprised of a group of individual shareholders), owning more than 25% of the total shares outstanding of the Fund as detailed below.

 

Fund   Control Ownership   Percentage of
Ownership
Asset Management Fund   US Bank N.A.   88.82%
Equity Fund   US Bank N.A.   95.33
Midcap Fund   US Bank N.A.   45.82
SMID Fund   National Financial Services   40.97
BTW Balanced Fund   US Bank N.A.   52.58
BTW Equity Fund   US Bank N.A.   29.82
BTW Midcap Fund   US Bank N.A.   56.13
BTW SMID Fund   US Bank N.A.   50.76
BTW International Equity Fund   US Bank N.A.   75.85

 

7. Business Combination:

 

In December 2019, the Board approved Boston Trust Walden’s proposal to merge Walden Small Cap Fund (the “Target Fund”) into Boston Trust Walden Small Cap Fund (the “Acquiring Fund”). The Agreement and Plan of Reorganization was approved by shareholders on March 26, 2020. The Target Fund and the Acquiring Fund shared identical investment goals, principal investment strategies, risks, and ESG screens. They also shared the same investment adviser. The transaction was effective after the close of business on April 3, 2020. The Acquiring Fund acquired all of the assets and assumed all of the liabilities of the Target Fund as shown in the table below. The transaction was structured to qualify as a tax-free reorganization under the Code. Pursuant to the Agreement and Plan of Reorganization, shareholders of the Target Fund received a number of shares of the corresponding class in the Acquiring Fund, with a value equal to their holdings in the Target Fund as of the close of business on April 3, 2020. The investment portfolio of the Target Fund, with a fair value of $103,000,783 and identified cost of $111,464,003 as of the date of the reorganization, was the principal asset acquired by the Acquiring Fund. For financial statement purposes, assets received and shares issued by the Acquiring Fund were recorded at fair value; however, the cost basis of the investments received from the Target Fund was carried forward to align ongoing reporting of the Acquiring Fund’s realized and unrealized gains and losses with amounts distributable to shareholders for tax purposes.

 

The following is a summary of Shares Outstanding, Net Assets, NAV and Net Unrealized Appreciation (Depreciation) immediately before and after the reorganization:

 

                      Net Unrealized  
    Shares           Net Asset Value     Appreciation  
Target Fund   Outstanding     Net Assets     Per Share     (Depreciation)  
Walden Small Cap Fund     7,088,420     $ 103,030,710     $ 14.54     $ (8,463,220 )
                                 
Acquiring Fund                                
Boston Trust Walden Walden Small Cap Fund     19,128,805     $ 189,922,749     $ 9.93     $ (23,454,940 )
                                 
Post Reorganization                                
Boston Trust Walden Walden Small Cap Fund     29,505,631     $ 292,953,459     $ 9.93     $ (31,918,160 )

 

Expenses related to reorganization were incurred by the Adviser. Expenses incurred by the Funds in the ordinary course during the reorganization continue to be treated as a Fund expense in accordance with the Funds’ advisory contracts.

 

70 

 

 

Notes to the Financial Statements December 31, 2020

 

Assuming the reorganization had been completed on January 1, 2020, the beginning of the annual reporting period, the pro forma results of operations of the Acquiring Fund, post reorganization for the year ended December 31, 2020, are as follows:

 

Net Investment income (loss)   $ 3,155,490  
Net realized/unrealized gains (losses)     72,763,265  
Change in net assets resulting from operations   $ 75,918,755  

 

Because the combined investment portfolios have been managed as a single integrated portfolio since the reorganization was completed, it is not practicable to separate the amounts of revenue and earnings of the Target Fund that have been included in the Statements of Operations of the Acquiring Fund, post reorganization since April 4, 2020

 

8. Subsequent Events:

 

Management has evaluated events and transactions through the date these financial statements were issued and concluded no subsequent events required recognition or disclosure in these financial statements.

 

71 

 

 

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and Board of Trustees of

Boston Trust Walden Funds

 

Opinion on the Financial Statements

 

We have audited the accompanying statements of assets and liabilities, including the schedules of portfolio investments, of Boston Trust Walden Funds comprising the funds listed below (the “Funds”) as of December 31, 2020, the related statements of operations, the statements of changes in net assets, the related notes, and the financial highlights for the periods indicated below (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of December 31, 2020, the results of their operations, the changes in net assets and the financial highlights for the periods indicated below, in conformity with accounting principles generally accepted in the United States of America.

 

    Statement of   Statements of Changes   Financial
Fund Name   Operations   In Net Assets   Highlights

Boston Trust Asset Management Fund

Boston Trust Equity Fund

Boston Trust Midcap Fund

Boston Trust SMID Cap Fund

Boston Trust Walden Balanced Fund

(Formerly, Walden Balanced Fund)

Boston Trust Walden Equity Fund (For merly, Walden Equity Fund)

Boston Trust Walden Midcap Fund (For merly, Walden Midcap Fund)

Boston Trust Walden SMID Cap Fund

(Formerly, Walden SMID Cap Fund)

Boston Trust Walden Small Cap Fund

  For the year ended December 31, 2020   For the two years ended December 31, 2020 and 2019    For the years ended December 31, 2020, 2019, 2018 and 2017, for the period ended December 31, 2016 and for the year ended March 31, 2016
Boston Trust Walden International Equity Fund (Formerly, Walden International Equity Fund)   For the year ended December 31, 2020   For the two years ended December 31, 2020 and 2019   For the years ended December 31, 2020, 2019, 2018 and 2017, for the period ended December 31, 2016 and for the period June 9, 2015 (commencement of operations) through March 31, 2016

 

Basis for Opinion

 

These financial statements are the responsibility of the Funds’ management. Our responsibility is to express an opinion on the Funds’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement whether due to error or fraud.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of December 31, 2020, by correspondence with the custodian and brokers; when replies were not received from brokers, we performed other auditing procedures. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.

 

72 

 

Report of Independent Registered Public Accounting Firm

 

We believe that our audits provide a reasonable basis for our opinion.

 

We have served as the Funds’ auditor since 2008.

 

 

 

COHEN & COMPANY, LTD.

Cleveland, Ohio 

February 26, 2021

 

73 

 

 

Supplementary Information (Unaudited) December 31, 2020

 

Federal Income Tax Information:

 

During the fiscal year ended December 31, 2020, the Funds declared long-term realized gain distributions in the following amounts:

 

Fund   Long-Term Capital Gain Distributions
Asset Management Fund   $ 26,917,374
Equity Fund     3,332,395
Midcap Fund     738,615
SMID Cap Fund     281,448
BTW Balanced Fund     3,639,885
BTW Equity Fund     8,027,497
BTW Midcap Fund     2,155,925
BTW SMID Cap Fund     793,869
BTW Small Cap Fund     7,329,749

 

During the fiscal year ended December 31, 2020, the Funds declared short-term realized gain distributions in the following amounts:

 

Fund   Short-Term Capital Gains Distributions
Asset Management Fund   $ 12,876
Midcap Fund     153,282
BTW Balanced Fund     162,256
BTW Equity Fund     134,292
BTW Midcap Fund     52,617
BTW SMID Cap Fund     4,002
BTW Small Cap Fund     344,160

 

For the fiscal year ended December 31, 2020, the following percentage of the total ordinary income distributions paid by the Funds qualify for the distributions received deduction available to corporate shareholders.

 

Fund   Distribution Received Deduction
Asset Management Fund   100.00%
Equity Fund   100.00
Midcap Fund   96.43
SMID Cap Fund   100.00
BTW Balanced Fund   100.00
BTW Equity Fund   100.00
BTW Midcap Fund   100.00
BTW SMID Cap Fund   100.00
BTW Small Cap Fund   100.00

 

For the fiscal year ended December 31, 2020, distributions paid by the Funds may be subject to a maximum tax rate of 15%, as provided for by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The Funds intend to designate the maximum amount allowable as taxed at a maximum rate of 15%. Complete information will be reported in conjunction with your 2019 Form 1099-DIV.

 

Fund   Qualified Dividend Income
Asset Management Fund   100.00 %
Equity Fund   100.00
Midcap Fund   97.02
SMID Cap Fund   100.00
BTW Balanced Fund   100.00
BTW Equity Fund   100.00
BTW Midcap Fund   100.00
BTW SMID Cap Fund   100.00
BTW Small Cap Fund   100.00
BTW International Equity Fund   100.00

 

During the year ended December 31, 2020, the following Funds designated the maximum amount allowable as interest-related dividends for certain non-U.S. resident investors:

 

Fund   Qualified Interest Income
Asset Management Fund   29.57%
Equity Fund   0.07
BTW Balanced Fund   34.10

 

74 

 

 

Supplementary Information (Unaudited) December 31, 2020

 

Federal Income Tax Information: (cont.)

 

The following Funds intend to elect to pass through to shareholders the income tax credit for taxes paid to foreign countries. Foreign source income and foreign tax expense per outstanding share on December 31, 2020 are as follows:

 

Fund   Foreign Source
Income Per Share
    Foreign Tax Expense
Per Share
 
BTW International Equity Fund     0.26       0.03  

 

The pass-through of this foreign tax credit will only affect those persons who are shareholders on the dividend record date in December 2020. These shareholders will receive more detailed information along with their 2020 Form 1099-DIV.

 

Continued

 

75 

 

 

Supplementary Information (Unaudited) December 31, 2020

 

Table of Shareholder Expenses:

 

As a shareholder of the Trust, you incur ongoing costs, including management fees, and other Fund expenses. These examples are intended to help you understand your ongoing costs (in dollars) of investing in the Boston Trust Walden Funds and to compare these costs with the ongoing costs of investing in other mutual funds.

 

These examples are based on an investment of $1,000 invested at the beginning of the period and held for the entire period from July 1, 2020 through December 31, 2020.

 

Actual Expenses

The table below provides information about actual account values and actual expenses. You may use the information below together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the table under the heading entitled “Expenses Paid During Period” to estimate the expenses you paid on your account during this period.

 

Please note that the expenses shown in the tables are meant to highlight your ongoing costs only and do not reflect the costs incurred by the Funds for buying and selling securities. The Funds do not charge transaction fees, such as redemption fees, nor do the Funds charge a sales charge (load). Therefore, the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds.

 

        Annualized
  Beginning Ending Expenses Paid Expense Ratio
  Account Value Account Value During Period During Period
  7/1/20 12/31/20 7/1/20 - 12/31/20* 7/1/20 - 12/31/20
Asset Management Fund $1,000.00 $1,154.00 $4.66 0.86%
Equity Fund 1,000.00 1,237.50 4.95 0.88
Midcap Fund 1,000.00 1,222.60 5.59 1.00
SMID Cap Fund 1,000.00 1,233.50 4.21 0.75
BTW Balanced Fund 1,000.00 1,145.00 5.39 1.00
BTW Equity Fund 1,000.00 1,230.90 5.61 1.00
BTW Midcap Fund 1,000.00 1,220.70 5.58 1.00
BTW SMID Cap Fund 1,000.00 1,230.60 5.61 1.00
BTW Small Cap Fund 1,000.00 1,274.60 5.72 1.00
BTW International Equity Fund 1,000.00 1,170.50 5.40 0.99

 

 

* Expenses are equal to the average account value multiplied by the Fund’s annualized expense ratio multiplied by 184/365 (the number of days in the most recent fiscal half-year divided by the number of days in the fiscal year).

 

Hypothetical Example for Comparison Purposes

The table below provides information about hypothetical account values and hypothetical expenses based on each Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Fund’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of other funds.

 

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect the costs incurred by the Funds for buying and selling securities. The Funds do not charge transaction fees, such as redemption fees, nor do the Funds charge a sales charge (load). Therefore, the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds.

 

        Annualized
  Beginning Ending Expenses Paid Expense Ratio
  Account Value Account Value During Period During Period
  7/1/20 12/31/20 7/1/20 - 12/31/20* 7/1/20 - 12/31/20
Asset Management Fund $1,000.00 $1,020.81 $4.37 0.86%
Equity Fund 1,000.00 1,020.71 4.47 0.88
Midcap Fund 1,000.00 1,020.11 5.08 1.00
SMID Cap Fund 1,000.00 1,021.37 3.81 0.75
BTW Balanced Fund 1,000.00 1,020.11 5.08 1.00
BTW Equity Fund 1,000.00 1,020.11 5.08 1.00
BTW Midcap Fund 1,000.00 1,020.11 5.08 1.00
BTW SMID Cap Fund 1,000.00 1,020.11 5.08 1.00
BTW Small Cap Fund 1,000.00 1,020.11 5.08 1.00
BTW International Equity Fund 1,000.00 1,020.16 5.03 0.99

 

 

* Expenses are equal to the average account value multiplied by the Fund’s annualized expense ratio multiplied by 184/365 (the number of days in the most recent fiscal half-year divided by the number of days in the fiscal year).

 

Continued

 

76 

 

 

Supplementary Information (Unaudited) December 31, 2020

 

Tabular Summary of Schedules of Portfolio Investments:

 

The Boston Trust Walden Funds invested, as a percentage of total net assets, in the following industries and countries as of December 31, 2020.

 

Asset Management Fund

 

    Percentage of
Security Allocation for the Schedule of Portfolio Investments   Total Net Assets
Information Technology   22.6 %
U.S. Government & U.S. Government Agency Obligations   19.5
Financials   10.5
Health Care   10.1
Industrials   8.4
Communication Services   7.8
Consumer Staples   6.7
Consumer Discretionary   6.1
Municipal Bonds   3.8
Materials   1.4
Energy   1.2
Investment Companies   1.0
Utilities   0.9
Other net assets   0.0
Total   100.0%
     
Equity Fund    

 

    Percentage of
Security Allocation for the Schedule of Portfolio Investments   Total Net Assets
Information Technology   28.0 %
Industrials   13.6
Health Care   12.5
Financials   12.3
Communication Services   10.8
Consumer Staples   9.1
Consumer Discretionary   7.5
Materials   2.5
Energy   1.8
Utilities   1.3
Investment Companies   0.6
Other net assets   0.0
Total   100.0%
     
Midcap Fund    

 

    Percentage of
Security Allocation for the Schedule of Portfolio Investments   Total Net Assets
Information Technology   20.4 %
Industrials   14.8
Health Care   13.6
Financials   12.0
Consumer Discretionary   10.7
Real Estate   6.2
Utilities   6.2
Materials   5.9
Consumer Staples   5.1
Communication Services   2.8
Investment Companies   1.1
Energy   1.1
Other net assets   0.1
Total   100.0%

 

SMID Cap Fund

 

    Percentage of
Security Allocation for the Schedule of Portfolio Investments   Total Net Assets
Health Care   18.3 %
Information Technology   17.3
Financials   13.8
Industrials   13.3
Consumer Discretionary   9.8
Real Estate   6.6
Materials   6.2
Utilities   4.6
Consumer Staples   4.4
Communication Services   2.8
Energy   1.7
Investment Companies   1.2
Other net assets   0.0
Total   100.0%

 

Continued

 

77 

 

 

Supplementary Information (Unaudited) December 31, 2020

 

Tabular Summary of Schedules of Portfolio Investments: (cont.)

 

BTW Balanced Fund

 

    Percentage of
Security Allocation for the Schedule of Portfolio Investments   Total Net Assets
U.S. Government & U.S. Government Agency Obligations   23.4 %
Information Technology   19.1
Health Care   11.3
Financials   8.9
Industrials   8.2
Communication Services   7.6
Consumer Discretionary   6.9
Consumer Staples   5.3
Municipal Bonds   2.4
Materials   2.2
Utilities   1.7
Investment Companies   1.6
Energy   1.1
Certificate of Deposit   0.1
Other net assets   0.2
Total   100.0%

 

BTW Equity Fund    
    Percentage of
Security Allocation for the Schedule of Portfolio Investments   Total Net Assets
Information Technology   25.9 %
Health Care   16.1
Financials   12.0
Industrials   11.1
Communication Services   10.7
Consumer Discretionary   8.4
Consumer Staples   8.1
Materials   3.0
Utilities   2.2
Energy   1.2
Investment Companies   1.2
Other net assets   0.1
Total   100.0%
     
BTW Midcap Fund    

 

    Percentage of
Security Allocation for the Schedule of Portfolio Investments   Total Net Assets
Information Technology   19.7 %
Industrials   15.4
Health Care   13.0
Financials   12.4
Consumer Discretionary   9.8
Utilities   7.0
Materials   6.3
Real Estate   6.0
Consumer Staples   5.3
Communication Services   2.8
Energy   1.1
Investment Companies   1.0
Other net assets   0.2
Total   100.0%

 

BTW SMID Cap Fund

 

    Percentage of
Security Allocation for the Schedule of Portfolio Investments   Total Net Assets
Information Technology   17.8 %
Health Care   16.5
Industrials   13.9
Financials   13.9
Consumer Discretionary   10.2
Real Estate   6.5
Materials   5.9
Utilities   4.5
Consumer Staples   4.4
Communication Services   3.3
Energy   1.7
Investment Companies   1.4
Other net assets   0.0
Total   100.0%
     
BTW Small Cap Fund    

 

    Percentage of
Security Allocation for the Schedule of Portfolio Investments   Total Net Assets
Health Care   22.5 %
Industrials   16.9
Information Technology   16.2
Financials   14.3
Consumer Discretionary   10.9
Real Estate   4.9
Utilities   4.8
Materials   3.8
Consumer Staples   2.6
Energy   1.4
Investment Companies   1.4
Other net assets   0.3
Total   100.0%
     
BTW International Equity Fund    

 

    Percentage of
Security Allocation for the Schedule of Portfolio Investments   Total Net Assets
Japan   22.9 %
United Kingdom   12.2
France   9.9
Switzerland   8.8
Canada   8.8
Germany   8.4
Australia   5.4
Hong Kong   3.2
Netherlands   3.1
Sweden   2.9
Denmark   2.4
Spain   2.2
Israel   1.6
Singapore   1.3
Italy   1.3
Finland   0.8
Luxembourg   0.7
Ireland   0.7
Norway   0.7
Belgium   0.6
United States   0.4
Other net assets   1.7
Total   100.0%

 

Continued

 

78 

 

 

Supplementary Information (Unaudited) December 31, 2020

 

Other Information:

A description of the policies and guidelines that the Funds use to determine how to vote proxies related to portfolio securities is available: (i) without charge, upon request, by calling 1-800-282-8782 ext. 7050, and (ii) on the Securities and Exchange Commission’s (the “Commission”) website at http:// www.sec.gov.

 

Proxy voting policies and guidelines as well as information regarding how the Funds voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available (i) without charge, upon request, by calling 1-800-282-8782 ext. 7050, (ii) online at https://www. bostontrustwalden.com/investment-services/mutual-funds/; and (iii) on the Commission’s website at http://www.sec.gov.

 

The Funds file their portfolio holdings information for each month in a fiscal quarter within 60 days after the end of the relevant fiscal quarter with the SEC on Form N-PORT. Portfolio holdings information for the third month of each fiscal quarter is available on the SEC’s website at http://www.sec.gov. The Funds’ Schedules of Portfolio Investments will be available no later than 60 days after each period end, without charge, online at https://www. bostontrustwalden.com/investment-services/mutual-funds/.

 

Continued

 

79 

 

 

Investment Adviser Contract Approval (Unaudited) December 31, 2020

 

The annual consideration by the Board of Trustees (the “Board”) of the continuation of the investment advisory agreement between Boston Trust Walden Inc., (the “Adviser”) and Boston Trust Asset Management Fund, Boston Trust Equity Fund, Boston Trust Midcap Fund, Boston Trust SMID Cap Fund, Boston Trust Walden Small Cap Fund, Boston Trust Walden Balanced Fund, Boston Trust Walden Equity Fund, Boston Trust Walden Midcap Fund, Boston Trust Walden SMID Cap Fund, and Boston Trust Walden International Equity Fund (the “Funds”).

 

Section 15 of the Investment Company Act of 1940 (the “1940 Act”) requires that the Investment Advisory Agreement with Boston Trust Walden Inc. (the “Adviser”) be renewed annually by the Board of Trustees of Boston Trust Walden Funds (the “Trust”), including a majority of the Board who are not “interested persons” of the Trust or of the Adviser. It is the duty of the Board to request as much information as is reasonably necessary to evaluate the terms of the Investment Advisory Agreement and determine whether its continuance is fair to the Funds and their shareholders. The Board considered the continuation of the Investment Advisory Agreement at an in-person meeting held on August 18, 2020. The Board requested, and the Adviser provided, information and data relating to: (i) the investment performance of each series of the Trust (the “Funds”) and the Adviser; (ii) the nature, extent and quality of the services provided by the Adviser to the Funds; (iii) the cost of the services to be provided and the profits to be realized by the Adviser and its affiliates from the relationship with the Funds; (iv) the extent to which economies of scale will be realized as the Funds grow; (v) whether the fee levels reflect these economies of scale to the benefit of Funds’ shareholders; (vi) the advisory fees paid by other comparable funds advised by the Adviser or by a different investment adviser; (vii) the Funds’ expense ratios and the expense ratios of similar funds; and (viii) the effect of any fee waivers and expense reimbursements made by the Adviser.

 

At the meeting on August 18, 2020, the Board engaged in a thorough review process to determine whether to continue the Investment Advisory Agreement. The Board met directly with representatives of the Adviser and reviewed the information and data listed above, as supplemented by Citi Fund Services Ohio, Inc., the Trust’s administrator. As part of its deliberations, the Board also considered and relied upon the information about the Funds and the Adviser that it had received throughout the year as part of its ongoing oversight of the Funds and their operations.

 

The Board carefully considered the nature, extent and quality of the services provided by the Adviser. The Board discussed the organizational structure of Adviser and its investment philosophy, portfolio construction process and fixed income approach. The Board discussed the Adviser’s approach to sustainable, responsible and impact investing, including its environmental, social and governance research framework and its portfolio screening guidelines. The Board reviewed the Adviser’s experience and the capabilities of its personnel, as well as the quality of the reports and other materials received from the Adviser. The Board reviewed biographical information about the employees of the Adviser and its parent, Boston Trust Walden Company (“Boston Trust”). The Board addressed the Adviser’s brokerage allocation and execution strategy, noting that the Adviser does not take into consideration sales of Fund shares in selecting brokers through which its affects Fund portfolio transactions. The Board also discussed the Adviser’s compliance program, business continuity and disaster recovery plans, succession planning and employee ownership. Considering the personnel involved in servicing the Funds, as well as the materials and services described above, the Board expressed satisfaction with the quality of the services received from the Adviser.

 

Next, the Board reviewed the performance of the Funds from inception through June 30, 2020, comparing the performance to various indices and, in the case of the Boston Trust Asset Management Fund and the Walden Balanced Fund, to a bond index, equity index and Treasury bills. The Board noted that as of June 30, 2020, while each Fund outperformed the index and its peer group at various times for the Year-to-Date, 1-year, 3-year, 5-year and Since Inception periods, each Fund generally performed in line with its peer group during the same periods. The Board noted that while the Funds underperformed their benchmarks at various times, performance was consistent with the long-term performance pattern of each Fund’s investment style, as they participated in rising markets and outperformed in falling markets. The Board noted that this downside protection is consistent with the Adviser’s strategy and is routinely communicated to clients and investors. The Board also noted that during a rising market lasting over a decade, the Funds have consistently adhered to a lower risk, higher quality strategy.

 

The Board noted that the advisory fees for each Fund are within the range of their peer groups. The Board noted that the Adviser has been operating under an Expense Limitation Agreement that requires the Adviser to waive fees and/or reimburse expenses to the extent total operating expenses exceed 0.75% for the Boston Trust SMID Cap Fund, 1.10% for the Walden International Equity Fund and 1.00% for all the other Funds.

 

Turning to total operating expenses, the Board discussed the components of the Funds’ expense ratios and the services and value shareholders receive in exchange for the fees paid and expense borne by the Funds. The Board noted that the expense ratios for all the Funds were within the range of total operating expenses of the funds in the peer groups. After considering the comparative data as described above, and the Expense Limitation Agreement that was previously renewed by the Board at its February 26, 2020 meeting, the Board concluded that the advisory fees and expense ratios were reasonable.

 

In reviewing the costs of the services to be provided and the profits to be realized by the Adviser, the Board reviewed the Adviser’s income statement for the 12-months ended December 31, 2019 and the six-months ended June 30, 2020, as well as the gross and net profit

 

80 

 

 

Investment Adviser Contract Approval (Unaudited) December 31, 2020

 

margins realized on each Fund. The Board noted that the Adviser is a wholly-owned subsidiary of Boston Trust and the payment of direct and indirect Trust expenses is governed by an Intercompany Services Agreement between the Adviser and Boston Trust. The Board noted that the Adviser’s relationship with the Funds was profitable even though the Adviser is operating under an Expense Limitation Agreement with the Trust. The Board discussed the custody and transfer agency fees earned by the Adviser for services provided to the Funds, which are reduced by amounts paid for sub-custody and sub-transfer agency services.

 

81 

 

 

Information about Trustees and Officers (Unaudited) December 31, 2020

 

Overall responsibility for management of the Funds rests with the Board of Trustees. The names of the Trustees and Officers of the Funds, their addresses, years of birth and principal occupations during the past five years are provided in the tables below. Trustees who are deemed “interested persons,” as defined in the 1940 Act, are referred to as Interested Trustees. Trustees who are not interested persons are referred to as Independent Trustees. The Funds’ Statement of Additional Information includes additional information about the Funds’ Trustees and is available, without charge and upon request, by calling 1-800-282-8782 or by visiting www.bostontrustwalden.com.

 

Name, Address,
and Year of Birth
  Position(s)
Held with
the Funds
  Term of Office*
and Length of
Time Served
  Principal Occupation(s)
During Past Five Years
  Number of Funds
in Fund Complex
Overseen by
Trustee***
  Other
Directorships
Held by Trustee
during the past
five years
INTERESTED TRUSTEES**                
                     
Lucia B. Santini
One Beacon Street
Boston, MA 02108
Year of Birth: 1958
  Trustee and President   Since 2011   President, Boston Trust Walden Inc., January 2017 to present, Managing Director, February, 2001 to  December 31, 2016; Managing Director and Senior Portfolio Manager, Boston Trust Walden Company (bank trust company), November 1993 to present.   10   None
Heidi Soumerai
One Beacon Street
Boston, MA 02108
Year of Birth: 1957
  Trustee   Since 2013   Managing Director and Director of ESG Research, Boston Trust Walden Company, August 2004 to present; Research Analyst, Boston Trust Walden Company, January 1985 to present.   10   None
                     
INDEPENDENT TRUSTEES                
Diane E. Armstrong
One Beacon Street
Boston, MA 02108
Year of Birth: 1964
  Trustee   Since 2005   Advisor, Investment Partners (financial planning firm), January 2018 to present; President, Armstrong Financial Services (financial planning firm), November 2012 to present.   10   None
                     
Elizabeth E. McGeveran
One Beacon Street
Boston, MA 02108
Year of Birth: 1971
  Trustee   Since 2016   Head of Investments, The McKnight Foundation, September 2014 to present.   10   None
                     
Michael M. Van Buskirk
One Beacon Street
Boston, MA 02108
Year of Birth: 1947
  Trustee and Chairman of the Board   Since 1992; Chairman Since 2006   Retired since 2014.   10   Advisers Investment Trust (2011 to present) (Chairman of the Board)
                 
OFFICERS WHO ARE NOT TRUSTEES              
Jennifer Ellis
One Beacon Street
Boston, MA 02108
Year of Birth: 1972
  Treasurer   Since 2011   Director of Finance/Treasurer, Boston Trust Walden Company, May 2011 to present.   N/A   N/A
                     
Curtis Barnes
4400 Easton Commons
Suite 200
Columbus, OH 43219
Year of Birth: 1953
  Secretary   Since 2007   Senior Vice President, Citi Fund Services Ohio, Inc. (fund administrator), August 2007 to present.   N/A   N/A
                     
Amy E. Siefer
4400 Easton Commons
Suite 200
Columbus, OH 43219
Year of Birth: 1977
  Chief Compliance Officer and AML Officer   Since 2018   Vice President, Citi Fund Services Ohio, Inc. (fund administrator), May 2012 to present.   N/A   N/A

 

 

* Trustees and officers hold their position until resignation or removal.

 

** Ms. Santini and Ms. Soumerai are considered “interested persons” of the Trust as defined in the 1940 Act due to their employment with Boston Trust Walden Inc., the Funds’ investment adviser.

 

82 

 

Investment Adviser

Boston Trust Walden Inc.

One Beacon Street

Boston, MA 02108

 

Transfer Agent

Boston Trust Walden Company

One Beacon Street

Boston, MA 02108

 

Administrator

Citi Fund Services Ohio, Inc.

4400 Easton Commons, Suite 200

Columbus, OH 43219

 

Distributor

Foreside Financial Services, LLC

Three Canal Plaza, Suite 100

Portland, ME 04101

 

Independent Registered Public Accounting Firm

Cohen & Company, Ltd.

1350 Euclid Avenue, Suite 800

Cleveland, OH 44115

 

Legal Counsel

Thompson Hine LLP

41 South High Street, Suite 1700

Columbus, OH 43215

 

This report is intended for the shareholders of the Funds and may not be used as sales literature unless preceded or accompanied by a current prospectus.

 

Past performance results shown should not be considered a representation of future performance.

Share price and returns will fluctuate so that shares, when redeemed, may be worth more or less than their original cost.

Statements and other information herein are dated and subject to change.

 

02/21

 

 

 

Item 2. Code of Ethics.

 

(a) The registrant has adopted a code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. This code of ethics is included as an Exhibit.

 

(b) During the period covered by the report, with respect to the registrant's code of ethics that applies to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions; there have been no amendments to, nor any waivers granted from, a provision that relates to any element of the code of ethics definition enumerated in paragraph (b) of this Item 2.

 

Item 3. Audit Committee Financial Expert.

 

3(a)(1) The registrant’s board of directors has determined that the registrant has at least one audit committee financial expert serving on its audit committee.

 

3(a)(2) The audit committee financial expert is Diane Armstrong, who is “independent” for purposes of this Item 3 of Form N-CSR.

 

Item 4. Principal Accountant Fees and Services.

 

      December 2020     December 2019  
(a) Audit Fees   $ 101,100     $ 114,500  
                   
(b) Audit-Related Fees   $ 17,220     $ 17,250  

 

The fees for 2019 and 2020 relate to the consent issuance in three Form 17f-2 filings filed with the Securities and Exchange Commission (“SEC”).

 

      December 2020     December 2019  
(c) Tax Fees   $ 33,000     $ 27,500  

 

Tax fees for both 2019 and 2020 relate to the preparation of the Funds’ federal and state income tax returns, federal excise tax return review and review of capital gain and income distribution calculations.

 

  December 2020     December 2019  
(d) All Other Fees   $ 0     $ 0  

 

 

 

 

(e)(1) The Audit Committee may pre-approve at any regularly scheduled Audit Committee meeting audit, audit-related, tax and other non-audit services to be rendered or that may be rendered by the Auditor to the Funds and certain non-audit services to be rendered by the Auditor to the Advisor which require pre-approval by the Audit Committee. In connection with such pre-approvals, the Auditor, or a Fund officer, with the assistance of the Auditor, shall provide the Audit Committee with a report containing information about each type of service to be pre-approved at the meeting.

 

(e)(2) For the fiscal years ended December 31, 2020 and 2019, 100% of all the fees in paragraph (b) through (d) were approved by the Audit Committee.

 

(f) Not applicable.

 

(g) For the fiscal year ended December 31, 2020, Cohen Fund Audit Services, Ltd. billed non-audit fees of $50,220. For the fiscal year ended December 31, 2019, Cohen Fund Audit Services, Ltd. billed non-audit fees of $44,750.

 

(h) Not applicable.

 

Item 5. Audit Committee of Listed Registrants.

 

Not applicable.

 

Item 6. Investments.

 

(a) Included as part of the report to shareholders filed under Item 1.

 

(b) Not applicable.

 

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

 

Not applicable.

 

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

 

Not applicable

 

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

 

Not applicable.

 

Item 10. Submission of Matters to a Vote of Security Holders.

 

Not applicable.

 

Item 11. Controls and Procedures.

 

(a)The registrant’s principal executive officer and principal financial officer have concluded, based on their evaluation of the registrant's disclosure controls and procedures as conducted within 90 days of the filing date of this report, that these disclosure controls and procedures are adequately designed and are operating effectively to ensure that information required to be disclosed by the registrant on Form N-CSR is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms.

 

(b)There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Act (17 CFR 270.30a-3(d)) that occurred during the period covered by this report that have materially affected or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

 

Not applicable.

 

Item 13. Exhibits.

 

(a)(1) The code of ethics that is the subject of the disclosure required by Item 2 is attached hereto.

 

(a)(2) Certifications pursuant to Rule 30a-2(a) are attached hereto.

 

 

 

 

(a)(3) Not applicable.

 

(b) Certifications pursuant to Rule 30a-2(b) are furnished herewith.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant) Boston Trust Walden Funds  

 

By (Signature and Title)* /s/ Lucia Santini, President  

 

Date March 8, 2021  

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By (Signature and Title)* /s/ Lucia Santini, President  

 

Date March 8, 2021  

 

By (Signature and Title)* /s/ Jennifer Ellis, Treasurer  

 

Date March 8, 2021  

 

 

Exhibit 99.CODEETH

  

BOSTON TRUST WALDEN FUNDS

 

CODE OF ETHICS FOR PRINCIPAL EXECUTIVE AND

PRINCIPAL FINANCIAL OFFICERS

 

I. Covered Officers/Purpose of the Code

 

The Boston Trust Walden Funds’ (the “Trust” or the “Funds”) code of ethics (this “Code”) applies to the Trust’s Principal Executive Officer (“President”) and Principal Financial Officer (“Treasurer”) (the “Covered Officers” each of whom are set forth in Exhibit A) for the purpose of promoting:

 

honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

 

full, fair, accurate, timely and understandable disclosure in reports and documents that a registrant files with, or submits to, the Securities and Exchange Commission (“SEC”) and in other public communications made by the Trust;

 

compliance with applicable laws and governmental rules and regulations;

 

the prompt internal reporting of violations of the Code to an appropriate person or persons identified in the Code; and

 

accountability for adherence to the Code.

 

Each Covered Officer should adhere to a high standard of business ethics and should be sensitive to situations that may give rise to actual as well as apparent conflicts of interest.1

 

 

1Item 2 of Form N-CSR requires a registered management investment company to disclose annually whether, as of the end of the period covered by the report, it has adopted a code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these officers are employed by the registrant or a third party. If the registrant has not adopted such a code of ethics, it must explain why it has not done so. The registrant must also: (1) file with the SEC a copy of the code as an exhibit to its annual report; (2) post the text of the code on its Internet website and disclose, in its most recent report on Form N-CSR, its Internet address and the fact that it has posted the code on its Internet website; or (3) undertake in its most recent report on Form N-CSR to provide to any person without charge, upon request, a copy of the code and explain the manner in which such request may be made. Disclosure is also required of amendments to, or waivers (including implicit waivers) from, a provision of the code in the registrant’s annual report on Form N-CSR or on its website. If the registrant intends to satisfy the requirement to disclose amendments and waivers by posting such information on its website, it will be required to disclose its Internet address and this intention.

 

 

 

 

II. Covered Officers Should Handle Ethically Actual and Apparent Conflicts of Interest

 

Overview. A “conflict of interest” occurs when a Covered Officer’s private interest interferes with the interests of, or his service to, the Trust. For example, a conflict of interest would arise if a Covered Officer, or a member of his family, receives improper personal benefits as a result of his position in the Trust.

 

Certain conflicts of interest arise out of the relationships between Covered Officers and the Trust and already are subject to conflict of interest provisions in the Investment Company Act of 1940 and the Investment Advisers Act of 1940. For example, Covered Officers may not individually engage in certain transactions (such as the purchase or sale of securities or other property) with the Trust because of their status as “affiliated persons” of the Trust. The compliance policies and procedures of the Trust and the investment adviser (the “Adviser”) are designed to prevent, or identify and correct, violations of these provisions. This Code does not, and is not intended to, repeat or replace these programs and procedures, and such conflicts fall outside of the parameters of this Code.

 

Although typically not presenting an opportunity for improper personal benefit, conflicts arise from, or as a result of, the contractual relationship between the Trust and the investment adviser of which the Covered Officers are also officers or employees. As a result, this Code recognizes that the Covered Officers will, in the normal course of their duties (whether formally for the Trust or for the investment adviser, or for both), be involved in establishing policies and implementing decisions which will have different effects on the investment adviser and the Trust. The participation of the Covered Officers in such activities is inherent in the contractual relationship between the Trust and the investment adviser and is consistent with the performance by the Covered Officers of their duties as officers of the Trust. Thus, if performed in conformity with the provisions of the Investment Company Act and the Investment Advisers Act, such activities will be deemed to have been handled ethically. In addition, it is recognized by the Board of Trustees (the “Board”) that the Covered Officers may also be officers or employees of one or more other investment companies covered by this or other Codes.

 

 

Other conflicts of interest are covered by the Code, even if such conflicts of interest are not subject to provisions in the Investment Company Act. The following list provides examples of conflicts of interest under the Code, but Covered Officers should keep in mind that these examples are not exhaustive. The overarching principle is that the personal interest of a Covered Officer should not be placed improperly before the interest of the Trust.

 

*         *         *         *

 

 

 

 

Each Covered Officer must:

 

not use his personal influence or personal relationships improperly to influence investment decisions or financial reporting by the Trust whereby the Covered Officer would benefit personally to the detriment of the Trust;

 

not cause the Trust to take action, or fail to take action, for the individual personal benefit of the Covered Officer rather than for the benefit of the Trust;

 

not use material non-public knowledge of portfolio transactions made or contemplated for the Trust to trade personally or cause others to trade personally in contemplation of the market effect of such transactions;

 

There are some conflict of interest situations that may be discussed with the Funds’ Legal Counsel, if material. Examples of these include:2

 

service as a director on the board of any public or private company;

 

the receipt of any non-nominal gifts;

 

the receipt of any entertainment from any company with which the Trust has current or prospective business dealings unless such entertainment is business- related, reasonable in cost, appropriate as to time and place, and not so frequent as to raise any question of impropriety as consistent with the Funds’ Code of Ethics;

 

any ownership interest in, or any consulting or employment relationship with, any of the Trust’s service providers, other than its investment adviser, subadviser, principal underwriter, administrator or any affiliated person thereof;

 

a direct or indirect financial interest in commissions, transaction charges or spreads paid by the Trust for effecting portfolio transactions or for selling or redeeming shares other than an interest arising from the Covered Officer’s employment, such as compensation or equity ownership.

 

III. Disclosure & Compliance

 

Each Covered Officer should familiarize himself with the disclosure requirements generally applicable to the Trust;

 

each Covered Officer should not knowingly misrepresent, or cause others to misrepresent, facts about the Trust to others, whether within or outside the Trust, including to the Trust’s directors and auditors, and to governmental regulators and self-regulatory organizations;

 

each Covered Officer should, to the extent appropriate within his area of responsibility, consult with other officers and employees of the Trust and the Trust’s adviser or subadviser with the goal of promoting full, fair, accurate, timely and understandable disclosure in the reports and documents the Trust files with, or submit to, the SEC and in other public communications made by the Trust; and

 

 

2 Any activity or relationship that would present a conflict for a Covered Officer would likely also present a conflict for the Covered Officer if a member of the Covered Officer’s family engages in such an activity or has such a relationship.

 

 

 

 

it is the responsibility of each Covered Officer to promote compliance with the standards and restrictions imposed by applicable laws, rules and regulations.

 

IV. Reporting and Accountability

 

Each Covered Officer must:

 

upon adoption of the Code (or thereafter as applicable, upon becoming a Covered Officer), affirm in writing to the Board that he has received, read, and understands the Code (Exhibit B – Initial Certification);

 

annually thereafter affirm to the Board that he has complied with the requirements of the Code (Exhibit C – Annual Certification);

 

not retaliate against any employee or Covered Officer or their affiliated persons for reports of potential violations that are made in good faith;

 

notify the Funds’ Legal Counsel promptly if he knows of any violation of this Code. Failure to do so is itself a violation of this Code; and

 

report at least annually any change in his affiliations from the prior year.

 

The Funds’ Legal Counsel is responsible for applying this Code to specific situations in which questions are presented under it and has the authority to interpret this Code in any particular situation. However, any approvals or waivers3 sought by the Principal Executive Officer will be considered by the Audit Committee (the “Committee”).

 

The Trust will follow these procedures in investigating and enforcing this Code:

 

the Funds’ Legal Counsel will take all appropriate action to investigate any potential violations reported to him;

 

if, after such investigation, the Funds’ Legal Counsel believes that no violation has occurred, the Funds’ Legal Counsel is not required to take any further action;

 

any matter that the Funds’ Legal Counsel believes is a violation will be reported to the Committee;

 

if the Committee concurs that a violation has occurred, it will inform and make a recommendation to the Board, which will consider appropriate action, which may include review of, and appropriate modifications to, applicable policies and procedures; notification to appropriate personnel of the investment adviser or its board; or a recommendation to dismiss the Covered Officer;

 

 

3 Item 2 of Form N-CSR defines “waiver” as “the approval by the registrant of a material departure from a provision of the code of ethics” and “implicit waiver,” which must also be disclosed, as “the registrant’s failure to take action within a reasonable period of time regarding a material departure from a provision of the code of ethics that has been made known to an executive officer” of the registrant.

 

 

 

 

the Committee will be responsible for granting waivers, as appropriate; and

 

any changes to or waivers of this Code will, to the extent required, be disclosed as provided by SEC rules.

 

V. Other Policies and Procedures

 

This Code shall be the sole code of ethics adopted by the Funds for purposes of Section 406 of the Sarbanes- Oxley Act of 2002 and the rules and forms applicable to registered investment companies thereunder. Insofar as other policies or procedures of the Funds, the Funds’ adviser, principal underwriter, or other service providers govern or purport to govern the behavior or activities of the Covered Officers who are subject to this Code, they are superceded by this Code to the extent that they overlap or conflict with the provisions of this Code. The Funds’ and their investment adviser’s, principal underwriter’s and service providers’ codes of ethics under Rule 17j-1 under the Investment Company Act and the adviser’s more detailed policies and procedures are separate requirements applying to the Covered Officers and others, and are not part of this Code.

 

VI. Amendments

 

Any amendments to this Code, other than amendments to Exhibit A, must be approved or ratified by a majority vote of the Trust’s board, including a majority of independent directors/trustees.

 

VII. Confidentiality

 

All reports and records prepared or maintained pursuant to this Code will be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law or this Code, such matters shall not be disclosed to anyone other than the appropriate Board and its counsel, the investment adviser and the administrator.

 

VIII. Internal Use

 

The Code is intended solely for the internal use by the Funds and does not constitute an admission, by or on behalf of any Company, as to any fact, circumstance, or legal conclusion.

 

Date: May 24, 2013

Revised: March 2020

 

 

 

 

Exhibit A

 

Persons Covered by this Code of Ethics - As of June 13, 2011

 

Principal Executive Officer and President – Lucia Santini

 

Principal Financial Officer and Treasurer – Jennifer Ellis

 

 

Exhibit 99.CERT

 

CERTIFICATIONS

 

I, Jennifer Ellis, certify that:

 

1. I have reviewed this report on Form N-CSR of Boston Trust Walden Funds (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

March 8, 2021   /s/ Jennifer Ellis
Date Jennifer Ellis
  Treasurer

 

 

 

 

CERTIFICATIONS

 

I, Lucia Santini, certify that:

 

1. I have reviewed this report on Form N-CSR of Boston Trust Walden Funds (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

March 8, 2021   /s/ Lucia Santini

Date Lucia Santini
  President

 

 

Exhibit 99.906CERT

 

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350, and accompanies the report on Form N-CSR for the period ended December 31, 2020 of Boston Trust Walden Funds (the “Registrant”).

 

Each of the undersigned, being the Principal Executive Officer and Principal Financial Officer of the Registrant, hereby certifies that, to such officer’s knowledge,

 

1. the Form N-CSR fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 ( 15 U.S.C. 78m(a) or 78o(d)); and

 

2. the information contained in the Form N-CSR fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

March 8, 2021  
Date  

 

  /s/ Lucia Santini
  Lucia Santini
  President

 

  /s/ Jennifer Ellis
  Jennifer Ellis
  Treasurer

 

 

This certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of Form N-CSR or as a separate disclosure document. A signed original of this written statement required by Section 906 has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.